Rank,Term,P-value,Z-score,Combined Score,Genes,Adjusted P-value,Gene_set,AD_genes,T2D_genes,Shared_genes,N_AD,N_T2D,N_Shared
1,MHC Class II Receptor Activity (GO:0032395),4.520319294189047e-12,656.3486842105264,17145.428127522347,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,4.5655224871309374e-10,GO_Molecular_Function_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
1,Alzheimer's Disease,9.574182241674643e-13,41.118721461187214,1137.941540767428,ATP8B4;GRN;APH1B;SHARPIN;IDUA;PLCG2;TREM2;APOE;PICALM;JAZF1,8.051887265248375e-10,GWAS_Catalog_2023,ATP8B4;GRN;APH1B;SHARPIN;IDUA;PLCG2;TREM2;APOE;PICALM;JAZF1,JAZF1,JAZF1,10,1,1
1,PD-1 signaling,4.855615043984755e-11,129.28864864864866,3070.3856465882127,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,1.0002566990608596e-08,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,6,6,6
1,MHC Class II Protein Complex (GO:0042613),1.0672247637960774e-10,262.4605263157895,6026.300852065919,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,1.0672247637960773e-08,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
1,Generation Of Second Messenger Molecules R-HSA-202433,5.966687389170186e-11,124.3097713097713,2926.5309833866436,PLCG2;HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,1.1575373534990161e-08,Reactome_2022,PLCG2;HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,6,5,5
2,Generation of second messenger molecules,1.274396005202308e-10,107.71351351351352,2454.077757096895,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,1.3126278853583772e-08,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1;HLA-DQB1,6,6,6
2,Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,2.1922037295036425e-10,218.6951754385965,4863.987067526058,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,2.1264376176185333e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
2,Clathrin-Coated Endocytic Vesicle (GO:0045334),5.542058197339156e-10,49.555911680911684,1056.2091794007956,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM,2.3878645295125722e-08,GO_Cellular_Component_2023,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,7,5,5
3,MHC Protein Complex (GO:0042611),7.163593588537716e-10,163.98848684210526,3453.0791943197,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,2.3878645295125722e-08,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
2,Peptide Antigen Assembly With MHC Class II Protein Complex (GO:0002503),7.126054022753395e-11,291.6374269005848,6814.014681558056,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,2.7435307987600572e-08,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
1,MHC Class II Protein Complex Assembly (GO:0002399),7.126054022753395e-11,291.6374269005848,6814.014681558056,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,2.7435307987600572e-08,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
3,Hepatitis B,6.449301462783392e-10,682.1880341880342,14436.380706597645,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,3.031171687508194e-08,Jensen_DISEASES,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,4,4,4
1,Lymphoma,2.768257519598744e-10,1023.3333333333334,22521.14429542145,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,3.031171687508194e-08,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,4,4,4
2,Systemic lupus erythematosus,4.676579157361417e-10,50.86513157894737,1092.750069267846,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,3.031171687508194e-08,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,7,7,7
4,PD-1 Signaling R-HSA-389948,7.163593588537716e-10,163.98848684210526,3453.0791943197,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,3.474342890440792e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
3,Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,5.466603686148285e-10,174.9298245614035,3730.7622006662746,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,3.474342890440792e-08,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
4,Type 1 diabetes mellitus,1.4557087603827975e-09,30.18209523809524,614.138420588885,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,5.131373380349361e-08,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,8
5,Alopecia areata,2.0580390182095984e-09,64.56324324324325,1291.3625000115092,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,5.803670031351067e-08,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
4,Lumenal Side Of Endoplasmic Reticulum Membrane (GO:0098553),2.8151685427880507e-09,119.22846889952153,2347.3991521536886,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,7.037921356970127e-08,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
3,Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),3.0305725396592343e-10,201.86234817813767,4424.237144341388,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,7.778469518458702e-08,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
4,Immunoglobulin Production Involved In Immunoglobulin-Mediated Immune Response (GO:0002381),4.106432110238532e-10,187.43421052631578,4051.071143509398,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,7.904881812209175e-08,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
2,MHC Class II Protein Complex Binding (GO:0023026),1.8585852639624547e-09,131.16447368421052,2636.8584711999583,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,9.385855583010397e-08,GO_Molecular_Function_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
2,Type 2 Diabetes,3.1745833832778926e-10,11.369909322303531,248.6675861562995,CDKN2B;GIPR;ZC3H4;BTNL2;JADE2;CCND2;MTNR1B;KCNQ1;IGF2BP3;IGF2BP2;APOE;HLA-DQA2;HLA-DQB1;NEUROG3;JAZF1,1.334912312668354e-07,GWAS_Catalog_2023,GIPR;ZC3H4;BTNL2;APOE;HLA-DQA2;HLA-DQB1;JAZF1,CDKN2B;GIPR;ZC3H4;BTNL2;JADE2;CCND2;MTNR1B;KCNQ1;IGF2BP3;IGF2BP2;HLA-DQA2;HLA-DQB1;NEUROG3;JAZF1,GIPR;ZC3H4;BTNL2;HLA-DQA2;HLA-DQB1;JAZF1,7,14,6
5,Clathrin-Coated Endocytic Vesicle Membrane (GO:0030669),6.806957411738077e-09,52.0357454228422,978.5488752865398,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.3613914823476154e-07,GO_Cellular_Component_2023,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
6,Systemic scleroderma,5.887671657247697e-09,100.86538461538461,1911.4399113151069,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,1.3836028394532087e-07,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,5,5,5
3,Diabetes (Standard GWA),1.1808307983278416e-09,145.75292397660817,2996.2497930861537,KCNQ1;IGF2BP2;HLA-DQA2;EML2;JAZF1,3.310262337979049e-07,GWAS_Catalog_2023,HLA-DQA2;EML2;JAZF1,KCNQ1;IGF2BP2;HLA-DQA2;EML2;JAZF1,HLA-DQA2;EML2;JAZF1,3,5,3
3,Asthma,4.945864057514308e-09,104.90526315789474,2006.2831710991154,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,3.396159986159825e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
5,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),2.297470661131175e-09,124.91228070175438,2484.6872643094102,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,3.538104818142009e-07,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
7,Multiple sclerosis,1.8966468269239348e-08,21.390385917400135,380.3337513478358,HLA-DRA;BTNL2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,3.8203886085182116e-07,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,8,7
6,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),3.421746720141571e-09,114.03890160183066,2222.9733868338863,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,4.3912416241816835e-07,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
4,Costimulation by the CD28 family,9.655091471878239e-09,48.87223587223587,901.975255215332,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4.972372108017292e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
7,Immunoglobulin Mediated Immune Response (GO:0016064),4.945864057514308e-09,104.90526315789474,2006.2831710991154,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5.440450463265739e-07,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
8,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),5.887671657247697e-09,100.86538461538461,1911.4399113151069,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5.666883970100909e-07,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DRB1,5,5,5
1,Asthma,5.887671657247697e-09,100.86538461538461,1911.4399113151069,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5.946548373820174e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
5,Allograft rejection,1.4961780385948585e-08,81.92845394736842,1476.1677825652787,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,6.164253519010818e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
6,Clathrin-Coated Vesicle Membrane (GO:0030665),3.739189150058048e-08,38.36486486486486,656.1087048215264,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.231981916763414e-07,GO_Cellular_Component_2023,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
1,"Diabetes Mellitus, Non-Insulin-Dependent",3.4116998000906893e-10,8.766283524904214,191.0930612197509,CDKN1C;CDKN2B;GRN;GIPR;JADE2;CCND2;MTNR1B;KCNQ1;HLA-DRA;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,7.444328963797884e-07,DisGeNET,GRN;GIPR;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;JADE2;CCND2;MTNR1B;KCNQ1;HLA-DRA;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,16,8
2,Allograft rejection,1.7201474354166096e-08,79.44178628389155,1420.2817631362598,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
3,Graft-versus-host disease,2.8968290670549333e-08,70.83926031294452,1229.5615771136167,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
4,Type I diabetes mellitus,3.272806411264204e-08,68.97160664819944,1188.7279095659992,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.263836188442116e-07,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
6,Graft-versus-host disease,2.5560108199449247e-08,72.81067251461988,1272.8931399153726,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,8.775637148477575e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
7,Type 1 diabetes mellitus,3.272806411264204e-08,68.97160664819944,1188.7279095659992,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,9.631401724577514e-07,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
2,Rosacea,9.255898558405019e-10,154.33436532507739,3210.245840551111,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,1.0098185327219875e-06,DisGeNET,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
5,Intestinal immune network for IgA production,5.775888887602694e-08,60.936352509179926,1015.6254913443141,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1667295552957442e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,Interferon-gamma signaling pathway,5.8689953518651786e-08,35.4012474012474,589.4660739870154,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.3433478249824743e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
8,Intestinal immune network for IgA production,5.775888887602694e-08,60.936352509179926,1015.6254913443141,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.3433478249824743e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
7,ER To Golgi Transport Vesicle Membrane (GO:0012507),1.1605114265495892e-07,52.386842105263156,836.5777850502533,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.4506392831869866e-06,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
8,Coated Vesicle Membrane (GO:0030662),1.1605114265495892e-07,52.386842105263156,836.5777850502533,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.4506392831869866e-06,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
6,Autoimmune thyroid disease,9.603605500319612e-08,54.57510964912281,881.8542092262969,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.6166069258871346e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
10,MHC class II antigen presentation,8.411639128182119e-08,33.20144887155197,540.8869412974382,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.6314051217304429e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
11,Autoimmune thyroid disease,8.711386572347025e-08,55.73908174692049,906.0972871573292,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.6314051217304429e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,Transport Vesicle Membrane (GO:0030658),1.8075876552190023e-07,47.61244019138756,739.2356258202076,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.8640551508432914e-06,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
10,Endocytic Vesicle (GO:0030139),1.8640551508432914e-07,20.337448559670783,315.135707574819,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM,1.8640551508432914e-06,GO_Cellular_Component_2023,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,7,5,5
7,Viral myocarditis,1.8075876552190023e-07,47.61244019138756,739.2356258202076,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.608090759673132e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
8,Epstein-Barr virus infection,2.287793210359463e-07,19.705698005698007,301.31013224526566,CCND2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.888338928078822e-06,KEGG_2021_Human,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,6,5
9,Inflammatory bowel disease,2.712201977434652e-07,43.63377192982456,659.7572405235024,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,3.0436933302322204e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),3.6865569777283416e-08,67.19973009446694,1150.1897597778088,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,3.154054303167581e-06,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
10,Positive Regulation Of Lymphocyte Activation (GO:0051251),5.182431506013049e-08,62.39035087719298,1046.623491098466,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,3.990472259630048e-06,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
10,Human T-cell leukemia virus 1 infection,3.953328439571179e-07,18.10993186582809,267.00446472841764,CDKN2B;CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,3.992861723966891e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;CCND2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,7,5
11,COPII-coated ER To Golgi Transport Vesicle (GO:0030134),5.961602245311755e-07,36.853224610822835,528.2082899028411,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5.419638404828868e-06,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
11,Leishmaniasis,6.365513088486486e-07,36.33954678362573,518.4636113529241,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.715542670762337e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,Antigen processing and presentation,6.790743767242382e-07,35.83994232155732,509.0180415551385,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.715542670762337e-06,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,trans-Golgi Network (GO:0005802),7.528787061846144e-07,16.38900759734093,231.07454606624893,ATP8B4;GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.27398921820512e-06,GO_Cellular_Component_2023,ATP8B4;GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,7,5,5
12,Cell adhesion molecules (CAMs),3.845959671900612e-07,25.320280910832093,374.0077047902264,HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.602230770096051e-06,BioPlanet_2019,HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,5,5
5,TCR Signaling R-HSA-202403,1.709911719813988e-07,29.25847665847666,455.89545715644977,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.634457472878273e-06,Reactome_2022,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
13,Viral myocarditis,4.2347642547259884e-07,39.65510366826156,581.9294459649357,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.685568326237096e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
14,Leishmaniasis,4.5435901246271527e-07,39.06127258444619,570.465596822135,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6.685568326237096e-06,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
13,Endocytic Vesicle Membrane (GO:0030666),1.097874356433638e-06,20.989931107578165,288.02666097134517,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,8.44518735718183e-06,GO_Cellular_Component_2023,HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
6,Costimulation By CD28 Family R-HSA-388841,3.4066251274515213e-07,41.54970760233918,618.7737664421848,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.101475457875992e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
15,Antigen processing and presentation,8.202559686212266e-07,34.420013850415515,482.35000604854355,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.126484863573151e-05,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
13,Th1 and Th2 cell differentiation,1.5471774043852934e-06,30.051421657592257,402.0603238806459,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1777303678164903e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
14,Rheumatoid arthritis,1.6324975395476103e-06,29.708433014354068,395.87673792918434,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.1777303678164903e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
15,Staphylococcus aureus infection,1.8142442837640376e-06,29.045321637426902,383.9745498021045,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.2215911510677854e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
8,Hodgkin's lymphoma,7.705543808342472e-07,249.3875,3510.4172562030494,HLA-DRA;BTNL2;HLA-DRB1,1.3581020962203606e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,3,3,3
16,Hematopoietic cell lineage,2.2254023151187074e-06,27.803751399776036,361.88175164987877,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.404785211418684e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
11,Regulation Of T Cell Activation (GO:0050863),2.134924854928327e-07,45.93721144967682,705.5801422273211,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.4944473984498289e-05,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
4,Medication Use For T2D (Number Of Purchases),7.886229150139492e-08,56.953661327231124,931.5091760457739,CCND2;MTNR1B;KCNQ1;JADE2;IGF2BP2,1.5874080281218174e-05,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1;JADE2;IGF2BP2,,0,5,0
5,Glucose Levels,9.437622045908545e-08,32.52743652743653,526.1630552954034,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,1.5874080281218174e-05,GWAS_Catalog_2023,ZC3H4;JAZF1,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,ZC3H4;JAZF1,2,6,2
14,trans-Golgi Network Membrane (GO:0032588),2.338821443560366e-06,27.509695290858726,356.6869516489501,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,1.6705867454002614e-05,GO_Cellular_Component_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
17,Th17 cell differentiation,3.2660834680045093e-06,25.612745098039216,323.53812162785135,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,1.9404378251085614e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
16,Interferon signaling,1.5137657299829793e-06,19.814814814814813,265.5365529867323,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,1.9489733773530858e-05,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
3,Diabetes,2.7766098690625647e-08,7.996807661612131,139.14005532349947,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,2.0195209114315056e-05,DisGeNET,GIPR;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,13,7
18,Toxoplasmosis,4.08904965763566e-06,24.40973930152484,302.85646797003545,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,2.2944111967844538e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
9,Asthma,1.5471774043852934e-06,30.051421657592257,402.0603238806459,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,2.423911266870293e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,5,5,5
6,A Body Shape Index,1.7823026010927974e-07,12.90919759424967,200.61137724979872,IDUA;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,2.4981941458650707e-05,GWAS_Catalog_2023,IDUA;HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,7
10,Liver cirrhosis,2.0090779258666183e-06,166.23333333333332,2180.6213857197426,HLA-DRA;BTNL2;HLA-DRB1,2.8327998754719317e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,3,3,3
5,Autoimmune Primary Adrenal Insufficiency,7.886229150139492e-08,56.953661327231124,931.5091760457739,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,3.441550401120875e-05,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
4,Sleep disturbances,7.479379607873701e-08,33.90384068278805,556.312217320639,MTNR1B;IDUA;HESX1;APOE;HLA-DQB2;HLA-DQB1,3.441550401120875e-05,DisGeNET,IDUA;HESX1;APOE;HLA-DQB2;HLA-DQB1,MTNR1B;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,5,3,2
7,Interferon Gamma Signaling R-HSA-877300,1.312104938213511e-06,31.12938596491228,421.61260221373493,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,3.636405114477445e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
8,Downstream TCR Signaling R-HSA-202424,1.7214821568988422e-06,29.373151981076287,389.85001699031733,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,4.174594230479692e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
11,Rheumatoid arthritis,4.01075466503539e-06,12.612577924459112,156.7305923160954,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5.141058252454454e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,7,7
19,Systemic lupus erythematosus,1.0189508024890478e-05,20.067813765182187,230.66250156581063,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5.4165279500733593e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,Ulcerative colitis,4.655828643185317e-06,23.74043062200957,291.47054098485273,PLCG2;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,5.470598655742747e-05,Jensen_DISEASES,PLCG2;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,5,4,4
7,Adult Asthma,4.872260936827863e-07,78.6232741617357,1142.7529316708928,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,5.853673496960333e-05,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,4,4,4
9,MHC Class II Antigen Presentation R-HSA-2132295,2.8387913965025493e-06,26.392876129718235,337.09330203716877,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.119172565794384e-05,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
6,Sequoiosis,1.8428963441211934e-07,498.85,7735.545837634853,HLA-DQB2;HLA-DRB1;HLA-DQB1,6.701999704787408e-05,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
15,Lysosome (GO:0005764),1.0119249156020401e-05,8.986782106782107,103.35761988876814,GRN;IDUA;KCNQ1;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6.746166104013601e-05,GO_Cellular_Component_2023,GRN;IDUA;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,KCNQ1;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,7,6,5
8,Alzheimer's Disease Or Family History Of Alzheimer's Disease,7.238105298586439e-07,35.353840682788054,499.8586262894535,APH1B;TREM2;ALPK2;APOE;PICALM,7.609058195138993e-05,GWAS_Catalog_2023,APH1B;TREM2;ALPK2;APOE;PICALM,,,5,0,0
13,Acquired metabolic disease,7.068076641023089e-06,11.52920443101712,136.7354671207085,MTNR1B;GIPR;ZC3H4;QPCTL;IGF2BP3;IGF2BP2;JAZF1,7.666144664494274e-05,Jensen_DISEASES,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;IGF2BP3;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,7,4
7,Diabetes Mellitus,2.689174392290527e-07,6.630002872462658,100.30439468373926,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,7.991221012409406e-05,DisGeNET,GIPR;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,13,7
8,Addison Disease,2.929870215365502e-07,42.91630716134599,645.5959106506756,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7.991221012409406e-05,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
20,Cell adhesion molecules,1.5912500595450613e-05,18.231505336768496,201.4290648690376,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8.03581280070256e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
21,Phagosome,1.8100250203065734e-05,17.73182957393484,193.62421662814722,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8.705358430998281e-05,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
12,Macrophage Activation Involved In Immune Response (GO:0002281),1.5090658842808145e-06,187.021875,2506.844900242801,GRN;PLCG2;TREM2,9.683172757468561e-05,GO_Biological_Process_2023,GRN;PLCG2;TREM2,,,3,0,0
11,"Diabetes Mellitus, Insulin-Dependent",5.156043774620517e-07,7.796473482777474,112.87676673622973,CDKN2B;HLA-DRA;BTNL2;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1,0.00010227715923838154,DisGeNET,HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1,CDKN2B;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,7
9,Hallucinations,4.5435901246271527e-07,39.06127258444619,570.465596822135,GRN;TREM2;APOE;HLA-DRB1;HLA-DQB1,0.00010227715923838154,DisGeNET,GRN;TREM2;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,5,2,2
10,Chronic iridocyclitis,5.144717054175412e-07,299.28,4333.611893054364,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00010227715923838154,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
16,Cytoplasmic Vesicle Membrane (GO:0030659),1.7578082958698162e-05,9.964005235602095,109.09447562971339,APH1B;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;APPL1,0.00010986301849186352,GO_Cellular_Component_2023,APH1B;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;APPL1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,7,5,5
12,Oropharyngeal Neoplasms,7.705543808342472e-07,249.3875,3510.4172562030494,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00014011247158169396,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
17,Systemic lupus erythematosus,1.1742310719056372e-05,19.464846818538884,220.97101291879463,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.00014228917694856545,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
22,Influenza A,3.278979798381879e-05,15.592499212102112,160.9986842135293,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.00015053498165298624,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
13,Finding of body mass index,1.047857872309331e-06,12.372533543804263,170.3544771163662,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,0.0001598891440131269,DisGeNET,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,8,4
14,Body mass index,1.047857872309331e-06,12.372533543804263,170.3544771163662,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,0.0001598891440131269,DisGeNET,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,8,4
15,"Hemoglobinuria, Paroxysmal",1.0991462695677833e-06,213.75,2932.858790587599,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0001598891440131269,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
16,Narcolepsy,1.187930311259485e-06,15.265825586542718,208.27620768254724,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.00016200399619801227,DisGeNET,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,7,7
23,Tuberculosis,4.074730373780997e-05,14.873684210526315,150.3449980262844,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0001789338120660351,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
18,Lytic Vacuole Membrane (GO:0098852),3.2334458901634783e-05,11.354813888621718,117.40170221042797,GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.0001796358827868599,GO_Cellular_Component_2023,GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
17,Golgi Membrane (GO:0000139),3.1932025262212154e-05,9.044907407407408,93.63198716676595,CHST15;HLA-DRA;IL17RD;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.0001796358827868599,GO_Cellular_Component_2023,HLA-DRA;IL17RD;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,6,5
18,Primary Progressive Nonfluent Aphasia,1.5090658842808145e-06,187.021875,2506.844900242801,GRN;TREM2;APOE,0.0001829323199722632,DisGeNET,GRN;TREM2;APOE,,,3,0,0
17,Antibody measurement (procedure),1.5090658842808145e-06,187.021875,2506.844900242801,HLA-DRA;BTNL2;HLA-DQB1,0.0001829323199722632,DisGeNET,HLA-DRA;BTNL2;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQB1,3,3,3
13,Positive Regulation Of T Cell Activation (GO:0050870),3.2660834680045093e-06,25.612745098039216,323.53812162785135,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.00019345263618180555,GO_Biological_Process_2023,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
9,Waist-to-hip Ratio Adjusted For BMI,2.2064145203977102e-06,7.373031496062992,96.02740732377764,KCNQ1;HLA-DRA;BTNL2;IGF2BP2;APOE;IL17RD;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00020617717907271937,GWAS_Catalog_2023,HLA-DRA;BTNL2;APOE;IL17RD;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,9,7
14,Negative Regulation Of Inflammatory Response (GO:0050728),3.912695086725387e-06,24.641261171797417,306.8153444406509,GRN;SHARPIN;TREM2;APOE;HLA-DRB1,0.0002151982297698963,GO_Biological_Process_2023,GRN;SHARPIN;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,5,1,1
18,Phagosome,1.927849577029726e-05,17.492052278346875,189.9028205092695,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0002206316738156242,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
19,Optic Neuritis,1.9530945963267187e-06,53.76248313090419,706.7667359874058,APOE;HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0002242974952202579,DisGeNET,APOE;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,4,3,3
14,Type 2 diabetes mellitus,2.247947162768211e-05,12.143047990956736,129.9659259399937,MTNR1B;GIPR;KCNQ1;IGF2BP2;HLA-DQA2;JAZF1,0.00022640039282165555,Jensen_DISEASES,GIPR;HLA-DQA2;JAZF1,MTNR1B;GIPR;KCNQ1;IGF2BP2;HLA-DQA2;JAZF1,GIPR;HLA-DQA2;JAZF1,3,6,3
22,Restrictive behavior,2.6078934902344307e-06,149.6025,1923.4345184728184,GRN;TREM2;APOE,0.00024086850389567742,DisGeNET,GRN;TREM2;APOE,,,3,0,0
21,Multiple Sclerosis,2.3935526333646988e-06,6.674411747360972,86.38512142402794,CDKN1C;MTNR1B;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00024086850389567742,DisGeNET,HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;MTNR1B;HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,10,10,8
20,"Multiple Sclerosis, Acute Fulminating",2.3613793112462104e-06,51.06923076923077,661.6664696109867,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.00024086850389567742,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,3,3
23,Idiopathic achalasia of esophagus,2.6078934902344307e-06,149.6025,1923.4345184728184,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00024086850389567742,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
24,Hypersensitivity,2.6493327651220248e-06,17.917560018118678,230.08302073456625,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.00024086850389567742,DisGeNET,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,6,6
19,Bounding Membrane Of Organelle (GO:0098588),4.987904841462173e-05,6.25718954248366,61.983153424970936,APH1B;CHST15;HLA-DRA;IL17RD;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;APPL1,0.0002625213074453776,GO_Cellular_Component_2023,APH1B;HLA-DRA;IL17RD;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;APPL1,CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,8,6,5
25,Semantic Dementia,3.314170277334519e-06,135.99545454545455,1715.8958918548644,GRN;TREM2;APOE,0.00028228917235662075,DisGeNET,GRN;TREM2;APOE,,,3,0,0
26,Sleep Disorders,3.3636656651109714e-06,46.417249417249415,584.972420622709,MTNR1B;APOE;HLA-DQB2;HLA-DQB1,0.00028228917235662075,DisGeNET,APOE;HLA-DQB2;HLA-DQB1,MTNR1B;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,3,3,2
19,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",2.8156875669944853e-05,11.649043203787729,122.05540109905262,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0003052798098951916,BioPlanet_2019,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
10,Glycated Hemoglobin Levels,3.843547921739476e-06,12.69767441860465,158.32875849462457,TSPAN15;CCND2;MTNR1B;KCNQ1;IGF2BP2;APOE;JAZF1,0.0003232423802182899,GWAS_Catalog_2023,APOE;JAZF1,TSPAN15;CCND2;MTNR1B;KCNQ1;IGF2BP2;JAZF1,JAZF1,2,6,1
12,Type 1 Diabetes,5.505465709096386e-06,22.902816251154203,277.34781869162896,KCNQ1;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,4,5,4
13,Waist-hip Index,5.84779052088106e-06,8.311163101604278,100.1449164487547,HLA-DRA;BTNL2;IGF2BP2;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,7
14,Two-hour Glucose,6.16354838092779e-06,106.8375,1281.7143070022444,GIPR;KCNQ1;IGF2BP2,0.00037025315631144796,GWAS_Catalog_2023,GIPR,GIPR;KCNQ1;IGF2BP2,GIPR,1,3,1
11,Asthma (Adult Onset),5.416073262819622e-06,40.834871794871795,495.1693516588297,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
27,"Alzheimer Disease, Early Onset",4.857850383224604e-06,23.525367472735894,287.8308602187795,IDUA;PLCG2;TREM2;APOE;PICALM,0.00039258627911837354,DisGeNET,IDUA;PLCG2;TREM2;APOE;PICALM,,,5,0,0
28,Steroid-sensitive nephrotic syndrome,5.0834725797279014e-06,115.06153846153846,1402.5444584489262,PLCG2;HLA-DQA1;HLA-DQB1,0.00039614775603451,DisGeNET,PLCG2;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
20,Adaptive immune system,3.854486618911474e-05,7.399522216913521,75.20643249505487,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0003970121217478819,BioPlanet_2019,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,6,6
29,"Hallucinations, Sensory",5.831765698965704e-06,40.032176973353444,482.4754325858409,GRN;TREM2;HLA-DRB1;HLA-DQB1,0.0004135839571299805,DisGeNET,GRN;TREM2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
31,Schizophrenia,5.8758490701326285e-06,5.067666217430368,61.03831651047737,CDKN1C;GRN;GIPR;TREM2;NPAS1;CCND2;MTNR1B;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM;HLA-DQB1,0.0004135839571299805,DisGeNET,GRN;GIPR;TREM2;NPAS1;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM;HLA-DQB1,CDKN1C;GIPR;NPAS1;CCND2;MTNR1B;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;NPAS1;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,11,11,7
30,Systemic onset juvenile chronic arthritis,5.831765698965704e-06,40.032176973353444,482.4754325858409,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0004135839571299805,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
15,Fasting Glucose,8.802118302802596e-06,20.70906432748538,241.064239157459,MTNR1B;QPCTL;KCNQ1;IGF2BP2;JAZF1,0.0004935054328437989,GWAS_Catalog_2023,QPCTL;JAZF1,MTNR1B;QPCTL;KCNQ1;IGF2BP2;JAZF1,QPCTL;JAZF1,2,5,2
20,Lysosomal Membrane (GO:0005765),0.00010661888485560471,9.084324324324324,83.08750049450788,GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.0005330944242780235,GO_Cellular_Component_2023,GRN;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,6,5,5
1,GTEX-QDT8-0011-R11A-SM-32PKD brain female 30-39 years,3.271607831502044e-07,6.521216407355022,97.3801122862463,CDKN1C;CDKN2B;GRN;TOX2;SHARPIN;KCNQ1;SLC22A18;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0005447227039450903,GTEx_Tissue_Expression_Down,GRN;SHARPIN;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;TOX2;KCNQ1;SLC22A18;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,10,5
16,Triglycerides,1.084754445302875e-05,10.767498430634024,123.08943164536338,CCND2;GIPR;ZC3H4;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,0.0005638554410020608,GWAS_Catalog_2023,GIPR;ZC3H4;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,CCND2;GIPR;ZC3H4;HLA-DRA;HLA-DRB1;HLA-DQA1,GIPR;ZC3H4;HLA-DRA;HLA-DRB1;HLA-DQA1,6,6,5
17,Alzheimer's Disease (Late Onset),1.1397791316331788e-05,33.452711223203025,380.7618021856374,PLCG2;TREM2;APOE;HLA-DRB1,0.0005638554410020608,GWAS_Catalog_2023,PLCG2;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
33,Anti-Glomerular Basement Membrane Disease,8.756780424589562e-06,93.4734375,1088.56195212828,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.0005790089359531644,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
32,Somnolence,8.756780424589562e-06,93.4734375,1088.56195212828,APOE;HLA-DRB1;HLA-DQB1,0.0005790089359531644,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
34,Autoimmune thyroid disease,9.134180010800497e-06,20.544964774140073,238.3932344585508,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0005861994348107847,DisGeNET,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
18,Type 2 Diabetes (Adjusted For BMI),1.2863331729415559e-05,32.38746438746439,364.71944022317945,GIPR;KCNQ1;SLC22A18;IGF2BP2,0.0006010034435799159,GWAS_Catalog_2023,GIPR,GIPR;KCNQ1;SLC22A18;IGF2BP2,GIPR,1,4,1
19,Glycated Hemoglobin HbA1c Levels,1.3854455888142476e-05,78.70263157894736,880.4387566559598,MTNR1B;KCNQ1;IGF2BP2,0.000613241968522517,GWAS_Catalog_2023,,MTNR1B;KCNQ1;IGF2BP2,,0,3,0
35,Rheumatic Fever,1.0059171925549804e-05,34.59017818339852,398.0300696782971,CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0006271175183299906,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
15,Membranous glomerulonephritis,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DQA2;HLA-DQA1,0.0006331459779142144,Jensen_DISEASES,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
36,Autoimmune Diseases,1.056509005964641e-05,6.196020019065777,70.99372092810948,GRN;PLCG2;HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.000640361847504124,DisGeNET,GRN;PLCG2;HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,8,8
20,Ulcerative Colitis,1.643896222622291e-05,18.103983918128655,199.43088521370046,PLCG2;HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,0.0006860755720189571,GWAS_Catalog_2023,PLCG2;HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,5,4,4
21,Blood Glucose Levels,1.7131494663969202e-05,29.998491704374057,329.2212069287722,CCND2;GIPR;KCNQ1;JAZF1,0.0006860755720189571,GWAS_Catalog_2023,GIPR;JAZF1,CCND2;GIPR;KCNQ1;JAZF1,GIPR;JAZF1,2,4,2
22,Fasting Plasma Glucose,2.123144935623196e-05,28.326210826210826,304.7907937318705,MTNR1B;GIPR;KCNQ1;IGF2BP2,0.0008116204049359581,GWAS_Catalog_2023,GIPR,MTNR1B;GIPR;KCNQ1;IGF2BP2,GIPR,1,4,1
1,beckwith-wiedemann syndrome,6.735595509725685e-05,243.32926829268294,2337.303967964173,CDKN1C;KCNQ1,0.0010103393264588529,ClinVar_2019,,CDKN1C;KCNQ1,,0,2,0
16,Dementia,0.00012289573606051108,17.696321070234113,159.34075825923392,GRN;TREM2;APOE;PICALM,0.001022965763643578,Jensen_DISEASES,GRN;TREM2;APOE;PICALM,,,4,0,0
17,Beckwith-Wiedemann syndrome,0.00012333629774426117,35.5625,320.08368833375835,CDKN1C;KCNQ1;SLC22A18,0.001022965763643578,Jensen_DISEASES,,CDKN1C;KCNQ1;SLC22A18,,0,3,0
38,Behavioral variant of frontotemporal dementia,1.8154235584669403e-05,71.2,777.2623941159866,GRN;TREM2;APOE,0.0010348859069288215,DisGeNET,GRN;TREM2;APOE,,,3,0,0
39,Ulcerative Colitis,1.8497044166005515e-05,6.379373848987108,69.52177580296704,IDUA;PLCG2;HLA-DRA;BTNL2;APOE;IL17RD;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.0010348859069288215,DisGeNET,IDUA;PLCG2;HLA-DRA;BTNL2;APOE;IL17RD;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,10,6,6
37,Inflammatory Bowel Diseases,1.7810072897318838e-05,6.409040460094844,70.08764093138335,GRN;IDUA;PLCG2;TREM2;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0010348859069288215,DisGeNET,GRN;IDUA;PLCG2;TREM2;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,5,5
1,GTEX-OXRL-0526-SM-2I3EZ lung male 50-59 years,3.9309261403514974e-07,8.009957924263675,118.14063637136353,TOX2;GRN;ZC3H4;HLA-DRA;TREM2;JADE2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0010401230567370062,GTEx_Tissue_Expression_Up,GRN;ZC3H4;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TOX2;ZC3H4;HLA-DRA;JADE2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,ZC3H4;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,7
21,Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs),0.0001253885401588909,162.20325203252034,1457.2491531056257,IGF2BP3;IGF2BP2,0.001123045185770936,BioPlanet_2019,,IGF2BP3;IGF2BP2,,0,2,0
22,Bystander B cell activation,0.0001253885401588909,162.20325203252034,1457.2491531056257,HLA-DRA;HLA-DRB1,0.001123045185770936,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
23,Eosinophils in the chemokine network of allergy,0.0001253885401588909,162.20325203252034,1457.2491531056257,HLA-DRA;HLA-DRB1,0.001123045185770936,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
15,Regulation Of Immune Response (GO:0050776),2.235994709175344e-05,27.93677555321391,299.15367722039247,HLA-DRA;TREM2;HLA-DRB1;APPL1,0.0011478106173766767,GO_Biological_Process_2023,HLA-DRA;TREM2;HLA-DRB1;APPL1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,4,2,2
21,Intracellular Vesicle (GO:0097708),0.00024529265118944116,108.11924119241192,898.8015841018229,PLCG2;APPL1,0.0011680602437592435,GO_Cellular_Component_2023,PLCG2;APPL1,,,2,0,0
16,Regulation Of Macromolecule Metabolic Process (GO:0060255),2.4601522304202134e-05,16.59403285283272,176.10752953921198,TREM2;IGF2BP3;ALPK2;IGF2BP2;APOE,0.0011839482608897278,GO_Biological_Process_2023,TREM2;ALPK2;APOE,IGF2BP3;IGF2BP2,,3,2,0
19,Primary immunodeficiency disease,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DQA1;HLA-DRB1,0.0011947449594672435,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
18,IgA glomerulonephritis,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.0011947449594672435,Jensen_DISEASES,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
40,Systemic Scleroderma,2.2524512122355895e-05,8.005363589479114,85.66464658177404,ATP8B4;GRN;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.001228712136274514,DisGeNET,ATP8B4;GRN;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,8,5,5
17,Regulation Of Cytokine Production (GO:0001817),2.8467413188584324e-05,16.077810266406757,168.2824289946451,TREM2;IGF2BP3;BTNL2;IGF2BP2;HLA-DRB1,0.0012894063620711724,GO_Biological_Process_2023,TREM2;BTNL2;HLA-DRB1,IGF2BP3;BTNL2;IGF2BP2;HLA-DRB1,BTNL2;HLA-DRB1,3,4,2
10,Interferon Signaling R-HSA-913531,6.723327393029232e-05,13.334682860998651,128.110862510313,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.001304325514247671,Reactome_2022,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,5,5,5
1,MACROPHAGE,1.2199298598734839e-05,4.549307568438003,51.47146679185819,ATP8B4;CDKN2B;GRN;IDUA;TREM2;NPAS1;TSPAN15;KCNQ1;SLC22A18;HESX1;CHST15;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB1,0.0013175242486633625,ARCHS4_Tissues,ATP8B4;GRN;IDUA;TREM2;NPAS1;HESX1;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB1,CDKN2B;NPAS1;TSPAN15;KCNQ1;SLC22A18;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,NPAS1;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,11,10,5
20,Lung cancer,0.00020095784945236813,8.051721772533956,68.53960022070409,ATP8B4;MTNR1B;PLCG2;HLA-DRA;BTNL2;HLA-DRB1,0.0014167528386391953,Jensen_DISEASES,ATP8B4;PLCG2;HLA-DRA;BTNL2;HLA-DRB1,MTNR1B;HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,5,4,3
23,Hemoglobin A1c Levels,4.2185930640259134e-05,10.808245533669263,108.87603768336932,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,0.0015126305437015539,GWAS_Catalog_2023,ZC3H4;JAZF1,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,ZC3H4;JAZF1,2,6,2
24,Asthma,4.458133836934389e-05,10.697805187738073,107.1727006755456,SHARPIN;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0015126305437015539,GWAS_Catalog_2023,SHARPIN;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,5,5
25,Entorhinal Cortical Thickness,4.496523613857176e-05,324.4552845528455,3247.674396403277,SHARPIN;APOE,0.0015126305437015539,GWAS_Catalog_2023,SHARPIN;APOE,,,2,0,0
41,Prediabetes syndrome,2.867516633613683e-05,26.13938198553583,273.4043194137663,MTNR1B;HLA-DRA;IGF2BP2;APPL1,0.0015260783645231844,DisGeNET,HLA-DRA;APPL1,MTNR1B;HLA-DRA;IGF2BP2,HLA-DRA,2,3,1
21,Dermatomyositis,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DQA1;HLA-DRB1,0.0016469649437005336,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
11,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) Bind RNA R-HSA-428359,9.416979940433038e-05,194.65365853658537,1804.5194228526939,IGF2BP3;IGF2BP2,0.0016608128258581904,Reactome_2022,,IGF2BP3;IGF2BP2,,0,2,0
43,Acute Confusional Senile Dementia,3.304077574106036e-05,25.167458056346945,259.6719966655491,PLCG2;TREM2;APOE;PICALM,0.001676627271325435,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
42,"Alzheimer's Disease, Focal Onset",3.304077574106036e-05,25.167458056346945,259.6719966655491,PLCG2;TREM2;APOE;PICALM,0.001676627271325435,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
26,Systemic Lupus Erythematosus,5.336653066054909e-05,10.345208845208845,101.77954517638686,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.0017262020109816071,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,6,6,6
27,Hay Fever And/Or Eczema,5.5492738682249425e-05,21.906810035842295,214.67049182992716,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0017284960456211765,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
44,Narcolepsy-Cataplexy Syndrome,3.609024832058106e-05,55.361111111111114,566.3158139575121,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.00178974822353427,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
28,Total Cholesterol Levels,6.237653953500452e-05,6.06950909860347,58.76693736113996,CCND2;GIPR;QPCTL;SLC22A18;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.0018735239196049573,GWAS_Catalog_2023,GIPR;QPCTL;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;GIPR;QPCTL;SLC22A18;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,7,8,6
46,Opportunistic Infections,3.989725268674927e-05,53.38125,540.7095225232104,APOE;HLA-DRB1;HLA-DQB1,0.00189251750788015,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
45,Creutzfeldt-Jakob disease,3.959534275652103e-05,23.978280542986425,243.06301151938413,GRN;TREM2;APOE;HLA-DQB1,0.00189251750788015,DisGeNET,GRN;TREM2;APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,4,1,1
18,"Positive Regulation Of CD4-positive, CD25-positive, Alpha-Beta Regulatory T Cell Differentiation (GO:0032831)",4.496523613857176e-05,324.4552845528455,3247.674396403277,HLA-DRA;HLA-DRB1,0.0019235128792611251,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
29,Acute Insulin Response,6.735595509725685e-05,243.32926829268294,2337.303967964173,MTNR1B;IGF2BP2,0.0019533226978204485,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
47,Cataplexy,4.395866073546934e-05,51.53793103448276,517.0419700965106,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.002040804206910513,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
24,B lymphocyte cell surface molecules,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DRA;HLA-DRB1,0.002105428589376037,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
49,"Nephritis, Interstitial",4.8282154573672834e-05,49.8175,495.1086599472201,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0021070332255950825,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
48,Adrenocortical carcinoma,4.643221983025662e-05,14.45687134502924,144.24367884299386,CDKN1C;GRN;GIPR;KCNQ1;HLA-DRB1,0.0021070332255950825,DisGeNET,GRN;GIPR;HLA-DRB1,CDKN1C;GIPR;KCNQ1;HLA-DRB1,GIPR;HLA-DRB1,3,4,2
50,Pemphigus,4.8282154573672834e-05,49.8175,495.1086599472201,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0021070332255950825,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
22,Vitiligo,0.0003359871776924858,24.87125,198.93114017307255,BTNL2;HLA-DRB1;HLA-DQA1,0.0021533723661200225,Jensen_DISEASES,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,3,3,3
12,Cyclin D Associated Events In G1 R-HSA-69231,0.00014051583727508416,33.94261363636364,301.0774440913921,CDKN1C;CDKN2B;CCND2,0.0021734899560716197,Reactome_2022,,CDKN1C;CDKN2B;CCND2,,0,3,0
13,Adaptive Immune System R-HSA-1280218,0.0001456462341697477,6.063290640394088,53.56510998013485,PLCG2;HLA-DRA;TREM2;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,0.0021734899560716197,Reactome_2022,PLCG2;HLA-DRA;TREM2;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1,8,6,6
51,Membranous glomerulonephritis,5.114661231669348e-05,22.390532544378697,221.2366941071893,BTNL2;APOE;HLA-DRB1;HLA-DQA1,0.0021882727073534347,DisGeNET,BTNL2;APOE;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,4,3,3
19,Regulation Of Defense Response (GO:0031347),5.5492738682249425e-05,21.906810035842295,214.67049182992716,GRN;TREM2;APOE;APPL1,0.002248916251859582,GO_Biological_Process_2023,GRN;TREM2;APOE;APPL1,,,4,0,0
30,Medication Use (Drugs Used In Diabetes),8.13748924347489e-05,19.769977595220315,186.16288254307304,CCND2;KCNQ1;IGF2BP2;JAZF1,0.002281209484587461,GWAS_Catalog_2023,JAZF1,CCND2;KCNQ1;IGF2BP2;JAZF1,JAZF1,1,4,1
31,Family History Of Alzheimer's Disease,8.65199983160333e-05,40.37837837837838,377.745179855569,APH1B;APOE;ALPK2,0.002347203825283355,GWAS_Catalog_2023,APH1B;APOE;ALPK2,,,3,0,0
22,Regulation Of Protein Secretion (GO:0050708),6.753306805856149e-05,20.783882783882785,199.5854062991739,MTNR1B;GIPR;TREM2;APOE,0.0023636573820496522,GO_Biological_Process_2023,GIPR;TREM2;APOE,MTNR1B;GIPR,GIPR,3,2,1
21,Regulation Of T-helper Cell Differentiation (GO:0045622),6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DRA;HLA-DRB1,0.0023636573820496522,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
20,Positive Regulation Of Amyloid-Beta Clearance (GO:1900223),6.735595509725685e-05,243.32926829268294,2337.303967964173,TREM2;APOE,0.0023636573820496522,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
52,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",5.774588151383535e-05,46.69921875,455.7590886284715,APOE;HLA-DRB1;HLA-DQB1,0.002378136768294028,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
53,Frontotemporal Lobar Degeneration,5.776409198881003e-05,21.67266775777414,211.50666863376287,GRN;TREM2;APOE;HLA-DRB1,0.002378136768294028,DisGeNET,GRN;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
33,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) Levels In Elite Athletes,9.416979940433038e-05,194.65365853658537,1804.5194228526939,KCNQ1;ALPK2,0.0023999030696679347,GWAS_Catalog_2023,ALPK2,KCNQ1,,1,1,0
32,Complement C4 Levels (C4A.C4B.4481.34.2),9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DRB1;HLA-DQA1,0.0023999030696679347,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,2,2
34,Hip Circumference Adjusted For BMI,0.00010306163978234728,5.664289958407606,51.99922010656095,KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.002549259972263355,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,6,9,6
55,Varicella Zoster Virus Infection,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DRB1;HLA-DQB1,0.002616444127224198,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
57,Leukoaraiosis,6.834890708147538e-05,43.94779411764706,421.4982387246933,GRN;TREM2;APOE,0.002616444127224198,DisGeNET,GRN;TREM2;APOE,,,3,0,0
56,Localized vitiligo,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DQA1;HLA-DRB1,0.002616444127224198,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
54,Impaired glucose tolerance,6.568636168008754e-05,9.951182432432432,95.83604898259614,MTNR1B;IGF2BP2;APOE;PICALM;HLA-DQB1;NEUROG3,0.002616444127224198,DisGeNET,APOE;PICALM;HLA-DQB1,MTNR1B;IGF2BP2;HLA-DQB1;NEUROG3,HLA-DQB1,3,4,1
2,GTEX-QDT8-3026-SM-32PKB brain female 30-39 years,3.322680164076515e-06,5.626571622242144,70.97773147996286,CDKN1C;GRN;TOX2;KCNQ1;SLC22A18;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.002766131236593699,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TOX2;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,10,6
35,Cholesteryl Ester Levels In Very Small VLDL,0.00011528633399315588,36.43170731707317,330.36606140387784,APOE;HLA-DQB1;JAZF1,0.0027701659110926885,GWAS_Catalog_2023,APOE;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,3,2,2
58,Idiopathic Membranous Glomerulonephritis,7.409634139154903e-05,42.69,405.9880644707658,HLA-DQA2;HLA-DQA1;HLA-DRB1,0.002787555464075172,DisGeNET,HLA-DQA2;HLA-DQA1;HLA-DRB1,HLA-DQA2;HLA-DQA1;HLA-DRB1,HLA-DQA2;HLA-DQA1;HLA-DRB1,3,3,3
23,Autoimmune thyroiditis,0.00046573681352710507,74.83677298311444,574.139479895918,HLA-DQA1;PICALM,0.002855169161187905,Jensen_DISEASES,HLA-DQA1;PICALM,HLA-DQA1,HLA-DQA1,2,1,1
25,Lck and Fyn tyrosine kinases in initiation of T cell receptor activation,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DRA;HLA-DRB1,0.002858632448907718,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
24,Positive Regulation Of Aspartic-Type Peptidase Activity (GO:1905247),9.416979940433038e-05,194.65365853658537,1804.5194228526939,GRN;PICALM,0.002900429821653376,GO_Biological_Process_2023,GRN;PICALM,,,2,0,0
25,"Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000514)",9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DRA;HLA-DRB1,0.002900429821653376,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
23,"Positive Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043372)",9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DRA;HLA-DRB1,0.002900429821653376,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
59,Sense of smell impaired,8.015092485645338e-05,41.50208333333333,391.43101347094785,HESX1;APOE;IL17RD,0.002914821967279688,DisGeNET,HESX1;APOE;IL17RD,,,3,0,0
60,Anosmia,8.015092485645338e-05,41.50208333333333,391.43101347094785,HESX1;APOE;IL17RD,0.002914821967279688,DisGeNET,HESX1;APOE;IL17RD,,,3,0,0
36,Peak Insulin Response,0.0001253885401588909,162.20325203252034,1457.2491531056257,MTNR1B;IGF2BP2,0.002929215618711868,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
26,Regulation Of Primary Metabolic Process (GO:0080090),0.00010758684868437002,37.344375,341.22347667903483,PLCG2;TREM2;APOE,0.0031862259033448048,GO_Biological_Process_2023,PLCG2;TREM2;APOE,,,3,0,0
26,G1 to S cell cycle control,0.00040289798305519274,23.312109375,182.22672999558148,CDKN1C;CDKN2B;CCND2,0.003192191711898835,BioPlanet_2019,,CDKN1C;CDKN2B;CCND2,,0,3,0
1,celiac disease,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DQA1;HLA-DQB1,0.003233517741015387,OMIM_Disease,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
66,Diffuse Scleroderma,0.00010023073893269744,38.30384615384615,352.7031805560676,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.003313688975017361,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
61,Physical Activity Measurement,9.385103813034023e-05,19.027078840162954,176.45335672947346,GIPR;ZC3H4;KCNQ1;JAZF1,0.003313688975017361,DisGeNET,GIPR;ZC3H4;JAZF1,GIPR;ZC3H4;KCNQ1;JAZF1,GIPR;ZC3H4;JAZF1,3,4,3
64,Reduced bone mineral density,0.00010023073893269744,38.30384615384615,352.7031805560676,HESX1;TREM2;IL17RD,0.003313688975017361,DisGeNET,HESX1;TREM2;IL17RD,,,3,0,0
65,Oligoarticular Juvenile Idiopathic Arthritis,0.00010023073893269744,38.30384615384615,352.7031805560676,HLA-DQA1;HLA-DRB1;JAZF1,0.003313688975017361,DisGeNET,HLA-DQA1;HLA-DRB1;JAZF1,HLA-DQA1;HLA-DRB1;JAZF1,HLA-DQA1;HLA-DRB1;JAZF1,3,3,3
62,Parasomnia,9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DQB2;HLA-DQB1,0.003313688975017361,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
63,"Lupus Erythematosus, Systemic",9.735527578752515e-05,5.179812632215171,47.8466732788959,CDKN1C;GRN;HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.003313688975017361,DisGeNET,GRN;HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,8,7
29,Positive Regulation Of Memory T Cell Differentiation (GO:0043382),0.0001253885401588909,162.20325203252034,1457.2491531056257,HLA-DRA;HLA-DRB1,0.0033292819283567586,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
27,Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062207),0.0001253885401588909,162.20325203252034,1457.2491531056257,TREM2;APPL1,0.0033292819283567586,GO_Biological_Process_2023,TREM2;APPL1,,,2,0,0
28,Positive Regulation Of Membrane Invagination (GO:1905155),0.0001253885401588909,162.20325203252034,1457.2491531056257,PLCG2;TREM2,0.0033292819283567586,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
67,Acute lymphocytic leukemia,0.00010933045420186533,5.618072841608804,51.243204042328436,CDKN1C;CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1,0.0035605828517682116,DisGeNET,HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1,CDKN1C;CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,8,3
37,Autism Spectrum Disorder Or Schizophrenia,0.00015796536596751328,16.538670002084636,144.7652071421949,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0035905100750994235,GWAS_Catalog_2023,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
70,Neuromyelitis Optica,0.00011528633399315588,36.43170731707317,330.36606140387784,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003593639725329516,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
69,Brittle diabetes,0.00011528633399315588,36.43170731707317,330.36606140387784,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003593639725329516,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
68,Apraxias,0.00011528633399315588,36.43170731707317,330.36606140387784,GRN;TREM2;APOE,0.003593639725329516,DisGeNET,GRN;TREM2;APOE,,,3,0,0
73,Overgrowth of external genitalia,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
71,Delirium,0.00012333629774426117,35.5625,320.08368833375835,GRN;MTNR1B;APOE,0.003697267494955405,DisGeNET,GRN;APOE,MTNR1B,,2,1,0
72,Adrenocortical cytomegaly,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
74,Pancreatic hyperplasia,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
38,Hip Circumference,0.0001728124079853278,16.14245014245014,139.8469512536839,SNRPD2;GIPR;ZC3H4;ALPK2,0.0038246114504121233,GWAS_Catalog_2023,SNRPD2;GIPR;ZC3H4;ALPK2,SNRPD2;GIPR;ZC3H4,SNRPD2;GIPR;ZC3H4,4,3,3
75,"Diabetes Mellitus, Ketosis-Prone",0.00013174379581985435,34.73372093023256,310.3336904970528,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0038328661663856295,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
78,IGA Glomerulonephritis,0.0001493391205772409,11.187046279491833,98.54994455266213,CDKN1C;HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,CDKN1C;HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,4,3
88,Ocular Cicatricial Pemphigoid,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
87,Mild hereditary factor VIII deficiency disease,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRA;HLA-DRB1,0.003991919449515875,DisGeNET,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
86,Abnormal rapid eye movement sleep,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
85,Spoken Word Recognition Deficit,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
79,Overweight,0.00015230253796766054,11.138468488818614,97.90314636760809,MTNR1B;GIPR;IGF2BP2;APOE;HLA-DQA1,0.003991919449515875,DisGeNET,GIPR;APOE;HLA-DQA1,MTNR1B;GIPR;IGF2BP2;HLA-DQA1,GIPR;HLA-DQA1,3,4,2
77,Sarcoidosis,0.0001464201064767919,11.236044657097288,99.2033823987381,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
84,Grammar-specific speech disorder,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
83,Gluten sensitivity,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DQA2;HLA-DQA1,0.003991919449515875,DisGeNET,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
82,Senile Paranoid Dementia,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
81,Allergic disposition,0.00015836441742673134,11.042553191489361,96.62909561111405,CDKN2B;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,5,4
80,Glaucoma,0.00015438765564128928,8.467891891891892,74.31459076420612,CDKN2B;CCND2;IDUA;APOE;HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,4,2
76,Hepatoblastoma,0.00014354503973751902,11.285469107551487,99.86355542280602,CDKN1C;CDKN2B;KCNQ1;SLC22A18;APOE,0.003991919449515875,DisGeNET,APOE,CDKN1C;CDKN2B;KCNQ1;SLC22A18,,1,4,0
31,"Positive Regulation Of Phagocytosis, Engulfment (GO:0060100)",0.00016099400163033776,139.02439024390245,1214.2589675263725,PLCG2;TREM2,0.003998883266301938,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
30,Regulation Of Memory T Cell Differentiation (GO:0043380),0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRA;HLA-DRB1,0.003998883266301938,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
39,Nonatopic Asthma,0.00019008625754043913,30.47142857142857,261.08019342249946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004099039553628444,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
89,Vitiligo,0.00016780178863595933,10.90170278637771,94.7655272980459,PLCG2;BTNL2;APOE;HLA-DRB1;HLA-DQA1,0.004113971941614194,DisGeNET,PLCG2;BTNL2;APOE;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,5,3,3
40,Alzheimer's Disease (Age Of Onset),0.0002009680615243086,121.64024390243902,1035.4461013159446,TREM2;APOE,0.004122296091266915,GWAS_Catalog_2023,TREM2;APOE,,,2,0,0
41,Gestational Diabetes Mellitus,0.0002009680615243086,121.64024390243902,1035.4461013159446,MTNR1B;IGF2BP2,0.004122296091266915,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
90,Uveitis,0.0001728124079853278,16.14245014245014,139.8469512536839,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004189740824710947,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
92,Pseudohyperkalemia Cardiff,0.000177978120582019,16.014536644457905,138.26710613967586,APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1,0.004221176729456146,DisGeNET,APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1,HLA-DQA2;HLA-DRB1;HLA-DQA1,HLA-DQA2;HLA-DRB1;HLA-DQA1,4,3,3
91,Disorder of eye,0.000177978120582019,16.014536644457905,138.26710613967586,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004221176729456146,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
22,Late Endosome (GO:0005770),0.0009674307879115139,10.080877662967215,69.97002780206786,GRN;KCNQ1;HLA-DRA;HLA-DRB1,0.0043974126723250635,GO_Cellular_Component_2023,GRN;HLA-DRA;HLA-DRB1,KCNQ1;HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,3,3,2
97,Blunted affect,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
96,"Toxoplasmosis, Cerebral",0.0002009680615243086,121.64024390243902,1035.4461013159446,HLA-DRB1;HLA-DQB1,0.00441634819327593,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
98,Dementia of frontal lobe type,0.0002009680615243086,121.64024390243902,1035.4461013159446,TREM2;APOE,0.00441634819327593,DisGeNET,TREM2;APOE,,,2,0,0
93,Seropositive rheumatoid arthritis,0.0002009680615243086,121.64024390243902,1035.4461013159446,HLA-DRB1;HLA-DQB1,0.00441634819327593,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
94,"HEMIHYPERPLASIA, ISOLATED",0.0002009680615243086,121.64024390243902,1035.4461013159446,CDKN1C;IDUA,0.00441634819327593,DisGeNET,IDUA,CDKN1C,,1,1,0
95,Temporal cortical atrophy,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
99,EEG with continuous slow activity,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
100,"Alzheimer Disease, Late Onset",0.0002023990922674578,10.456812393887946,88.93800339475749,GRN;PLCG2;TREM2;APOE;PICALM,0.00441634819327593,DisGeNET,GRN;PLCG2;TREM2;APOE;PICALM,,,5,0,0
101,Diffuse Large B-Cell Lymphoma,0.00020523970386451983,6.637470657276995,56.36096682370493,CDKN1C;CDKN2B;CCND2;PLCG2;HLA-DRB1;PICALM;HLA-DQB1,0.004433990433983983,DisGeNET,PLCG2;HLA-DRB1;PICALM;HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,5,2
42,Eosinophil Counts,0.00022278944239134945,5.680236861584012,47.766721758748,TOX2;SHARPIN;HLA-DRA;ALPK2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004461093358360117,GWAS_Catalog_2023,SHARPIN;HLA-DRA;ALPK2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,TOX2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,5,4
34,Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),0.00020119015054404125,29.8605,254.15048145446983,CDKN1C;CDKN2B;CCND2,0.004556365174085641,GO_Biological_Process_2023,,CDKN1C;CDKN2B;CCND2,,0,3,0
33,"Regulation Of Phagocytosis, Engulfment (GO:0060099)",0.0002009680615243086,121.64024390243902,1035.4461013159446,PLCG2;TREM2,0.004556365174085641,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
32,CRD-mediated mRNA Stabilization (GO:0070934),0.0002009680615243086,121.64024390243902,1035.4461013159446,IGF2BP3;IGF2BP2,0.004556365174085641,GO_Biological_Process_2023,,IGF2BP3;IGF2BP2,,0,2,0
45,Response To Hepatitis B Vaccine,0.00024529265118944116,108.11924119241192,898.8015841018229,BTNL2;HLA-DQA1,0.004584247103340445,GWAS_Catalog_2023,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
44,Moderate To Vigorous Physical Activity Levels,0.00024529265118944116,108.11924119241192,898.8015841018229,APOE;HLA-DQB1,0.004584247103340445,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
43,Total Testosterone Levels,0.00023876631980728532,7.7893618434158975,64.96347426639448,ZC3H4;QPCTL;SLC22A18;JADE2;HLA-DQA1;JAZF1,0.004584247103340445,GWAS_Catalog_2023,ZC3H4;QPCTL;HLA-DQA1;JAZF1,ZC3H4;QPCTL;SLC22A18;JADE2;HLA-DQA1;JAZF1,ZC3H4;QPCTL;HLA-DQA1;JAZF1,4,6,4
102,Psoriasis vulgaris,0.00021731712578879178,15.172598545732875,127.96801544965346,GRN;BTNL2;APOE;HLA-DRB1,0.004648882043834741,DisGeNET,GRN;BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,4,2,2
24,Alzheimer's disease,0.0008032099177403704,10.61404215330917,75.6451582346225,ATP8B4;APOE;PVRL2;PICALM,0.0047188582667246765,Jensen_DISEASES,ATP8B4;APOE;PVRL2;PICALM,,,4,0,0
25,Aphasia,0.0008370330222898128,54.03523035230352,382.87456973669936,GRN;APOE,0.004720866245714544,Jensen_DISEASES,GRN;APOE,,,2,0,0
104,Mycosis Fungoides,0.00024242034731166733,14.729840208101077,122.6235241631035,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,4,3
105,Eosinophilia-Myalgia Syndrome,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DQA1;HLA-DRB1,0.004778826472280006,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
106,Hyperorality,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
107,Alexia,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
108,Asymmetric overgrowth,0.00024529265118944116,108.11924119241192,898.8015841018229,CDKN1C;KCNQ1,0.004778826472280006,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
109,Pathological Dilatation,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DRB1;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
110,Posterior helix pit,0.00024529265118944116,108.11924119241192,898.8015841018229,CDKN1C;KCNQ1,0.004778826472280006,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
111,Postherpetic neuralgia,0.00024529265118944116,108.11924119241192,898.8015841018229,APOE;HLA-DRB1,0.004778826472280006,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
103,"Lymphoma, T-Cell, Cutaneous",0.00022968286180705802,10.166150670794634,85.18025570099593,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,5,2
112,Difficulty making arithmetical calculations,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
113,Leprosy,0.0002490087681467491,14.623132263420032,121.34307979185846,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004808293204391209,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
26,Celiac disease,0.0008944087786701765,17.534117647058824,123.07806733345828,ALPK2;HLA-DQA1;HLA-DQB1,0.00485044760740365,Jensen_DISEASES,ALPK2;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
49,Body Mass Index And Type 2 Diabetes (Pairwise),0.0002939497556798544,97.30243902439024,791.2733302207097,IGF2BP2;JAZF1,0.004939527661650218,GWAS_Catalog_2023,JAZF1,IGF2BP2;JAZF1,JAZF1,1,2,1
47,Multiple Sclerosis,0.00027812068625435583,9.740304709141274,79.74831053714851,TOX2;ALPK2;JADE2;HLA-DQA1;JAZF1,0.004939527661650218,GWAS_Catalog_2023,ALPK2;HLA-DQA1;JAZF1,TOX2;JADE2;HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,3,4,2
48,"Alzheimer's Disease, Proxy Alzheimer's Disease Or Related Dementias",0.0002939497556798544,97.30243902439024,791.2733302207097,TREM2;APOE,0.004939527661650218,GWAS_Catalog_2023,TREM2;APOE,,,2,0,0
50,Cholesteryl Esters To Total Lipids Ratio In Small VLDL,0.00030541669251582797,25.73146551724138,208.26619783387193,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
51,Takayasu Arteritis,0.00030541669251582797,25.73146551724138,208.26619783387193,PLCG2;HLA-DQB2;HLA-DQB1,0.004939527661650218,GWAS_Catalog_2023,PLCG2;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,3,2,2
52,Cholesteryl Esters To Total Lipids Ratio In Medium VLDL,0.00030541669251582797,25.73146551724138,208.26619783387193,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
46,Free Cholesterol To Total Lipids Ratio In Medium VLDL,0.00027670290974554537,26.653125,218.35748980907536,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
115,Nerve Degeneration,0.00026257096906837215,14.414257137661393,118.84539376467356,GRN;IDUA;TREM2;APOE,0.004969790930281587,DisGeNET,GRN;IDUA;TREM2;APOE,,,4,0,0
116,Hypothyroidism,0.00026420520069324663,9.852911747048228,81.17601639805463,KCNQ1;HESX1;APOE;HLA-DRB1;HLA-DQB1,0.004969790930281587,DisGeNET,HESX1;APOE;HLA-DRB1;HLA-DQB1,KCNQ1;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,3,2
114,Frontotemporal dementia,0.00026257096906837215,14.414257137661393,118.84539376467356,GRN;TREM2;BTNL2;APOE,0.004969790930281587,DisGeNET,GRN;TREM2;BTNL2;APOE,BTNL2,BTNL2,4,1,1
121,Recurrent respiratory papillomatosis,0.0002939497556798544,97.30243902439024,791.2733302207097,HLA-DRB1;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
118,SVEINSSON CHORIORETINAL ATROPHY,0.00027670290974554537,26.653125,218.35748980907536,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
119,Libman-Sacks Disease,0.00027670290974554537,26.653125,218.35748980907536,HLA-DRB1;HLA-DQA1;JAZF1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQA1;JAZF1,HLA-DRB1;HLA-DQA1;JAZF1,HLA-DRB1;HLA-DQA1;JAZF1,3,3,3
120,Oropharyngeal Carcinoma,0.00029083087231990317,26.18421052631579,213.21196871726985,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
122,Frontotemporal cerebral atrophy,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
123,"Myasthenia Gravis, Ocular",0.0002939497556798544,97.30243902439024,791.2733302207097,HLA-DQA1;HLA-DRB1,0.004972080363515058,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
124,"Restrictive behavior, interests, and activities",0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
117,"Glaucoma, Primary Open Angle",0.0002766567746533795,14.211224672763134,116.42876793643745,CDKN2B;APOE;HLA-DRB1;HLA-DQB1,0.004972080363515058,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,3,2
125,Abnormal brain FDG positron emission tomography,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
127,Lack of insight,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
128,Berylliosis,0.0002939497556798544,97.30243902439024,791.2733302207097,BTNL2;HLA-DRB1,0.004972080363515058,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
129,Developmental arithmetic disorder,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
126,Insulin measurement,0.0002939497556798544,97.30243902439024,791.2733302207097,GIPR;MTNR1B,0.004972080363515058,DisGeNET,GIPR,GIPR;MTNR1B,GIPR,1,2,1
130,Mild cognitive disorder,0.00029879307630711384,13.917105725324904,112.94787989424374,GRN;TREM2;APOE;PICALM,0.005015126865400942,DisGeNET,GRN;TREM2;APOE;PICALM,,,4,0,0
140,Neuro-degenerative disease,0.0003359871776924858,24.87125,198.93114017307255,IDUA;TREM2;APOE,0.005086290684541416,DisGeNET,IDUA;TREM2;APOE,,,3,0,0
141,"Hallucinations, Visual",0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;APOE,0.005086290684541416,DisGeNET,GRN;APOE,,,2,0,0
142,Heymann Nephritis,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DQA1;HLA-DRB1,0.005086290684541416,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
143,Inappropriate behavior,0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;TREM2,0.005086290684541416,DisGeNET,GRN;TREM2,,,2,0,0
139,Large fontanelle,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
131,Thickened facial skin with coarse facial features,0.0003064464687823347,13.821733821733822,111.8242878786689,CDKN1C;IDUA;KCNQ1;HESX1,0.005086290684541416,DisGeNET,IDUA;HESX1,CDKN1C;KCNQ1,,2,2,0
137,Wide bregma sutures,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
144,Beryllium Disease,0.00034692141370239296,88.45232815964523,704.6477129931925,BTNL2;HLA-DRB1,0.005086290684541416,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
136,"Large, late-closing fontanelle",0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
132,"Infant, Premature",0.0003127575046915473,9.487179487179487,76.56232032930447,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
133,Coarse facial features,0.00031423965646541486,13.727650727650728,110.71837130067722,CDKN1C;IDUA;KCNQ1;HESX1,0.005086290684541416,DisGeNET,IDUA;HESX1,CDKN1C;KCNQ1,,2,2,0
138,Large bregma sutures,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
134,nervous system disorder,0.00031924571016525897,7.364047768698931,59.27726703722372,CDKN2B;KCNQ1;TREM2;APOE;HLA-DRB1;HLA-DQB1,0.005086290684541416,DisGeNET,TREM2;APOE;HLA-DRB1;HLA-DQB1,CDKN2B;KCNQ1;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,4,2
145,Mediastinal lymphadenopathy,0.00034692141370239296,88.45232815964523,704.6477129931925,APOE;HLA-DRB1,0.005086290684541416,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
147,Diabetes in children,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
146,Compulsive hoarding,0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;TREM2,0.005086290684541416,DisGeNET,GRN;TREM2,,,2,0,0
151,Chronic Fatigue Syndrome,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
135,"Inclusion Body Myopathy, Sporadic",0.0003359871776924858,24.87125,198.93114017307255,BTNL2;APOE;HLA-DRB1,0.005086290684541416,DisGeNET,BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
149,High-Grade Squamous Intraepithelial Lesions,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
150,Allergic Reaction,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
148,Rheumatoid Arthritis,0.0003507289537576655,3.8552372854333847,30.67032805838523,GRN;MTNR1B;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.005086290684541416,DisGeNET,GRN;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,MTNR1B;HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,9,8
35,"Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043370)",0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DRA;HLA-DRB1,0.005246537261551936,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
36,Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902991),0.00024529265118944116,108.11924119241192,898.8015841018229,APOE;PICALM,0.005246537261551936,GO_Biological_Process_2023,APOE;PICALM,,,2,0,0
156,Gestational Diabetes,0.00040289798305519274,23.312109375,182.22672999558148,MTNR1B;IGF2BP2;PICALM,0.005377694901597237,DisGeNET,PICALM,MTNR1B;IGF2BP2,,1,2,0
164,Pure Red-Cell Aplasia,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
163,Corticobasal degeneration,0.0004041897176269234,81.07723577235772,633.5072130174765,GRN;APOE,0.005377694901597237,DisGeNET,GRN;APOE,,,2,0,0
162,Congenital hemihypertrophy,0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;KCNQ1,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
161,Angioedema,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
155,Schistosomiasis,0.00040289798305519274,23.312109375,182.22672999558148,APOE;HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
160,Allergy to peanuts,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
153,Beckwith-Wiedemann Syndrome,0.00038543363890109416,23.683333333333334,186.17803506279176,CDKN1C;KCNQ1;SLC22A18,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1;SLC22A18,,0,3,0
154,Nephritis,0.0004001906328909762,12.852320675105485,100.551024579804,CCND2;IL17RD;HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,IL17RD;HLA-DRB1;HLA-DQB1,CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,3,2
159,Genital ulcers,0.0004041897176269234,81.07723577235772,633.5072130174765,APOE;HLA-DRB1,0.005377694901597237,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
158,"Hydatidiform Mole, Partial",0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;HLA-DRB1,0.005377694901597237,DisGeNET,HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,1,2,1
157,Renal cortical cysts,0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;KCNQ1,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
152,GRN-related frontotemporal dementia,0.00038543363890109416,23.683333333333334,186.17803506279176,GRN;TREM2;APOE,0.005377694901597237,DisGeNET,GRN;TREM2;APOE,,,3,0,0
37,Negative Regulation Of Protein Metabolic Process (GO:0051248),0.0002766567746533795,14.211224672763134,116.42876793643745,TREM2;IGF2BP3;IGF2BP2;APOE,0.005520519801792388,GO_Biological_Process_2023,TREM2;APOE,IGF2BP3;IGF2BP2,,2,2,0
39,"Positive Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000516)",0.0002939497556798544,97.30243902439024,791.2733302207097,HLA-DRA;HLA-DRB1,0.005520519801792388,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
40,Positive Regulation Of Calcium-Mediated Signaling (GO:0050850),0.0002939497556798544,97.30243902439024,791.2733302207097,PLCG2;TREM2,0.005520519801792388,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
41,Positive Regulation Of Neuroinflammatory Response (GO:0150078),0.0002939497556798544,97.30243902439024,791.2733302207097,PLCG2;TREM2,0.005520519801792388,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
38,Astrocyte Activation (GO:0048143),0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.005520519801792388,GO_Biological_Process_2023,GRN;TREM2,,,2,0,0
165,Recurrent infections,0.0004208635722139596,22.95230769230769,178.41292023227638,PLCG2;HLA-DRB1;HLA-DQB1,0.00556560190649006,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
53,Waist-hip Ratio,0.0003507564101949369,6.054392556808016,48.16522693695417,GIPR;QPCTL;BTNL2;IGF2BP2;APOE;IL17RD;JAZF1,0.005565776244791357,GWAS_Catalog_2023,GIPR;QPCTL;BTNL2;APOE;IL17RD;JAZF1,GIPR;QPCTL;BTNL2;IGF2BP2;JAZF1,GIPR;QPCTL;BTNL2;JAZF1,6,5,4
54,Waist Circumference,0.0003640184005452328,13.188811188811188,104.43304462432606,CCND2;GIPR;ZC3H4;QPCTL,0.005669249534417422,GWAS_Catalog_2023,GIPR;ZC3H4;QPCTL,CCND2;GIPR;ZC3H4;QPCTL,GIPR;ZC3H4;QPCTL,3,4,3
27,Inhibition of T cell receptor signaling by activated Csk,0.0007543579072186544,57.21664275466284,411.3672708004445,HLA-DRA;HLA-DRB1,0.005755471440260844,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
166,Progressive supranuclear palsy,0.0004393364318997317,22.60340909090909,174.7298918871199,GRN;TREM2;APOE,0.0057748921349711725,DisGeNET,GRN;TREM2;APOE,,,3,0,0
167,Recurrent hepatitis,0.00046573681352710507,74.83677298311444,574.139479895918,APOE;HLA-DRB1,0.006013240988852918,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
168,Complex Regional Pain Syndromes,0.00046573681352710507,74.83677298311444,574.139479895918,HLA-DRB1;HLA-DQB1,0.006013240988852918,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
169,Perseveration,0.00046573681352710507,74.83677298311444,574.139479895918,GRN;TREM2,0.006013240988852918,DisGeNET,GRN;TREM2,,,2,0,0
170,"Tuberculosis, Pulmonary",0.0004695726308822086,12.302719502719503,94.28419856606095,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0060271028269704655,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
55,Sarcoidosis,0.0004041897176269234,81.07723577235772,633.5072130174765,BTNL2;HLA-DQB1,0.006070063437932903,GWAS_Catalog_2023,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,2,2,2
56,Blood Sugar Levels,0.0004041897176269234,81.07723577235772,633.5072130174765,KCNQ1;IGF2BP2,0.006070063437932903,GWAS_Catalog_2023,,KCNQ1;IGF2BP2,,0,2,0
171,Rhabdoid Tumor,0.00047782785171347563,21.93639705882353,167.73139610325921,CDKN1C;CDKN2B;KCNQ1,0.006091086161444096,DisGeNET,,CDKN1C;CDKN2B;KCNQ1,,0,3,0
172,Complete atrioventricular block,0.0004801406140093421,12.227988878591288,93.4393400234872,KCNQ1;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.006091086161444096,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,KCNQ1;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
43,Regulation Of Immune Effector Process (GO:0002697),0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DRA;HLA-DRB1,0.006212313687228897,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
42,Negative Regulation Of Neuroinflammatory Response (GO:0150079),0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;TREM2,0.006212313687228897,GO_Biological_Process_2023,GRN;TREM2,,,2,0,0
3,GTEX-TKQ1-1426-SM-4GICK muscle male 30-39 years,1.1639082389653266e-05,3.915228426395939,44.48146592394129,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;LRRC16A;NPAS1;EML2;TOX2;APH1B;SHARPIN;CCND2;SLC22A18;HESX1;PLCG2;APOE;PVRL2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1;JAZF1,0.0064596907262575625,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SHARPIN;HESX1;PLCG2;APOE;PVRL2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1;JAZF1,GIPR;QPCTL;LRRC16A;NPAS1;EML2;TOX2;CCND2;SLC22A18;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;NPAS1;EML2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,19,12,8
174,Chorea,0.0005184195970282122,21.3075,161.18539095065847,TREM2;HLA-DRB1;HLA-DQB1,0.006501100923652638,DisGeNET,TREM2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
173,Guillain-Barre Syndrome,0.0005184195970282122,21.3075,161.18539095065847,APOE;HLA-DRB1;HLA-DQB1,0.006501100923652638,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
175,Celiac Disease,0.000529800881623874,8.421909823418481,63.526544265471834,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.006552717365101217,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
176,Achalasia,0.0005315449008354333,69.48780487804878,523.9187926178153,HLA-DQA1;HLA-DQB1,0.006552717365101217,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
177,Neurofibrillary degeneration (morphologic abnormality),0.0005315449008354333,69.48780487804878,523.9187926178153,TREM2;APOE,0.006552717365101217,DisGeNET,TREM2;APOE,,,2,0,0
178,Uveomeningoencephalitic Syndrome,0.0005395177057599866,21.006338028169015,158.06922667033186,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.006613638393080284,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
179,Mucosa-Associated Lymphoid Tissue Lymphoma,0.0005471451300707842,11.797853309481216,88.61127499841832,CDKN1C;BTNL2;HLA-DQA1;HLA-DQB1,0.006669668568795816,DisGeNET,BTNL2;HLA-DQA1;HLA-DQB1,CDKN1C;BTNL2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA1;HLA-DQB1,3,4,3
3,N6-methyladenosine-containing RNA Binding (GO:1990247),0.0002009680615243086,121.64024390243902,1035.4461013159446,IGF2BP3;IGF2BP2,0.006765924737985055,GO_Molecular_Function_2023,,IGF2BP3;IGF2BP2,,0,2,0
28,T cell activation co-stimulatory signal,0.0009238809256518343,51.18870346598203,357.6517529213759,HLA-DRA;HLA-DRB1,0.006797123953009924,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
27,Collagen disease,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DQB2;HLA-DQB1,0.006854958258824098,Jensen_DISEASES,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
57,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis),0.00046573681352710507,74.83677298311444,574.139479895918,CCND2;JAZF1,0.006871660704847287,GWAS_Catalog_2023,JAZF1,CCND2;JAZF1,JAZF1,1,2,1
23,Vesicle (GO:0031982),0.0016006305971496021,8.758352758352759,56.38064872893336,PLCG2;APOE;PICALM;APPL1,0.006959263465867835,GO_Cellular_Component_2023,PLCG2;APOE;PICALM;APPL1,,,4,0,0
180,Hyperglycemia,0.0005799133916465143,6.552091510597735,48.83032548497465,MTNR1B;GIPR;IGF2BP2;APOE;HLA-DRB1;APPL1,0.006993756673162802,DisGeNET,GIPR;APOE;HLA-DRB1;APPL1,MTNR1B;GIPR;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
182,Acromegaly,0.0005833472568815902,20.42876712328767,152.12747032552738,CDKN2B;GIPR;APOE,0.006993756673162802,DisGeNET,GIPR;APOE,CDKN2B;GIPR,GIPR,2,2,1
181,Glioblastoma,0.0005809597658814701,3.626041055718475,27.017012046347645,CDKN1C;CDKN2B;GRN;CCND2;IDUA;SLC22A18;CHST15;HLA-DRA;TREM2;IGF2BP2;APOE;HLA-DRB1,0.006993756673162802,DisGeNET,GRN;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1,CDKN1C;CDKN2B;CCND2;SLC22A18;CHST15;HLA-DRA;IGF2BP2;HLA-DRB1,HLA-DRA;HLA-DRB1,6,8,2
184,Familial Dementia,0.0006015962324961352,64.85203252032521,480.9377475175773,GRN;TREM2,0.007057435372615952,DisGeNET,GRN;TREM2,,,2,0,0
185,Fragmented sleep,0.0006015962324961352,64.85203252032521,480.9377475175773,HLA-DRB1;HLA-DQB1,0.007057435372615952,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
186,Lofgrens syndrome,0.0006015962324961352,64.85203252032521,480.9377475175773,BTNL2;HLA-DRB1,0.007057435372615952,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
183,Erythema Multiforme,0.0006015962324961352,64.85203252032521,480.9377475175773,HLA-DQB2;HLA-DQB1,0.007057435372615952,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
44,Regulation Of Microglial Cell Activation (GO:1903978),0.0004041897176269234,81.07723577235772,633.5072130174765,GRN;TREM2,0.0070733200584711595,GO_Biological_Process_2023,GRN;TREM2,,,2,0,0
187,insulinoma,0.0006078628697954807,11.461683326090105,84.88019783684098,CDKN1C;CDKN2B;CCND2;HLA-DQB1,0.007092817015474539,DisGeNET,HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DQB1,HLA-DQB1,1,4,1
60,Venous Thromboembolism Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),0.0005315449008354333,69.48780487804878,523.9187926178153,TSPAN15;PLCG2,0.007450487693376657,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
59,Childhood Steroid-Sensitive Nephrotic Syndrome,0.0005315449008354333,69.48780487804878,523.9187926178153,BTNL2;HLA-DQB1,0.007450487693376657,GWAS_Catalog_2023,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,2,2,2
58,Body Mass Index,0.000516328204963962,3.6788455008488965,27.844327877700252,CCND2;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;APOE;NPAS1;EML2;HLA-DRB1;JAZF1,0.007450487693376657,GWAS_Catalog_2023,GIPR;ZC3H4;QPCTL;APOE;NPAS1;EML2;HLA-DRB1;JAZF1,CCND2;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;NPAS1;EML2;HLA-DRB1;JAZF1,GIPR;ZC3H4;QPCTL;NPAS1;EML2;HLA-DRB1;JAZF1,8,11,7
61,LDL Cholesterol Levels,0.0005453851745755094,8.366547436552546,62.86639029997533,QPCTL;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,0.007519162816688582,GWAS_Catalog_2023,QPCTL;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,QPCTL;HLA-DRA;HLA-DRB1;HLA-DQA1,QPCTL;HLA-DRA;HLA-DRB1;HLA-DQA1,5,4,4
30,Th1/Th2 differentiation pathway,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRA;HLA-DRB1,0.0075814005797255075,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
29,Cyclins and cell cycle regulation,0.0011100252238666322,46.3089430894309,315.0569917577159,CDKN2B;CCND2,0.0075814005797255075,BioPlanet_2019,,CDKN2B;CCND2,,0,2,0
31,Immune system,0.001140890378502382,4.379105339105339,29.672582565738555,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0075814005797255075,BioPlanet_2019,PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,6,6
63,Birth Weight,0.0005830293250192724,11.593846153846155,86.34253827026593,CCND2;MTNR1B;KCNQ1;IGF2BP3,0.007665547547459646,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1;IGF2BP3,,0,4,0
62,Neutrophil Count,0.0005698810705617067,5.563015166501813,41.556184284386035,TSPAN15;TOX2;IGF2BP3;JADE2;HLA-DQA2;HLA-DQA1;HLA-DQB1,0.007665547547459646,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1;HLA-DQB1,TSPAN15;TOX2;IGF2BP3;JADE2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DQA1;HLA-DQB1,3,7,3
64,Direct Bilirubin Levels,0.0005833472568815902,20.42876712328767,152.12747032552738,SLC22A18;APOE;JAZF1,0.007665547547459646,GWAS_Catalog_2023,APOE;JAZF1,SLC22A18;JAZF1,JAZF1,2,2,1
28,Addison's disease,0.0015316216181504704,38.89170731707317,252.0738094731918,HLA-DQA1;HLA-DRB1,0.007712808862829154,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
191,Primary Progressive Aphasia (disorder),0.0006758731147824064,60.795731707317074,443.7787597089313,GRN;APOE,0.007721231080917334,DisGeNET,GRN;APOE,,,2,0,0
188,Smith-Lemli-Opitz Syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,SLC22A18;APOE,0.007721231080917334,DisGeNET,APOE,SLC22A18,,1,1,0
189,Primary antiphospholipid syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,HLA-DRB1;HLA-DQB1,0.007721231080917334,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
190,Primary cutaneous B-cell lymphoma,0.0006758731147824064,60.795731707317074,443.7787597089313,CDKN2B;IGF2BP3,0.007721231080917334,DisGeNET,,CDKN2B;IGF2BP3,,0,2,0
45,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.00045832254489166206,22.26492537313433,171.17135193275797,CDKN1C;CDKN2B;APOE,0.007796029269910238,GO_Biological_Process_2023,APOE,CDKN1C;CDKN2B,,1,2,0
46,Regulation Of Amyloid-Beta Clearance (GO:1900221),0.00046573681352710507,74.83677298311444,574.139479895918,TREM2;APOE,0.007796029269910238,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
47,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),0.00047782785171347563,21.93639705882353,167.73139610325921,TREM2;APOE;EML2,0.007828243528071835,GO_Biological_Process_2023,TREM2;APOE;EML2,EML2,EML2,3,1,1
192,Familial Alzheimer Disease (FAD),0.0007007151246070292,11.021739130434783,80.05540071471528,PLCG2;TREM2;APOE;PICALM,0.007963335426523634,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
193,Alzheimer's Disease,0.0007146962692512135,3.5343703946291143,25.601752372063284,GRN;APH1B;IDUA;KCNQ1;PLCG2;HLA-DRA;TREM2;BTNL2;APOE;HLA-DRB1;PICALM;APPL1,0.008080141240964496,DisGeNET,GRN;APH1B;IDUA;PLCG2;HLA-DRA;TREM2;BTNL2;APOE;HLA-DRB1;PICALM;APPL1,KCNQ1;HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,11,4,3
65,Asthma (Childhood Onset),0.0006334395984132004,11.332473857613522,83.45625748745468,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,0.008195733881007715,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
194,Graves Disease,0.0007306802009089565,7.825757575757576,56.513979696127414,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.008218269063831664,DisGeNET,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
195,"Aneurysm, Dissecting",0.0007543579072186544,57.21664275466284,411.3672708004445,CDKN2B;APOE,0.008314673651429249,DisGeNET,APOE,CDKN2B,,1,1,0
197,Pulmonary Infiltrate,0.0007543579072186544,57.21664275466284,411.3672708004445,APOE;HLA-DRB1,0.008314673651429249,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
198,Maturity onset diabetes mellitus in young,0.0007544937593872554,18.6346875,133.97340656516064,MTNR1B;NEUROG3;APPL1,0.008314673651429249,DisGeNET,APPL1,MTNR1B;NEUROG3,,1,2,0
196,Mixed Connective Tissue Disease,0.0007543579072186544,57.21664275466284,411.3672708004445,HLA-DRB1;HLA-DQB1,0.008314673651429249,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
14,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.0006015962324961352,64.85203252032521,480.9377475175773,CDKN1C;CCND2,0.008336404936017875,Reactome_2022,,CDKN1C;CCND2,,0,2,0
199,Cerebral atrophy,0.0007605751908131133,7.7540698593330175,55.68535318473843,GRN;TREM2;APOE;HLA-DRB1;PICALM,0.008339573197759867,DisGeNET,GRN;TREM2;APOE;HLA-DRB1;PICALM,HLA-DRB1,HLA-DRB1,5,1,1
15,Amyloid Fiber Formation R-HSA-977225,0.0006532602581931894,19.61940789473684,143.87961350157394,TSPAN15;APH1B;APOE,0.008448832672631917,Reactome_2022,APH1B;APOE,TSPAN15,,2,1,0
49,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),0.0005395177057599866,21.006338028169015,158.06922667033186,CDKN2B;PLCG2;APPL1,0.008473075801725433,GO_Biological_Process_2023,PLCG2;APPL1,CDKN2B,,2,1,0
48,Negative Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002862),0.0005315449008354333,69.48780487804878,523.9187926178153,TREM2;HLA-DRB1,0.008473075801725433,GO_Biological_Process_2023,TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
50,Regulation Of Gene Expression (GO:0010468),0.0005501997273847683,4.4604598547827,33.47677356965697,PLCG2;TREM2;IGF2BP3;BTNL2;ALPK2;JADE2;IGF2BP2;APOE;PICALM,0.008473075801725433,GO_Biological_Process_2023,PLCG2;TREM2;BTNL2;ALPK2;APOE;PICALM,IGF2BP3;BTNL2;JADE2;IGF2BP2,BTNL2,6,4,1
66,Asthma-COPD Overlap Syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,IL17RD;HLA-DQB1,0.008612261962606118,GWAS_Catalog_2023,IL17RD;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
200,Thrombocytopenia,0.0007913778790344561,7.683662280701754,54.87467969297853,CDKN1C;CDKN2B;BTNL2;APOE;HLA-DRB1,0.008633932660265917,DisGeNET,BTNL2;APOE;HLA-DRB1,CDKN1C;CDKN2B;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,4,2
52,Amyloid Precursor Protein Metabolic Process (GO:0042982),0.0006015962324961352,64.85203252032521,480.9377475175773,APH1B;APOE,0.008740171679660833,GO_Biological_Process_2023,APH1B;APOE,,,2,0,0
53,Positive Regulation Of Regulatory T Cell Differentiation (GO:0045591),0.0006015962324961352,64.85203252032521,480.9377475175773,HLA-DRA;HLA-DRB1,0.008740171679660833,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
51,Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002861),0.0006015962324961352,64.85203252032521,480.9377475175773,TREM2;HLA-DRB1,0.008740171679660833,GO_Biological_Process_2023,TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
201,"Amnesia, Transient Global",0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRB1;HLA-DQB1,0.008997074160770304,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
202,Vulval intraepithelial neoplasia,0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRB1;HLA-DQB1,0.008997074160770304,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
203,Dysgraphia,0.0008370330222898128,54.03523035230352,382.87456973669936,GRN;TREM2,0.008997074160770304,DisGeNET,GRN;TREM2,,,2,0,0
30,Crohn's disease,0.0019482960977915294,8.28625472887768,51.712859211282435,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,0.009156991659620188,Jensen_DISEASES,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,4,4,4
29,Cardiovascular system disease,0.0018916885408923104,8.355583810129264,52.39189551472568,MTNR1B;APOE;PVRL2;HLA-DQB1,0.009156991659620188,Jensen_DISEASES,APOE;PVRL2;HLA-DQB1,MTNR1B;HLA-DQB1,HLA-DQB1,3,2,1
69,Idiopathic Membranous Nephropathy,0.0007543579072186544,57.21664275466284,411.3672708004445,BTNL2;HLA-DQA1,0.009194420289433163,GWAS_Catalog_2023,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
68,Type Ii Diabetes,0.0007543579072186544,57.21664275466284,411.3672708004445,KCNQ1;IGF2BP2,0.009194420289433163,GWAS_Catalog_2023,,KCNQ1;IGF2BP2,,0,2,0
67,C-X-C Motif Chemokine 16 Levels,0.0007543579072186544,57.21664275466284,411.3672708004445,TOX2;HLA-DQA1,0.009194420289433163,GWAS_Catalog_2023,HLA-DQA1,TOX2;HLA-DQA1,HLA-DQA1,1,2,1
55,Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),0.0006758731147824064,60.795731707317074,443.7787597089313,APOE;PICALM,0.009318357231758067,GO_Biological_Process_2023,APOE;PICALM,,,2,0,0
54,Response To Axon Injury (GO:0048678),0.0006758731147824064,60.795731707317074,443.7787597089313,PLCG2;TREM2,0.009318357231758067,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
56,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),0.0006776987077642231,19.363636363636363,141.29273193710048,TREM2;PICALM;APPL1,0.009318357231758067,GO_Biological_Process_2023,TREM2;PICALM;APPL1,,,3,0,0
70,Venous Thromboembolism Or Tissue Plasminogen Activator Levels (Pleiotropy),0.0008370330222898128,54.03523035230352,382.87456973669936,TSPAN15;PLCG2,0.009777010718690731,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
71,Venous Thromboembolism Or Factor XI Levels (Pleiotropy),0.0008370330222898128,54.03523035230352,382.87456973669936,TSPAN15;PLCG2,0.009777010718690731,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
72,Sarcoidosis (Lofgren's Syndrome Vs non-Lofgren's Syndrome),0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRA;HLA-DQA1,0.009777010718690731,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,2,2,2
206,Diastasis recti,0.0009238809256518343,51.18870346598203,357.6517529213759,CDKN1C;KCNQ1,0.009785962037729624,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
205,Neonatal Systemic lupus erythematosus,0.0009238809256518343,51.18870346598203,357.6517529213759,HLA-DQA1;HLA-DQB1,0.009785962037729624,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
204,Restlessness,0.0009238809256518343,51.18870346598203,357.6517529213759,GRN;TREM2,0.009785962037729624,DisGeNET,GRN;TREM2,,,2,0,0
57,Regulation Of Neuroinflammatory Response (GO:0150077),0.0007543579072186544,57.21664275466284,411.3672708004445,PLCG2;TREM2,0.010014751526868343,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
58,Positive Regulation Of Alpha-Beta T Cell Activation (GO:0046635),0.0007543579072186544,57.21664275466284,411.3672708004445,HLA-DRA;HLA-DRB1,0.010014751526868343,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
24,Cell cycle,0.002395537611775861,12.29504132231405,74.19009409618413,CDKN1C;CDKN2B;CCND2,0.010081220782890081,KEGG_2021_Human,,CDKN1C;CDKN2B;CCND2,,0,3,0
59,Regulation Of Kinase Activity (GO:0043549),0.0008086445561002566,18.178353658536587,129.43262478902307,CDKN1C;TREM2;HLA-DRB1,0.010553496749105044,GO_Biological_Process_2023,TREM2;HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,2,2,1
60,Negative Regulation Of Phosphate Metabolic Process (GO:0045936),0.0008370330222898128,54.03523035230352,382.87456973669936,CDKN1C;CDKN2B,0.010565826674805833,GO_Biological_Process_2023,,CDKN1C;CDKN2B,,0,2,0
61,Microglial Cell Activation (GO:0001774),0.0008370330222898128,54.03523035230352,382.87456973669936,GRN;TREM2,0.010565826674805833,GO_Biological_Process_2023,GRN;TREM2,,,2,0,0
210,Adrenal Cortical Adenoma,0.001017451521498842,16.742696629213484,115.36478575635245,CDKN1C;CDKN2B;GIPR,0.010571805809097494,DisGeNET,GIPR,CDKN1C;CDKN2B;GIPR,GIPR,1,3,1
207,Herpes zoster disease,0.001014884135775059,48.62682926829268,335.18380172445745,APOE;HLA-DRB1,0.010571805809097494,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
209,Pancolitis,0.001014884135775059,48.62682926829268,335.18380172445745,HLA-DRB1;HLA-DQB1,0.010571805809097494,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
208,Hypothalamic gonadotropin-releasing hormone deficiency,0.001014884135775059,48.62682926829268,335.18380172445745,HESX1;IL17RD,0.010571805809097494,DisGeNET,HESX1;IL17RD,,,2,0,0
211,Presenile dementia,0.0010338962260585923,7.223942208462332,49.66041907847833,GRN;PLCG2;TREM2;APOE;PICALM,0.010691760972795492,DisGeNET,GRN;PLCG2;TREM2;APOE;PICALM,,,5,0,0
212,Metabolic Syndrome X,0.0010604541550718932,5.808816196270071,39.78491912344245,GRN;MTNR1B;GIPR;IGF2BP2;APOE;HLA-DRB1,0.010914674369655052,DisGeNET,GRN;GIPR;APOE;HLA-DRB1,MTNR1B;GIPR;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
221,Petechiae,0.0011100252238666322,46.3089430894309,315.0569917577159,APOE;HLA-DRB1,0.010959615558719419,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
220,Chromosome 11p11.2 Deletion Syndrome,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
219,Macule,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
218,Loss of speech,0.0011100252238666322,46.3089430894309,315.0569917577159,GRN;TREM2,0.010959615558719419,DisGeNET,GRN;TREM2,,,2,0,0
216,Typhoid Fever,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
215,Esophageal Achalasia,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DQA1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
214,Enlarged kidney,0.0011100252238666322,46.3089430894309,315.0569917577159,CDKN1C;KCNQ1,0.010959615558719419,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
213,Macroglossia,0.001082789485515373,16.373076923076923,111.7988847060665,CDKN1C;IDUA;KCNQ1,0.010959615558719419,DisGeNET,IDUA,CDKN1C;KCNQ1,,1,2,0
217,Andersen Syndrome,0.0011100252238666322,46.3089430894309,315.0569917577159,KCNQ1;APOE,0.010959615558719419,DisGeNET,APOE,KCNQ1,,1,1,0
222,Blast Phase,0.001134307320495641,9.644444444444444,65.40604816498089,CDKN1C;CDKN2B;CCND2;HLA-DRB1,0.011098917369154658,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1,HLA-DRB1,1,4,1
223,Parkinsonian Disorders,0.001134307320495641,9.644444444444444,65.40604816498089,GRN;TREM2;APOE;HLA-DRB1,0.011098917369154658,DisGeNET,GRN;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
224,Nephroblastoma,0.0011394901155391826,7.062725306416727,47.86532102575984,CDKN1C;CCND2;KCNQ1;SLC22A18;HLA-DRB1,0.011099854607618288,DisGeNET,HLA-DRB1,CDKN1C;CCND2;KCNQ1;SLC22A18;HLA-DRB1,HLA-DRB1,1,5,1
225,Diabetic Nephropathy,0.0011963792643215003,5.668955441928415,38.14331478012957,GIPR;IDUA;KCNQ1;IGF2BP2;APOE;HLA-DRB1,0.011373550979745828,DisGeNET,GIPR;IDUA;APOE;HLA-DRB1,GIPR;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
227,Repeated speech,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;TREM2,0.011373550979745828,DisGeNET,GRN;TREM2,,,2,0,0
229,Generalized overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
228,Fetal overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
226,Erectile abnormalities,0.0012092868136118387,44.20177383592018,296.9353391905164,HESX1;IL17RD,0.011373550979745828,DisGeNET,HESX1;IL17RD,,,2,0,0
232,Echolalia,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;TREM2,0.011373550979745828,DisGeNET,GRN;TREM2,,,2,0,0
230,Cognitive changes,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;APOE,0.011373550979745828,DisGeNET,GRN;APOE,,,2,0,0
231,Overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
233,Hypercalcemia,0.0012212982724261697,15.680526315789473,105.18247463067819,CDKN1C;CDKN2B;HLA-DRB1,0.011437222448214174,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;HLA-DRB1,HLA-DRB1,1,3,1
62,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),0.0009238809256518343,51.18870346598203,357.6517529213759,HLA-DRA;HLA-DRB1,0.011474005044385685,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
234,Nonorganic psychosis,0.0012561939417458329,9.37369420702754,62.613172835144184,GRN;MTNR1B;APOE;NPAS1,0.011713740089270973,DisGeNET,GRN;APOE;NPAS1,MTNR1B;NPAS1,NPAS1,3,2,1
73,Offspring Birth Weight,0.001017451521498842,16.742696629213484,115.36478575635245,CCND2;MTNR1B;KCNQ1,0.011721599035349674,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1,,0,3,0
74,Low Density Lipoprotein Cholesterol Levels,0.0010377928539311593,5.000371857801577,34.35585029238203,CCND2;GIPR;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.011794375542650068,GWAS_Catalog_2023,GIPR;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;GIPR;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,6,6,5
75,Lung Function (FEV1),0.0010578293776537704,9.833706746328106,67.37599802120471,ATP8B4;IGF2BP3;HLA-DQB1;JAZF1,0.011861793421424278,GWAS_Catalog_2023,ATP8B4;HLA-DQB1;JAZF1,IGF2BP3;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,3,3,2
63,Regulation Of Epithelial Cell Proliferation (GO:0050678),0.0009857442763293743,16.933806818181818,117.21773433426443,CDKN1C;CDKN2B;GRN,0.012047985599581241,GO_Biological_Process_2023,GRN,CDKN1C;CDKN2B,,1,2,0
2,PLASMACYTOID DENDRITIC CELL,0.00022415466109515552,3.702477605680218,31.11256463662098,BTNL2;JADE2;TSPAN15;TOX2;KCNQ1;HESX1;HLA-DRA;ALPK2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.012104351699138398,ARCHS4_Tissues,BTNL2;HESX1;HLA-DRA;ALPK2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;JADE2;TSPAN15;TOX2;KCNQ1;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,10,12,8
236,Port-Wine Stain,0.0013126515814769549,42.27783669141039,280.54329796205764,CDKN1C;KCNQ1,0.012136465045689472,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
235,Lupus anticoagulant disorder,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DRB1;HLA-DQB1,0.012136465045689472,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
64,Positive Regulation Of Cholesterol Efflux (GO:0010875),0.001014884135775059,48.62682926829268,335.18380172445745,TREM2;APOE,0.012210324758543677,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
237,Cardiovascular Diseases,0.0013303948840433938,4.780591168091168,31.65841077330397,TSPAN15;CDKN2B;GIPR;KCNQ1;IGF2BP2;APOE;HLA-DRB1,0.012248614502036646,DisGeNET,GIPR;APOE;HLA-DRB1,TSPAN15;CDKN2B;GIPR;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,3,6,2
2,diabetes mellitus type 2,0.001647192500753881,37.39399624765478,239.64626637110106,MTNR1B;IGF2BP2,0.012353943755654108,ClinVar_2019,,MTNR1B;IGF2BP2,,0,2,0
65,Negative Regulation Of Amide Metabolic Process (GO:0034249),0.0010497982542413567,16.555833333333332,113.55906460386798,IGF2BP3;IGF2BP2;APOE,0.012436071627166841,GO_Biological_Process_2023,APOE,IGF2BP3;IGF2BP2,,1,2,0
76,Neutrophil-to-lymphocyte Ratio,0.001150725295437434,16.019354838709678,108.40878671592486,BTNL2;HLA-DQA1;JAZF1,0.012733683861353711,GWAS_Catalog_2023,BTNL2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA1;JAZF1,3,3,3
66,Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),0.0011100252238666322,46.3089430894309,315.0569917577159,TREM2;APPL1,0.01283061559262614,GO_Biological_Process_2023,TREM2;APPL1,,,2,0,0
67,T Cell Receptor Signaling Pathway (GO:0050852),0.001116430187929807,16.19429347826087,110.08263730245073,PLCG2;BTNL2;HLA-DRB1,0.01283061559262614,GO_Biological_Process_2023,PLCG2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
241,Dermatitis Herpetiformis,0.0014201022558982558,40.514227642276424,265.65286017600937,HLA-DQA1;HLA-DQB1,0.012857523329336075,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
238,Generalized pustular psoriasis,0.0014201022558982558,40.514227642276424,265.65286017600937,APOE;HLA-DRB1,0.012857523329336075,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
239,Aortic root dilatation,0.0014201022558982558,40.514227642276424,265.65286017600937,HLA-DQB2;HLA-DRB1,0.012857523329336075,DisGeNET,HLA-DQB2;HLA-DRB1,HLA-DQB2;HLA-DRB1,HLA-DQB2;HLA-DRB1,2,2,2
240,Personality change,0.0014201022558982558,40.514227642276424,265.65286017600937,GRN;TREM2,0.012857523329336075,DisGeNET,GRN;TREM2,,,2,0,0
78,Subcutaneous Adipose Tissue,0.0012092868136118387,44.20177383592018,296.9353391905164,SNRPD2;QPCTL,0.013038592439071236,GWAS_Catalog_2023,SNRPD2;QPCTL,SNRPD2;QPCTL,SNRPD2;QPCTL,2,2,2
77,Triglyceride Levels,0.0012082488405706707,4.864913805591772,32.68532819694104,CCND2;ZC3H4;KCNQ1;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.013038592439071236,GWAS_Catalog_2023,ZC3H4;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;ZC3H4;KCNQ1;HLA-DQA1;HLA-DQB1;JAZF1,ZC3H4;HLA-DQA1;HLA-DQB1;JAZF1,5,6,4
4,GTEX-SNMC-1426-SM-2XCFM muscle male 20-29 years,3.1495296887134386e-05,3.8442757237871676,39.84850249299332,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;EML2;SHARPIN;CCND2;SLC22A18;PLCG2;IGF2BP2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.013109917329269688,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;EML2;SHARPIN;PLCG2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;JADE2;LRRC16A;EML2;CCND2;SLC22A18;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;EML2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,14,12,7
5,GTEX-XOTO-0011-R11B-SM-4B64O brain male 50-59 years,3.959984491314667e-05,4.662738165389904,47.264709680185504,CDKN1C;CDKN2B;GRN;CCND2;KCNQ1;SLC22A18;CHST15;PLCG2;HLA-DRA;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.01318674835607784,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;CCND2;KCNQ1;SLC22A18;CHST15;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,10,4
242,Pick Disease of the Brain,0.0014896249030591868,14.599264705882353,95.02998543179133,GRN;TREM2;APOE,0.013431246026756799,DisGeNET,GRN;TREM2;APOE,,,3,0,0
68,Positive Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903846),0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;CDKN2B,0.013494939804074142,GO_Biological_Process_2023,,CDKN1C;CDKN2B,,0,2,0
69,Positive Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030511),0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;CDKN2B,0.013494939804074142,GO_Biological_Process_2023,,CDKN1C;CDKN2B,,0,2,0
10,GTEX-T8EM-1326-SM-3DB7G muscle male 40-49 years,8.14666277719075e-05,3.5440335711672155,33.3681998741256,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;EML2;CCND2;SNRPD2;KCNQ1;SLC22A18;PLCG2;IGF2BP2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0135641935240226,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;EML2;SNRPD2;PLCG2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;JADE2;EML2;CCND2;SNRPD2;KCNQ1;SLC22A18;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;EML2;SNRPD2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,14,13,8
9,GTEX-WVLH-0011-R11A-SM-3MJFO brain male 50-59 years,7.62099043777754e-05,4.349870943952802,41.24555948187364,CDKN1C;CDKN2B;GRN;TOX2;KCNQ1;SLC22A18;CHST15;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQB2;HLA-DQA1,0.0135641935240226,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQB2;HLA-DQA1,CDKN1C;CDKN2B;TOX2;KCNQ1;SLC22A18;CHST15;HLA-DRA;HLA-DQB2;HLA-DQA1,HLA-DRA;HLA-DQB2;HLA-DQA1,7,9,3
8,GTEX-P4PP-0008-SM-48TDV skin female 30-39 years,7.255068742771542e-05,4.167054986020503,39.7171390902235,CDKN1C;ATP8B4;TREM2;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0135641935240226,GTEx_Tissue_Expression_Down,ATP8B4;TREM2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,11,6
7,GTEX-QDT8-0011-R7A-SM-32PKF brain female 30-39 years,6.224320241058938e-05,5.484123531970422,53.11078170837908,GRN;SHARPIN;SLC22A18;HLA-DRA;ALPK2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0135641935240226,GTEx_Tissue_Expression_Down,GRN;SHARPIN;HLA-DRA;ALPK2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,7,6
6,GTEX-P44H-0011-R11A-SM-2XCER brain male 40-49 years,5.258600878420383e-05,4.525401376146789,44.589053393445596,CDKN1C;CDKN2B;GRN;GIPR;TOX2;SHARPIN;KCNQ1;SLC22A18;CHST15;PLCG2;HLA-DRA;PVRL2;HLA-DRB1,0.0135641935240226,GTEx_Tissue_Expression_Down,GRN;GIPR;SHARPIN;PLCG2;HLA-DRA;PVRL2;HLA-DRB1,CDKN1C;CDKN2B;GIPR;TOX2;KCNQ1;SLC22A18;CHST15;HLA-DRA;HLA-DRB1,GIPR;HLA-DRA;HLA-DRB1,7,9,3
245,Aphasia,0.0015316216181504704,38.89170731707317,252.0738094731918,GRN;APOE,0.013640809676752352,DisGeNET,GRN;APOE,,,2,0,0
244,Apathy,0.0015316216181504704,38.89170731707317,252.0738094731918,GRN;APOE,0.013640809676752352,DisGeNET,GRN;APOE,,,2,0,0
243,Generalized vitiligo,0.0015316216181504704,38.89170731707317,252.0738094731918,BTNL2;HLA-DQA1,0.013640809676752352,DisGeNET,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
246,Rhabdomyosarcoma,0.001555683824772726,6.567199248120301,42.46246005483993,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1,0.013798789047374341,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1,HLA-DRB1,1,5,1
79,Asthma (Moderate Or Severe),0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DQA1;HLA-DQB1,0.013799249750276488,GWAS_Catalog_2023,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
80,Hepatitis B,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DRA;HLA-DQB2,0.013799249750276488,GWAS_Catalog_2023,HLA-DRA;HLA-DQB2,HLA-DRA;HLA-DQB2,HLA-DRA;HLA-DQB2,2,2,2
247,Lymphoma,0.001577336681489445,3.8051980422369254,24.551204355169563,CDKN2B;GRN;CCND2;PLCG2;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;HLA-DQA1,0.013934205016234692,DisGeNET,GRN;PLCG2;APOE;HLA-DRB1;HLA-DQA1,CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,5,6,2
248,"Plaque, Amyloid",0.0016006305971496021,8.758352758352759,56.38064872893336,GRN;MTNR1B;TREM2;APOE,0.014037274901415079,DisGeNET,GRN;TREM2;APOE,MTNR1B,,3,1,0
249,Cystic Fibrosis,0.0016018705089149196,5.341698841698841,34.38228936843787,KCNQ1;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.014037274901415079,DisGeNET,APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,KCNQ1;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,4
251,Hyperinsulinemic hypoglycemia,0.001647192500753881,37.39399624765478,239.64626637110106,CDKN1C;CDKN2B,0.014150291482854209,DisGeNET,,CDKN1C;CDKN2B,,0,2,0
252,Agranulocytosis,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRB1;HLA-DQB1,0.014150291482854209,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
250,Uveal melanoma,0.001625703298135029,8.720159151193634,55.99924672905672,CDKN2B;CCND2;MTNR1B;EML2,0.014150291482854209,DisGeNET,EML2,CDKN2B;CCND2;MTNR1B;EML2,EML2,1,4,1
253,Plasma cell dyscrasia,0.001647192500753881,37.39399624765478,239.64626637110106,CDKN2B;CCND2,0.014150291482854209,DisGeNET,,CDKN2B;CCND2,,0,2,0
254,Psoriasiform eczema,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRB1;HLA-DQB1,0.014150291482854209,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
255,Psoriasis,0.0016610652763271816,4.5904233456637895,29.38006886478563,GRN;APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.01421350758018004,DisGeNET,GRN;APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,7,5,5
256,"Hepatitis B, Chronic",0.0016766684128947064,8.644751260135875,55.24814317285851,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.014290978425532223,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4,4,4
83,Fasting Blood Glucose (BMI Interaction),0.0014201022558982558,40.514227642276424,265.65286017600937,MTNR1B;IGF2BP2,0.014389228882053412,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
82,Mental Health Study Participation (Completed Survey),0.0014201022558982558,40.514227642276424,265.65286017600937,JADE2;APOE,0.014389228882053412,GWAS_Catalog_2023,APOE,JADE2,,1,1,0
81,Parental Longevity (Mother'S Age At Death Or Mother'S Attained Age),0.0014201022558982558,40.514227642276424,265.65286017600937,APOE;JAZF1,0.014389228882053412,GWAS_Catalog_2023,APOE;JAZF1,JAZF1,JAZF1,2,1,1
70,Positive Regulation Of Peptidase Activity (GO:0010952),0.0013126515814769549,42.27783669141039,280.54329796205764,GRN;APH1B,0.014439167396246504,GO_Biological_Process_2023,GRN;APH1B,,,2,0,0
257,Small testicle,0.0017022427928104391,13.913551401869158,88.71014078934452,CDKN1C;HESX1;IL17RD,0.014452504956857503,DisGeNET,HESX1;IL17RD,CDKN1C,,2,1,0
31,Frontotemporal dementia,0.0031810145747939787,26.262359920896508,151.0231473713992,GRN;TREM2,0.014468485646643582,Jensen_DISEASES,GRN;TREM2,,,2,0,0
84,Medication Use (HMG CoA Reductase Inhibitors),0.0014492243445094362,14.744554455445545,96.38112427033386,CCND2;IGF2BP2;APOE,0.014509496115862332,GWAS_Catalog_2023,APOE,CCND2;IGF2BP2,,1,2,0
258,Parkinson Disease,0.0017173289984586467,4.091125541125541,26.048135375016184,GRN;APH1B;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1;PICALM,0.014524077033475842,DisGeNET,GRN;APH1B;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1;PICALM,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,8,2,2
265,Cortical white matter abnormalities seen on MRI,0.0017667977889501455,36.00722673893406,228.23492237875305,GRN;TREM2,0.01454774632260082,DisGeNET,GRN;TREM2,,,2,0,0
264,Neonatal hypoglycemia,0.0017667977889501455,36.00722673893406,228.23492237875305,CDKN1C;KCNQ1,0.01454774632260082,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
259,"Diabetes, Autoimmune",0.0017469205497262674,13.784027777777778,87.52720800686893,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.01454774632260082,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
260,Multiple Endocrine Neoplasia Type 1,0.0017469205497262674,13.784027777777778,87.52720800686893,CDKN2B;GRN;NEUROG3,0.01454774632260082,DisGeNET,GRN,CDKN2B;NEUROG3,,1,2,0
263,Anterior hypopituitarism,0.0017667977889501455,36.00722673893406,228.23492237875305,HESX1;IL17RD,0.01454774632260082,DisGeNET,HESX1;IL17RD,,,2,0,0
262,Social disinhibition,0.0017667977889501455,36.00722673893406,228.23492237875305,GRN;TREM2,0.01454774632260082,DisGeNET,GRN;TREM2,,,2,0,0
261,Erythema Nodosum,0.0017667977889501455,36.00722673893406,228.23492237875305,BTNL2;HLA-DRB1,0.01454774632260082,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
85,Weight,0.0015081656262016078,5.408010420058613,35.13509297927943,CCND2;GIPR;KCNQ1;JADE2;IGF2BP2;JAZF1,0.014872368000912012,GWAS_Catalog_2023,GIPR;JAZF1,CCND2;GIPR;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;JAZF1,2,6,2
86,Body Mass Index (MTAG),0.0015370930967812757,4.656215277777778,30.162321156281493,CCND2;GIPR;ZC3H4;JADE2;APOE;EML2;JAZF1,0.014872368000912012,GWAS_Catalog_2023,GIPR;ZC3H4;APOE;EML2;JAZF1,CCND2;GIPR;ZC3H4;JADE2;EML2;JAZF1,GIPR;ZC3H4;EML2;JAZF1,5,6,4
87,Non-HDL Cholesterol Levels,0.001538520827680553,6.584331673172701,42.646280533204376,CCND2;ZC3H4;APOE;HLA-DQB1;JAZF1,0.014872368000912012,GWAS_Catalog_2023,ZC3H4;APOE;HLA-DQB1;JAZF1,CCND2;ZC3H4;HLA-DQB1;JAZF1,ZC3H4;HLA-DQB1;JAZF1,4,4,3
4,Amyloid-Beta Binding (GO:0001540),0.0006532602581931894,19.61940789473684,143.87961350157394,TREM2;APOE;PICALM,0.014907876799984886,GO_Molecular_Function_2023,TREM2;APOE;PICALM,,,3,0,0
5,Protein Kinase Binding (GO:0019901),0.0007380137029695488,6.246293818571046,45.04544873053108,CDKN2B;CCND2;KCNQ1;PLCG2;TREM2;APPL1,0.014907876799984886,GO_Molecular_Function_2023,PLCG2;TREM2;APPL1,CDKN2B;CCND2;KCNQ1,,3,3,0
267,Amyloidosis,0.00184260316056414,4.503531073446328,28.356825429201223,GRN;QPCTL;SLC22A18;TREM2;APOE;HLA-DRB1;PICALM,0.01505827751442305,DisGeNET,GRN;QPCTL;TREM2;APOE;HLA-DRB1;PICALM,QPCTL;SLC22A18;HLA-DRB1,QPCTL;HLA-DRB1,6,3,2
266,Erythema,0.0018384652062925309,13.532045454545454,85.23597514715335,PLCG2;HLA-DRB1;HLA-DQB1,0.01505827751442305,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
90,Venous Thromboembolism Or Factor VII Levels (Pleiotropy),0.001647192500753881,37.39399624765478,239.64626637110106,TSPAN15;PLCG2,0.015222954869604548,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
88,Urea Levels,0.0016150547035770834,14.18,91.1545198708865,APH1B;GIPR;APOE,0.015222954869604548,GWAS_Catalog_2023,APH1B;GIPR;APOE,GIPR,GIPR,3,1,1
89,Blood Urea Nitrogen Levels,0.001625703298135029,8.720159151193634,55.99924672905672,APH1B;GIPR;APOE;HLA-DQA1,0.015222954869604548,GWAS_Catalog_2023,APH1B;GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,4,2,2
91,Sj?gren's Syndrome,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRA;HLA-DQA1,0.015222954869604548,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,2,2,2
268,Urticaria,0.0018853406860438778,13.409459459459459,84.12621161107936,PLCG2;HLA-DRB1;HLA-DQB1,0.015277397613422335,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
269,"Delirium, Dementia, Amnestic, Cognitive Disorders",0.0018904204196260454,34.71951219512195,217.72453437258292,TREM2;APOE,0.015277397613422335,DisGeNET,TREM2;APOE,,,2,0,0
270,Gonadoblastoma,0.0018904204196260454,34.71951219512195,217.72453437258292,CDKN1C;KCNQ1,0.015277397613422335,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
273,"Carcinoma, Granular Cell",0.0019329572618860178,13.2890625,83.03942050809016,CDKN1C;KCNQ1;APOE,0.015449497236026706,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
271,Splenomegaly,0.0019198473507759867,8.320776617072914,52.05069801510453,IDUA;APOE;HLA-DRB1;HLA-DQB1,0.015449497236026706,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
272,"Carcinoma, Cribriform",0.0019329572618860178,13.2890625,83.03942050809016,CDKN1C;KCNQ1;APOE,0.015449497236026706,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
274,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.0019573216732023716,5.12586115527292,31.965783764492816,CDKN1C;CDKN2B;IDUA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.015587138288056843,DisGeNET,IDUA;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,5,3
277,PEELING SKIN SYNDROME,0.00201804338139322,33.5206055508831,208.01637017204203,HLA-DRB1;HLA-DQB1,0.015896644975451287,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
276,Latent autoimmune diabetes mellitus in adult,0.00201804338139322,33.5206055508831,208.01637017204203,HLA-DRB1;HLA-DQB1,0.015896644975451287,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
275,Brain Diseases,0.002006069631949149,8.218052949760267,51.04707590465461,GRN;IDUA;TREM2;APOE,0.015896644975451287,DisGeNET,GRN;IDUA;TREM2;APOE,,,4,0,0
71,Regulation Of Neuron Apoptotic Process (GO:0043523),0.0014896249030591868,14.599264705882353,95.02998543179133,GRN;TREM2;APOE,0.01592783644690345,GO_Biological_Process_2023,GRN;TREM2;APOE,,,3,0,0
72,Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.00150303545896052,8.914492262509883,57.94659392825817,GRN;TREM2;ALPK2;IL17RD,0.01592783644690345,GO_Biological_Process_2023,GRN;TREM2;ALPK2;IL17RD,,,4,0,0
73,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),0.0015270330435687314,8.874943769680613,57.548939322837434,SHARPIN;PLCG2;TREM2;HLA-DRB1,0.01592783644690345,GO_Biological_Process_2023,SHARPIN;PLCG2;TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
74,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),0.0015307271390530587,14.456796116504854,93.7091317231499,CDKN2B;CCND2;APPL1,0.01592783644690345,GO_Biological_Process_2023,APPL1,CDKN2B;CCND2,,1,2,0
278,"Adenocarcinoma, Basal Cell",0.0020304304736449906,13.054605263157894,80.93212261743199,CDKN1C;KCNQ1;APOE,0.015936688106091258,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
92,Estimated Glomerular Filtration Rate (Cystatin C),0.0017469205497262674,13.784027777777778,87.52720800686893,APH1B;KCNQ1;APOE,0.01596913241651947,GWAS_Catalog_2023,APH1B;APOE,KCNQ1,,2,1,0
93,Carotid Intima Media Thickness,0.0017667977889501455,36.00722673893406,228.23492237875305,APOE;NEUROG3,0.015977171403301852,GWAS_Catalog_2023,APOE,NEUROG3,,1,1,0
33,Cytokines and inflammatory response,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;HLA-DRB1,0.016031794629593324,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
32,MEF2D role in T cell apoptosis,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;HLA-DRB1,0.016031794629593324,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
11,GTEX-QMR6-1326-SM-32PLB brain male 50-59 years,0.00010689584669920657,4.193757802746567,38.34627698832557,CDKN1C;GRN;TOX2;SHARPIN;SNRPD2;KCNQ1;SLC22A18;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1,0.016180144068561723,GTEx_Tissue_Expression_Down,GRN;SHARPIN;SNRPD2;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1,CDKN1C;TOX2;SNRPD2;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1,SNRPD2;HLA-DRA;HLA-DQA2;HLA-DRB1,9,8,4
279,Red Blood Cell Count measurement,0.002080295409013854,12.940434782608696,79.91036000024108,TOX2;ZC3H4;HLA-DQA1,0.01626955047479652,DisGeNET,ZC3H4;HLA-DQA1,TOX2;ZC3H4;HLA-DQA1,ZC3H4;HLA-DQA1,2,3,2
95,Apolipoprotein B Levels,0.0018499643842394518,6.304502063983488,39.67163965640283,CCND2;GIPR;HLA-DRA;APOE;HLA-DQA1,0.016377053127846094,GWAS_Catalog_2023,GIPR;HLA-DRA;APOE;HLA-DQA1,CCND2;GIPR;HLA-DRA;HLA-DQA1,GIPR;HLA-DRA;HLA-DQA1,4,4,3
94,High-density Lipoprotein Levels (MTAG),0.0018362344944614516,8.426068376068375,53.08455327400216,GIPR;ZC3H4;SLC22A18;APOE,0.016377053127846094,GWAS_Catalog_2023,GIPR;ZC3H4;APOE,GIPR;ZC3H4;SLC22A18,GIPR;ZC3H4,3,3,2
96,Venous Thromboembolism Or Factor VIII Levels (Pleiotropy),0.0018904204196260454,34.71951219512195,217.72453437258292,TSPAN15;PLCG2,0.016560870551099,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
12,GTEX-QVUS-2926-SM-3GIJB brain female 60-69 years,0.00011982288432345178,4.372786357402659,39.48405635220383,CDKN1C;GRN;KCNQ1;SLC22A18;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQB1,0.016625425199878936,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQB1,CDKN1C;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQB1,9,8,5
25,Herpes simplex virus 1 infection,0.004140547981131802,5.194832924095228,28.503669745019156,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.01672781384377248,KEGG_2021_Human,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
280,Prominent metopic ridge,0.0021496497140763666,32.40162601626016,199.02537983535302,CDKN1C;KCNQ1,0.01675191312898083,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
1,citalopram DB00215 human GSE7036 sample 3292,3.2969925233861656e-05,11.3139735480161,116.75924270955488,CCND2;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.016880601719737168,Drug_Perturbations_from_GEO_down,PLCG2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,CCND2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,4
6,Low-Density Lipoprotein Particle Receptor Binding (GO:0050750),0.001014884135775059,48.62682926829268,335.18380172445745,APOE;PICALM,0.01708388295221349,GO_Molecular_Function_2023,APOE;PICALM,,,2,0,0
13,GTEX-TKQ1-0008-SM-4DXSO skin male 30-39 years,0.00013454950750044328,4.089696652719665,36.45383150553143,CDKN1C;GIPR;TREM2;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.01723268692217216,GTEx_Tissue_Expression_Down,GIPR;TREM2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;GIPR;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,11,7
7,mRNA 5'-UTR Binding (GO:0048027),0.0012092868136118387,44.20177383592018,296.9353391905164,IGF2BP3;IGF2BP2,0.01744828116782796,GO_Molecular_Function_2023,,IGF2BP3;IGF2BP2,,0,2,0
24,Early Endosome (GO:0005769),0.0041950289047322795,6.652788355758653,36.416399129799785,KCNQ1;APOE;PICALM;APPL1,0.017479287103051164,GO_Cellular_Component_2023,APOE;PICALM;APPL1,KCNQ1,,3,1,0
282,Meniere Disease,0.0022852225093912054,31.35483870967742,190.6779260779712,MTNR1B;HLA-DRB1,0.017512445313642197,DisGeNET,HLA-DRB1,MTNR1B;HLA-DRB1,HLA-DRB1,1,2,1
283,Childhood T Acute Lymphoblastic Leukemia,0.0022852225093912054,31.35483870967742,190.6779260779712,CDKN2B;CCND2,0.017512445313642197,DisGeNET,,CDKN2B;CCND2,,0,2,0
284,"Adenocarcinoma, Oxyphilic",0.0022873725547149525,12.50294117647059,76.02227683860059,CDKN1C;KCNQ1;APOE,0.017512445313642197,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
285,Waist-Hip Ratio,0.0022873725547149525,12.50294117647059,76.02227683860059,MTNR1B;QPCTL;BTNL2,0.017512445313642197,DisGeNET,QPCTL;BTNL2,MTNR1B;QPCTL;BTNL2,QPCTL;BTNL2,2,3,2
281,Agitation,0.0022852225093912054,31.35483870967742,190.6779260779712,GRN;TREM2,0.017512445313642197,DisGeNET,GRN;TREM2,,,2,0,0
75,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.0017469205497262674,13.784027777777778,87.52720800686893,CDKN1C;CDKN2B;IL17RD,0.01790045128278437,GO_Biological_Process_2023,IL17RD,CDKN1C;CDKN2B,,1,2,0
76,Positive Regulation Of Endopeptidase Activity (GO:0010950),0.0017667977889501455,36.00722673893406,228.23492237875305,APH1B;PICALM,0.01790045128278437,GO_Biological_Process_2023,APH1B;PICALM,,,2,0,0
286,Endothelial dysfunction,0.0023778912835050003,7.83104750546611,47.31159613854709,MTNR1B;APOE;HLA-DRB1;APPL1,0.018141813918209477,DisGeNET,APOE;HLA-DRB1;APPL1,MTNR1B;HLA-DRB1,HLA-DRB1,3,2,1
34,Cyclin D-associated events in G1,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN2B;CCND2,0.01830973571632348,BioPlanet_2019,,CDKN2B;CCND2,,0,2,0
288,Familial M??ni??re disease,0.0024507905332330584,12.193647540983607,73.30021778565637,MTNR1B;HLA-DRB1;HLA-DQA1,0.01856814216498102,DisGeNET,HLA-DRB1;HLA-DQA1,MTNR1B;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,3,2
287,"Adenocarcinoma, Tubular",0.0024507905332330584,12.193647540983607,73.30021778565637,CDKN1C;KCNQ1;APOE,0.01856814216498102,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
289,Memory Loss,0.00250682887301696,12.09390243902439,72.42719764647528,GRN;TREM2;APOE,0.01888073041565718,DisGeNET,GRN;TREM2;APOE,,,3,0,0
290,Childhood Acute Lymphoblastic Leukemia,0.002509354638194584,5.863674597452535,35.11009839262281,CDKN1C;CDKN2B;CCND2;HLA-DRA;HLA-DRB1,0.01888073041565718,DisGeNET,HLA-DRA;HLA-DRB1,CDKN1C;CDKN2B;CCND2;HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,5,2
77,Regulation Of Calcium-Mediated Signaling (GO:0050848),0.0018904204196260454,34.71951219512195,217.72453437258292,PLCG2;TREM2,0.018904204196260453,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
97,Sex Hormone-Binding Globulin Levels In Postmenopausal Women,0.002182302426567309,12.717948717948717,77.92763848903097,CCND2;IGF2BP2;JAZF1,0.018920787017970172,GWAS_Catalog_2023,JAZF1,CCND2;IGF2BP2;JAZF1,JAZF1,1,3,1
291,"Gastritis, Atrophic",0.0025636564565395072,11.995766129032258,71.57058820236952,GRN;HLA-DRB1;HLA-DQA1,0.018931799463698783,DisGeNET,GRN;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
292,Excessive daytime somnolence,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
293,Sparse axillary hair,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;IL17RD,0.018931799463698783,DisGeNET,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
294,Hepatitis B Virus-Related Hepatocellular Carcinoma,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DQA1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
295,Intrahepatic Cholestasis,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
296,Low Grade Squamous Intraepithelial Neoplasia,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
299,Biliary Tract Cancer,0.002621277075775762,11.8992,70.72995911800506,CDKN2B;CCND2;IGF2BP3,0.01912918588408934,DisGeNET,,CDKN2B;CCND2;IGF2BP3,,0,3,0
297,Colorectal Cancer,0.0026153057024511372,2.7208346024977157,16.17910091369031,CDKN1C;CDKN2B;GRN;EML2;CCND2;KCNQ1;SLC22A18;HLA-DRA;IGF2BP3;ALPK2;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.01912918588408934,DisGeNET,GRN;EML2;HLA-DRA;ALPK2;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;EML2;CCND2;KCNQ1;SLC22A18;HLA-DRA;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,EML2;HLA-DRA;HLA-DRB1;JAZF1,8,11,4
298,Arthralgia,0.002621277075775762,11.8992,70.72995911800506,PLCG2;TREM2;HLA-DRB1,0.01912918588408934,DisGeNET,PLCG2;TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,3,1,1
8,Lipoprotein Particle Receptor Binding (GO:0070325),0.0015316216181504704,38.89170731707317,252.0738094731918,APOE;PICALM,0.01933672292914969,GO_Molecular_Function_2023,APOE;PICALM,,,2,0,0
300,"Hepatitis, Autoimmune",0.002679694489174682,11.804166666666667,69.90489457160028,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.019490311251263853,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
303,Autoimmune state,0.002715571355744258,28.58393113342898,168.89538608185973,HLA-DRB1;HLA-DQB1,0.019491370717874903,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
302,Low Tension Glaucoma,0.002715571355744258,28.58393113342898,168.89538608185973,CDKN2B;APOE,0.019491370717874903,DisGeNET,APOE,CDKN2B,,1,1,0
301,Thickened nuchal skin fold,0.002715571355744258,28.58393113342898,168.89538608185973,GRN;TREM2,0.019491370717874903,DisGeNET,GRN;TREM2,,,2,0,0
304,Oestrogen deficiency,0.002715571355744258,28.58393113342898,168.89538608185973,PLCG2;APOE,0.019491370717874903,DisGeNET,PLCG2;APOE,,,2,0,0
14,GTEX-POYW-0526-SM-2XCEY muscle male 60-69 years,0.00016412854946521016,4.216771117690031,36.74857246846654,ATP8B4;TOX2;APH1B;CCND2;GIPR;IDUA;ZC3H4;QPCTL;TREM2;APOE;NPAS1;EML2,0.019519573918541065,GTEx_Tissue_Expression_Down,ATP8B4;APH1B;GIPR;IDUA;ZC3H4;QPCTL;TREM2;APOE;NPAS1;EML2,TOX2;CCND2;GIPR;ZC3H4;QPCTL;NPAS1;EML2,GIPR;ZC3H4;QPCTL;NPAS1;EML2,10,7,5
98,Venous Thromboembolism Or Von Willebrand Factor Levels (Pleiotropy),0.0022852225093912054,31.35483870967742,190.6779260779712,TSPAN15;PLCG2,0.019610940106102075,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
79,Positive Regulation Of Cholesterol Transport (GO:0032376),0.00201804338139322,33.5206055508831,208.01637017204203,TREM2;APOE,0.01966953675535164,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
78,Regulation Of Response To Biotic Stimulus (GO:0002831),0.00201804338139322,33.5206055508831,208.01637017204203,TREM2;APPL1,0.01966953675535164,GO_Biological_Process_2023,TREM2;APPL1,,,2,0,0
16,DAP12 Signaling R-HSA-2424491,0.001647192500753881,37.39399624765478,239.64626637110106,PLCG2;TREM2,0.01997220907164081,Reactome_2022,PLCG2;TREM2,,,2,0,0
18,GTEX-OOBK-0008-SM-3NB27 skin male 40-49 years,0.00021602938742042215,4.083557347670251,34.465616471403244,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.01998271833638905,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
17,GTEX-X261-0011-R11A-SM-4E3JY brain male 50-59 years,0.00021109040660064133,4.351813826146475,36.830375430006804,CDKN1C;CDKN2B;GRN;KCNQ1;SLC22A18;CHST15;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DQB2,0.01998271833638905,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DQB2,CDKN1C;CDKN2B;KCNQ1;SLC22A18;CHST15;HLA-DRA;HLA-DQA2;HLA-DQB2,HLA-DRA;HLA-DQA2;HLA-DQB2,6,8,3
16,GTEX-UJMC-1826-SM-3GADT muscle male 50-59 years,0.00020731422164050158,3.17058742470176,26.89062365981755,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;TOX2;APH1B;CCND2;SNRPD2;KCNQ1;SLC22A18;PLCG2;APOE;PVRL2;PICALM;JAZF1,0.01998271833638905,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SNRPD2;PLCG2;APOE;PVRL2;PICALM;JAZF1,GIPR;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;SNRPD2;KCNQ1;SLC22A18;JAZF1,GIPR;QPCTL;NPAS1;EML2;SNRPD2;JAZF1,15,12,6
15,GTEX-WXYG-2526-SM-3NB3F muscle female 50-59 years,0.00019271595245956184,3.1599344507374294,27.031005790897787,ATP8B4;GRN;GIPR;IDUA;QPCTL;JADE2;NPAS1;EML2;TOX2;APH1B;CCND2;SLC22A18;HESX1;PLCG2;HLA-DRA;IGF2BP2;PVRL2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1;JAZF1,0.01998271833638905,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;NPAS1;EML2;APH1B;HESX1;PLCG2;HLA-DRA;PVRL2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1;JAZF1,GIPR;QPCTL;JADE2;NPAS1;EML2;TOX2;CCND2;SLC22A18;HLA-DRA;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;NPAS1;EML2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,17,14,9
26,Vibrio cholerae infection,0.005180691162792406,20.232723577235774,106.48111760263689,KCNQ1;PLCG2,0.020124992593924345,KEGG_2021_Human,PLCG2,KCNQ1,,1,1,0
19,GTEX-WFG7-0008-SM-4LMKB skin male 20-29 years,0.0002304035414829707,4.052725250278087,33.944322765377805,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.020190626135218222,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
307,Congenital hypoplasia of breast,0.002866841941964989,27.765853658536585,162.55641815307325,HESX1;IL17RD,0.020376055756897736,DisGeNET,HESX1;IL17RD,,,2,0,0
306,Increased calcium level in kidney,0.002866841941964989,27.765853658536585,162.55641815307325,CDKN1C;KCNQ1,0.020376055756897736,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
305,Adenocarcinoma,0.002862567080424187,3.2501869458391197,19.03321330919581,CDKN1C;CDKN2B;SHARPIN;CCND2;KCNQ1;SLC22A18;IGF2BP3;APOE;HLA-DQA1;HLA-DQB1,0.020376055756897736,DisGeNET,SHARPIN;APOE;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;CCND2;KCNQ1;SLC22A18;IGF2BP3;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,4,8,2
80,Regulation Of Cholesterol Efflux (GO:0010874),0.0021496497140763666,32.40162601626016,199.02537983535302,TREM2;APOE,0.020690378497985027,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
308,beta Thalassemia,0.002921406105638229,11.438653846153846,66.75244055817723,APOE;HLA-DQA1;HLA-DQB1,0.02069645494319031,DisGeNET,APOE;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
309,Common acute lymphoblastic leukemia,0.0030219952153155262,26.993224932249323,156.61031811173902,HLA-DQA1;HLA-DQB1,0.021071708018668457,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
310,Prominent back of the head,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;KCNQ1,0.021071708018668457,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
311,Prominent occiput,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;KCNQ1,0.021071708018668457,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
312,End Stage Liver Disease,0.0030219952153155262,26.993224932249323,156.61031811173902,HLA-DRB1;HLA-DQB1,0.021071708018668457,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
313,Malignant neoplasm of ovary,0.003022660224492771,3.0608250620347395,17.75773767158818,CDKN1C;CDKN2B;GRN;CCND2;CHST15;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.021071708018668457,DisGeNET,GRN;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;CCND2;CHST15;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,HLA-DRB1;JAZF1,5,8,2
314,Motor Neuron Disease,0.0030471379886528576,11.264204545454545,65.25976032911598,GRN;TREM2;APOE,0.021107476480128683,DisGeNET,GRN;TREM2;APOE,,,3,0,0
315,Dystonia Disorders,0.0030471379886528576,11.264204545454545,65.25976032911598,APOE;HLA-DRB1;HLA-DQB1,0.021107476480128683,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
316,Crohn Disease,0.0030693280356545137,4.093431553100062,23.68580916905406,HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.0211939043474625,DisGeNET,HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,7,6,6
81,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),0.0022852225093912054,31.35483870967742,190.6779260779712,HLA-DRA;HLA-DRB1,0.021200257014834075,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
82,Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),0.0022852225093912054,31.35483870967742,190.6779260779712,PLCG2;TREM2,0.021200257014834075,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
83,Regulation Of Amyloid-Beta Formation (GO:1902003),0.0022852225093912054,31.35483870967742,190.6779260779712,APOE;PICALM,0.021200257014834075,GO_Biological_Process_2023,APOE;PICALM,,,2,0,0
317,Coronary heart disease,0.0030881051821298063,4.088698798135884,23.633486922167613,CDKN2B;KCNQ1;IGF2BP2;APOE;HLA-DRB1;HLA-DQB1;JAZF1,0.021256294976048067,DisGeNET,APOE;HLA-DRB1;HLA-DQB1;JAZF1,CDKN2B;KCNQ1;IGF2BP2;HLA-DRB1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQB1;JAZF1,4,6,3
318,"Amyotrophic Lateral Sclerosis, Sporadic",0.0031112354458513506,11.178947368421053,64.53310500947813,GRN;TREM2;APOE,0.02134816271335738,DisGeNET,GRN;TREM2;APOE,,,3,0,0
320,Low Grade Lymphoma (neoplasm),0.0031810145747939787,26.262359920896508,151.0231473713992,CDKN1C;HLA-DRB1,0.02169054313187644,DisGeNET,HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,1,2,1
319,Fasting blood glucose measurement,0.0031810145747939787,26.262359920896508,151.0231473713992,MTNR1B;IGF2BP2,0.02169054313187644,DisGeNET,,MTNR1B;IGF2BP2,,0,2,0
22,GTEX-OHPK-0008-SM-4E3JL skin female 50-59 years,0.0002873853134298829,3.9480829803410447,32.195379719438705,TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.02174984303912523,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,6
21,GTEX-TSE9-0011-R11A-SM-3DB7N brain female 60-69 years,0.00027770949362439966,4.2054666777188325,34.43829317436936,CDKN2B;TOX2;GRN;SHARPIN;SNRPD2;KCNQ1;SLC22A18;CHST15;PLCG2;PVRL2;HLA-DRB1,0.02174984303912523,GTEx_Tissue_Expression_Down,GRN;SHARPIN;SNRPD2;PLCG2;PVRL2;HLA-DRB1,CDKN2B;TOX2;SNRPD2;KCNQ1;SLC22A18;CHST15;HLA-DRB1,SNRPD2;HLA-DRB1,6,7,2
20,GTEX-QCQG-0008-SM-48U2G skin female 50-59 years,0.00026986362087378306,4.220600465735196,34.68318036490544,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.02174984303912523,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,10,5
99,Neurofibrillary Tangles,0.002568200110565921,29.45158906134516,175.66547469692333,APOE;HLA-DRB1,0.021816730232181208,GWAS_Catalog_2023,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
84,Positive Regulation Of Neuron Death (GO:1901216),0.0024247449101167736,30.3734756097561,182.90994948965815,GRN;PICALM,0.02222682834273709,GO_Biological_Process_2023,GRN;PICALM,,,2,0,0
322,Sparse pubic hair,0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DRA;IL17RD,0.02231300832870677,DisGeNET,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
321,"Dermatomyositis, Childhood Type",0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DQA1;HLA-DRB1,0.02231300832870677,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
323,"Purpura, Thrombotic Thrombocytopenic",0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DRB1;HLA-DQB1,0.02231300832870677,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
325,Malignant neoplasm of stomach stage IV,0.003343883466309401,25.569961489088573,145.76469607458566,KCNQ1;IGF2BP2,0.02231300832870677,DisGeNET,,KCNQ1;IGF2BP2,,0,2,0
326,Congenital omphalocele,0.003343883466309401,25.569961489088573,145.76469607458566,CDKN1C;KCNQ1,0.02231300832870677,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
327,Psychiatric symptom,0.003343883466309401,25.569961489088573,145.76469607458566,TREM2;APOE,0.02231300832870677,DisGeNET,TREM2;APOE,,,2,0,0
324,Islet Cell Tumor,0.003343883466309401,25.569961489088573,145.76469607458566,GRN;NEUROG3,0.02231300832870677,DisGeNET,GRN,NEUROG3,,1,1,0
328,"Cholangitis, Sclerosing",0.0033759166298489595,10.85036496350365,61.75038615247198,HLA-DRB1;NEUROG3;JAZF1,0.02245807953149521,DisGeNET,HLA-DRB1;JAZF1,HLA-DRB1;NEUROG3;JAZF1,HLA-DRB1;JAZF1,2,3,2
25,Membrane Raft (GO:0045121),0.005708965774535606,8.94171686746988,46.19038238151303,KCNQ1;PLCG2;TREM2,0.022835863098142423,GO_Cellular_Component_2023,PLCG2;TREM2,KCNQ1,,2,1,0
100,Free Cholesterol To Total Lipids Ratio In Large VLDL,0.002715571355744258,28.58393113342898,168.89538608185973,APOE;HLA-DQB1,0.022837955101809207,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
23,GTEX-T5JW-0426-SM-4DM7M ovary female 20-29 years,0.00032317491010420914,7.3465855646830125,59.04683605154258,CDKN2B;CCND2;GIPR;IGF2BP2;NPAS1;EML2,0.022849814178922807,GTEx_Tissue_Expression_Down,GIPR;NPAS1;EML2,CDKN2B;CCND2;GIPR;IGF2BP2;NPAS1;EML2,GIPR;NPAS1;EML2,3,6,3
24,GTEX-X638-0008-SM-47JZ7 skin female 70-79 years,0.0003500365497694886,4.377755887043813,34.835874188653285,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.022849814178922807,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
25,GTEX-T2IS-0011-R11A-SM-32QPC brain female 20-29 years,0.00035249880178174985,3.8529088913282106,30.632410873286187,CDKN1C;TOX2;GRN;SHARPIN;KCNQ1;SLC22A18;PLCG2;ALPK2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.022849814178922807,GTEx_Tissue_Expression_Down,GRN;SHARPIN;PLCG2;ALPK2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;TOX2;KCNQ1;SLC22A18;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,8,7,3
26,GTEX-V1D1-2426-SM-3GAER muscle male 50-59 years,0.00035681391510630214,3.302786317279071,26.218495934081137,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;KCNQ1;SLC22A18;APOE;JAZF1,0.022849814178922807,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APOE;JAZF1,GIPR;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;KCNQ1;SLC22A18;JAZF1,GIPR;QPCTL;NPAS1;EML2;JAZF1,10,11,5
27,GTEX-QVJO-0008-SM-447AU skin female 60-69 years,0.00037126484644656757,3.6497796663519044,28.828130979273162,CDKN1C;GIPR;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.022894665530871668,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;GIPR;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,12,7
86,Macrophage Activation (GO:0042116),0.002568200110565921,29.45158906134516,175.66547469692333,PLCG2;TREM2,0.02299434982715999,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
85,Regulation Of Response To External Stimulus (GO:0032101),0.0025636564565395072,11.995766129032258,71.57058820236952,GRN;TREM2;APPL1,0.02299434982715999,GO_Biological_Process_2023,GRN;TREM2;APPL1,,,3,0,0
331,Dysphasia,0.003510585390397297,24.91307066916823,140.8079897526317,GRN;TREM2,0.02314228798141058,DisGeNET,GRN;TREM2,,,2,0,0
330,"Nephrotic Syndrome, Minimal Change",0.003510585390397297,24.91307066916823,140.8079897526317,APOE;HLA-DRB1,0.02314228798141058,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
329,Schwartz-Jampel Syndrome,0.003510585390397297,24.91307066916823,140.8079897526317,HLA-DRB1;HLA-DQB1,0.02314228798141058,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
332,Myositis,0.0035832287206006993,10.61625,59.78531641106525,APOE;HLA-DRB1;HLA-DQA1,0.02350431187941442,DisGeNET,APOE;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
333,ovarian neoplasm,0.003587046680038956,3.973684210526316,22.373535160359225,CDKN1C;CDKN2B;GRN;CCND2;APOE;HLA-DRB1;HLA-DQA1,0.02350431187941442,DisGeNET,GRN;APOE;HLA-DRB1;HLA-DQA1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,4,5,2
101,BMI In Non-Smokers,0.002866841941964989,27.765853658536585,162.55641815307325,ZC3H4;QPCTL,0.023871426467253026,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
87,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),0.002715571355744258,28.58393113342898,168.89538608185973,HLA-DRA;HLA-DRB1,0.024034367171529635,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
334,"Mitral regurgitation, mild",0.003681103895283636,24.289024390243902,136.12887191337333,CCND2;IDUA,0.024048409279966747,DisGeNET,IDUA,CCND2,,1,1,0
35,Interleukin-12/STAT4 pathway,0.004215395129783775,22.59103800340329,123.55065676287644,HLA-DRA;HLA-DRB1,0.024121427687096048,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
36,Wnt interactions in lipid metabolism and immune response,0.004215395129783775,22.59103800340329,123.55065676287644,PLCG2;APOE,0.024121427687096048,BioPlanet_2019,PLCG2;APOE,,,2,0,0
17,Nuclear Signaling By ERBB4 R-HSA-1251985,0.0021496497140763666,32.40162601626016,199.02537983535302,APH1B;APOE,0.024531296737106772,Reactome_2022,APH1B;APOE,,,2,0,0
102,Phospholipids To Total Lipids Ratio In Very Large VLDL,0.0030219952153155262,26.993224932249323,156.61031811173902,APOE;HLA-DQB1,0.02491664682431723,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
88,Positive Regulation Of Immune Effector Process (GO:0002699),0.002866841941964989,27.765853658536585,162.55641815307325,HLA-DRA;HLA-DRB1,0.02508486699219365,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
89,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),0.0029838627187143757,11.350763358778625,65.9994290271906,PLCG2;BTNL2;HLA-DRB1,0.025815441498989542,GO_Biological_Process_2023,PLCG2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
103,Free Cholesterol Levels In Medium LDL,0.0031810145747939787,26.262359920896508,151.0231473713992,APOE;HLA-DQA1,0.025973138421376076,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
338,Neurocognitive Disorders,0.004033525091037281,23.130081300813007,127.51878829292204,TREM2;APOE,0.02603891049894481,DisGeNET,TREM2;APOE,,,2,0,0
337,Birth Weight,0.004033525091037281,23.130081300813007,127.51878829292204,MTNR1B;IGF2BP3,0.02603891049894481,DisGeNET,,MTNR1B;IGF2BP3,,0,2,0
336,Toxic Shock Syndrome,0.004033525091037281,23.130081300813007,127.51878829292204,HLA-DRA;HLA-DRB1,0.02603891049894481,DisGeNET,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
335,Sickle Cell Trait,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;IL17RD,0.02603891049894481,DisGeNET,APOE;IL17RD,,,2,0,0
28,GTEX-NFK9-0008-SM-4E3JE skin male 40-49 years,0.0004393443996539639,3.579675174013921,27.67170147732725,CDKN1C;TREM2;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.02612530090799464,GTEx_Tissue_Expression_Down,TREM2;PLCG2;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,6
106,Concentration Of Small HDL Particles,0.003343883466309401,25.569961489088573,145.76469607458566,CCND2;HLA-DRB1,0.02653024523741704,GWAS_Catalog_2023,HLA-DRB1,CCND2;HLA-DRB1,HLA-DRB1,1,2,1
105,Ocular Sarcoidosis,0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DQA1;HLA-DQB1,0.02653024523741704,GWAS_Catalog_2023,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
104,Hippocampal Volume,0.003343883466309401,25.569961489088573,145.76469607458566,SHARPIN;APOE,0.02653024523741704,GWAS_Catalog_2023,SHARPIN;APOE,,,2,0,0
37,Chondroitin sulfate/dermatan sulfate metabolism,0.004783448141947699,21.114528101802758,112.80634320901902,IDUA;CHST15,0.026632170736249353,BioPlanet_2019,IDUA,CHST15,,1,1,0
339,Primary Sj??gren's syndrome,0.004173663308685989,10.038344594594594,54.99969991889258,APOE;HLA-DRB1;HLA-DQB1,0.02686411014617354,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
341,"Obesity, Visceral",0.004215395129783775,22.59103800340329,123.55065676287644,GRN;APOE,0.026888375604930785,DisGeNET,GRN;APOE,,,2,0,0
342,Hypopituitarism,0.004215395129783775,22.59103800340329,123.55065676287644,HESX1;APOE,0.026888375604930785,DisGeNET,HESX1;APOE,,,2,0,0
343,Infection caused by Helicobacter pylori,0.004243652573133693,6.630566801619433,36.21835008844818,CDKN1C;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.026888375604930785,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
344,Aneurysm,0.00425137011168704,9.970469798657717,54.4438896108531,CDKN2B;HESX1;APOE,0.026888375604930785,DisGeNET,HESX1;APOE,CDKN2B,,2,1,0
345,Decreased platelet count,0.00425137011168704,9.970469798657717,54.4438896108531,BTNL2;APOE;HLA-DRB1,0.026888375604930785,DisGeNET,BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
340,Sleeplessness,0.004215395129783775,22.59103800340329,123.55065676287644,HLA-DRB1;HLA-DQB1,0.026888375604930785,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
38,Interleukin-5 signaling pathway,0.004980226270684628,20.664244940321744,109.56761169296043,HLA-DRA;HLA-DRB1,0.026998068730553514,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
107,FEV1,0.003444176857695517,10.771195652173914,61.084208203667956,IGF2BP2;HLA-DQB1;JAZF1,0.02707058633011149,GWAS_Catalog_2023,HLA-DQB1;JAZF1,IGF2BP2;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,3,2
108,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),0.003510585390397297,24.91307066916823,140.8079897526317,CDKN2B;JAZF1,0.027086259755267218,GWAS_Catalog_2023,JAZF1,CDKN2B;JAZF1,JAZF1,1,2,1
109,Total Lipid Levels In Large LDL,0.003510585390397297,24.91307066916823,140.8079897526317,APOE;HLA-DQA1,0.027086259755267218,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
346,Familial lichen amyloidosis,0.004329954319218911,9.9035,53.89681073389184,GRN;APOE;PICALM,0.027281300801930464,DisGeNET,GRN;APOE;PICALM,,,3,0,0
348,"Sarcoidosis, Pulmonary",0.004401016444674392,22.07649667405765,119.78529941576386,HLA-DRB1;HLA-DQB1,0.027281300801930464,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
349,"Sleep Apnea, Central",0.004401016444674392,22.07649667405765,119.78529941576386,APOE;HLA-DRB1,0.027281300801930464,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
350,Infiltrating Cervical Carcinoma,0.004401016444674392,22.07649667405765,119.78529941576386,HLA-DQB2;HLA-DQB1,0.027281300801930464,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
351,Moyamoya disease 1,0.004401016444674392,22.07649667405765,119.78529941576386,APOE;JAZF1,0.027281300801930464,DisGeNET,APOE;JAZF1,JAZF1,JAZF1,2,1,1
347,"Kidney Failure, Acute",0.004342044383891917,6.586559410088822,35.8269970258904,CDKN2B;GRN;APOE;HLA-DRB1,0.027281300801930464,DisGeNET,GRN;APOE;HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,3,2,1
352,Decreased fertility,0.004401016444674392,22.07649667405765,119.78529941576386,HESX1;IL17RD,0.027281300801930464,DisGeNET,HESX1;IL17RD,,,2,0,0
353,Aplastic Anemia,0.0044897668135540645,9.772203947368421,52.828090033158816,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.02775260959539651,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
110,Free Cholesterol Levels In LDL,0.003681103895283636,24.289024390243902,136.12887191337333,APOE;HLA-DQA1,0.027890165548950793,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
111,Free Cholesterol Levels In Small LDL,0.003681103895283636,24.289024390243902,136.12887191337333,APOE;HLA-DQA1,0.027890165548950793,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
354,Body Height,0.00454344522626694,6.500248138957816,35.06279149182547,CCND2;KCNQ1;IGF2BP3;JAZF1,0.02800507763761148,DisGeNET,JAZF1,CCND2;KCNQ1;IGF2BP3;JAZF1,JAZF1,1,4,1
355,Mitral Valve Insufficiency,0.004590372832968766,21.584823848238482,116.20824579394697,CCND2;IDUA,0.028135375060499568,DisGeNET,IDUA,CCND2,,1,1,0
356,Carcinoma in situ of uterine cervix,0.004590372832968766,21.584823848238482,116.20824579394697,HLA-DQB2;HLA-DQB1,0.028135375060499568,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
112,Platelet Count,0.003825252034737163,3.925011795234725,21.847129524397076,ATP8B4;KCNQ1;PLCG2;IGF2BP2;APOE;PICALM;HLA-DQB1,0.028442196393125462,GWAS_Catalog_2023,ATP8B4;PLCG2;APOE;PICALM;HLA-DQB1,KCNQ1;IGF2BP2;HLA-DQB1,HLA-DQB1,5,3,1
114,Cholesterol Levels In Large LDL,0.0038554225788541055,23.695419393218323,131.70564916179435,APOE;HLA-DQA1,0.028442196393125462,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
113,Cholesterol Levels In Very Small VLDL,0.0038554225788541055,23.695419393218323,131.70564916179435,APOE;HLA-DQA1,0.028442196393125462,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
26,Endosome Membrane (GO:0010008),0.007399795527486081,5.63097033685269,27.62724615305941,APH1B;HLA-DRA;HLA-DRB1;APPL1,0.02846075202879262,GO_Cellular_Component_2023,APH1B;HLA-DRA;HLA-DRB1;APPL1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,4,2,2
90,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),0.003343883466309401,25.569961489088573,145.76469607458566,CCND2;PLCG2,0.028608780767313765,GO_Biological_Process_2023,PLCG2,CCND2,,1,1,0
357,Psychotic Disorders,0.004698579911177822,6.4369623986237405,34.50530451149253,GRN;MTNR1B;APOE;NPAS1,0.028717930997731112,DisGeNET,GRN;APOE;NPAS1,MTNR1B;NPAS1,NPAS1,3,2,1
115,Triglycerides To Total Lipids Ratio In Large VLDL,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;HLA-DQA1,0.029243056910020285,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
116,Cerebrospinal Fluid Biomarker Levels,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;IL17RD,0.029243056910020285,GWAS_Catalog_2023,APOE;IL17RD,,,2,0,0
18,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.002715571355744258,28.58393113342898,168.89538608185973,CDKN1C;CCND2,0.029267824611910336,Reactome_2022,,CDKN1C;CCND2,,0,2,0
359,Cardiomegaly,0.004820049529951936,9.519711538461538,50.787385700500494,CDKN1C;CCND2;KCNQ1,0.029296234190404245,DisGeNET,,CDKN1C;CCND2;KCNQ1,,0,3,0
358,Malignant neoplasm of large intestine,0.004809793854085136,5.007209805335256,26.723984727458,CDKN1C;CDKN2B;GRN;KCNQ1;ALPK2,0.029296234190404245,DisGeNET,GRN;ALPK2,CDKN1C;CDKN2B;KCNQ1,,2,3,0
119,Calcium Levels,0.004243652573133693,6.630566801619433,36.21835008844818,TOX2;CCND2;SLC22A18;JADE2,0.02999085557987761,GWAS_Catalog_2023,,TOX2;CCND2;SLC22A18;JADE2,,0,4,0
118,Waist Circumference Adjusted For Body Mass Index,0.004217035970031896,3.8519870235198703,21.06506396384544,CCND2;KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;JAZF1,0.02999085557987761,GWAS_Catalog_2023,HLA-DRA;BTNL2;JAZF1,CCND2;KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;JAZF1,HLA-DRA;BTNL2;JAZF1,3,7,3
117,BMI (Standard GWA),0.004173663308685989,10.038344594594594,54.99969991889258,GIPR;JADE2;NPAS1,0.02999085557987761,GWAS_Catalog_2023,GIPR;NPAS1,GIPR;JADE2;NPAS1,GIPR;NPAS1,2,3,2
361,Weight decreased,0.004990565217077276,9.398259493670887,49.81271235109973,BTNL2;HLA-DRB1;HLA-DQB1,0.030164579788539102,DisGeNET,BTNL2;HLA-DRB1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB1,3,3,3
360,Abnormality of vision,0.004980226270684628,20.664244940321744,109.56761169296043,HLA-DRB1;HLA-DQB1,0.030164579788539102,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
91,Positive Regulation Of Transferase Activity (GO:0051347),0.0035832287206006993,10.61625,59.78531641106525,TREM2;APOE;HLA-DRB1,0.03031962763585207,GO_Biological_Process_2023,TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,3,1,1
2,"1,2,4-BENZENETRIOL 10787 human GSE7664 sample 3535",0.00011957298135031777,11.750416765896642,106.12487194838809,GRN;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.030610683225681348,Drug_Perturbations_from_GEO_down,GRN;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,4,4
120,Cholesterol To Total Lipids Ratio In Small HDL,0.004401016444674392,22.07649667405765,119.78529941576386,GIPR;APOE,0.0308437902497597,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
19,Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;CCND2,0.03085616167216906,Reactome_2022,,CDKN1C;CCND2,,0,2,0
362,Varicella zoster,0.005180691162792406,20.232723577235774,106.48111760263689,APOE;HLA-DRB1,0.031055681640695134,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
363,Advanced bone age,0.005180691162792406,20.232723577235774,106.48111760263689,CDKN1C;KCNQ1,0.031055681640695134,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
364,Moyamoya Disease,0.005180691162792406,20.232723577235774,106.48111760263689,APOE;JAZF1,0.031055681640695134,DisGeNET,APOE;JAZF1,JAZF1,JAZF1,2,1,1
122,Venous Thromboembolism Or Fibrinogen Levels (Pleiotropy),0.004590372832968766,21.584823848238482,116.20824579394697,TSPAN15;PLCG2,0.03105775774856803,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
124,Pulse Pressure,0.004615171336138523,4.277166054943833,23.004336795288783,ATP8B4;CCND2;MTNR1B;GIPR;QPCTL;APOE,0.03105775774856803,GWAS_Catalog_2023,ATP8B4;GIPR;QPCTL;APOE,CCND2;MTNR1B;GIPR;QPCTL,GIPR;QPCTL,4,4,2
125,Lymphocyte Count,0.004645697125970472,4.27108478341355,22.943472338696758,CCND2;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.03105775774856803,GWAS_Catalog_2023,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,CCND2;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,5,6,5
126,Peak Expiratory Flow,0.004653124228679633,9.644318181818182,51.79207574258261,IGF2BP2;HLA-DQB1;JAZF1,0.03105775774856803,GWAS_Catalog_2023,HLA-DQB1;JAZF1,IGF2BP2;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,3,2
121,Estimated Glomerular Filtration Rate (Creatinine),0.004584794865183838,4.283264033264033,23.065419286372652,APH1B;GIPR;KCNQ1;SLC22A18;APOE;IL17RD,0.03105775774856803,GWAS_Catalog_2023,APH1B;GIPR;APOE;IL17RD,GIPR;KCNQ1;SLC22A18,GIPR,4,3,1
123,Age At First Birth,0.004590372832968766,21.584823848238482,116.20824579394697,JADE2;HLA-DQA2,0.03105775774856803,GWAS_Catalog_2023,HLA-DQA2,JADE2;HLA-DQA2,HLA-DQA2,1,2,1
127,Body Surface Area,0.004698579911177822,6.4369623986237405,34.50530451149253,GIPR;ZC3H4;IGF2BP2;JAZF1,0.03111421815197282,GWAS_Catalog_2023,GIPR;ZC3H4;JAZF1,GIPR;ZC3H4;IGF2BP2;JAZF1,GIPR;ZC3H4;JAZF1,3,4,3
365,Polycystic Ovary Syndrome,0.0052133143061567685,4.908576623901404,25.80212682520637,GRN;CCND2;MTNR1B;APOE;HLA-DRB1,0.03116562141379197,DisGeNET,GRN;APOE;HLA-DRB1,CCND2;MTNR1B;HLA-DRB1,HLA-DRB1,3,3,1
367,Pancreatic carcinoma,0.0053803365325682,2.950103509544069,15.414303682834731,CDKN1C;CDKN2B;CCND2;MTNR1B;KCNQ1;CHST15;IGF2BP3;EML2;HLA-DRB1;NEUROG3,0.03158519384950702,DisGeNET,EML2;HLA-DRB1,CDKN1C;CDKN2B;CCND2;MTNR1B;KCNQ1;CHST15;IGF2BP3;EML2;HLA-DRB1;NEUROG3,EML2;HLA-DRB1,2,10,2
368,"Cockayne Syndrome, Type I",0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DRB1,0.03158519384950702,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
369,Tardive Dyskinesia,0.005384826815772965,19.818815331010452,103.53686305193918,MTNR1B;APOE,0.03158519384950702,DisGeNET,APOE,MTNR1B,,1,1,0
370,Tumors of Adrenal Cortex,0.005384826815772965,19.818815331010452,103.53686305193918,CDKN1C;CCND2,0.03158519384950702,DisGeNET,,CDKN1C;CCND2,,0,2,0
371,C-reactive protein measurement,0.005384826815772965,19.818815331010452,103.53686305193918,TREM2;APOE,0.03158519384950702,DisGeNET,TREM2;APOE,,,2,0,0
372,Drug-induced tardive dyskinesia,0.005384826815772965,19.818815331010452,103.53686305193918,MTNR1B;APOE,0.03158519384950702,DisGeNET,APOE,MTNR1B,,1,1,0
366,Primary biliary cirrhosis,0.005354910558227355,6.1955029585798815,32.40087755860056,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.03158519384950702,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,3,3
373,Fatigue,0.005412236933629751,6.176183734465943,32.23407600024988,HESX1;TREM2;BTNL2;HLA-DRB1,0.0316608605608046,DisGeNET,HESX1;TREM2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,4,2,2
374,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.00543270588228766,9.107668711656443,47.499388099014006,BTNL2;HLA-DRB1;HLA-DQA1,0.03169562629719699,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,3,3,3
375,Squamous cell carcinoma,0.005524088835887893,2.9378998993146905,15.273075006528131,CDKN1C;CDKN2B;GRN;CCND2;SLC22A18;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.03214283157308635,DisGeNET,GRN;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,8,4
92,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),0.0038554225788541055,23.695419393218323,131.70564916179435,HLA-DRA;HLA-DRB1,0.032268210714322405,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
376,Hippocampal sclerosis,0.005592617272449293,19.421463414634147,100.72568904417493,GRN;APOE,0.032455028958735,DisGeNET,GRN;APOE,,,2,0,0
128,Body Mass Index In Physically Active Individuals,0.004980226270684628,20.664244940321744,109.56761169296043,GIPR;ZC3H4,0.032467986772447846,GWAS_Catalog_2023,GIPR;ZC3H4,GIPR;ZC3H4,GIPR;ZC3H4,2,2,2
129,Predicted Developmental Stuttering,0.004980226270684628,20.664244940321744,109.56761169296043,TOX2;JADE2,0.032467986772447846,GWAS_Catalog_2023,,TOX2;JADE2,,0,2,0
31,GTEX-U8T8-0008-SM-4DXSP skin male 60-69 years,0.0006316462507982846,3.5888632477213487,26.43980531063803,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
29,GTEX-QDVN-0008-SM-48U2D skin male 50-59 years,0.0005824357417628761,3.826595744680851,28.501601298263125,TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,7
32,GTEX-WEY5-0008-SM-4LMKC skin female 40-49 years,0.0006510989877867311,3.7715581883623277,27.671352441261977,TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
33,GTEX-OIZH-1626-SM-2HMKI muscle male 50-59 years,0.0006670885026643441,2.813825561312608,20.57634656439664,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;TOX2;APH1B;CCND2;SNRPD2;KCNQ1;SLC22A18;HESX1;PLCG2;HLA-DRA;APOE;PVRL2;HLA-DRB1;PICALM,0.03257678883029341,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SNRPD2;HESX1;PLCG2;HLA-DRA;APOE;PVRL2;HLA-DRB1;PICALM,GIPR;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;SNRPD2;KCNQ1;SLC22A18;HLA-DRA;HLA-DRB1,GIPR;QPCTL;NPAS1;EML2;SNRPD2;HLA-DRA;HLA-DRB1,17,13,7
30,GTEX-S3XE-2026-SM-3K2B5 muscle male 50-59 years,0.0006127503755119388,2.8515479298769115,21.09447672295325,ATP8B4;GRN;IDUA;QPCTL;TREM2;JADE2;NPAS1;EML2;TOX2;APH1B;SHARPIN;CCND2;SNRPD2;SLC22A18;HESX1;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DQB2;PICALM;JAZF1,0.03257678883029341,GTEx_Tissue_Expression_Down,ATP8B4;GRN;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SHARPIN;SNRPD2;HESX1;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DQB2;PICALM;JAZF1,QPCTL;JADE2;NPAS1;EML2;TOX2;CCND2;SNRPD2;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DQB2;JAZF1,QPCTL;NPAS1;EML2;SNRPD2;HLA-DRA;HLA-DQA2;HLA-DQB2;JAZF1,18,12,8
35,GTEX-SN8G-0008-SM-4DM4X skin female 50-59 years,0.0007114630788935282,3.53636199806681,25.632213180886904,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
36,GTEX-S341-0826-SM-4AD73 fallopian tube female 40-49 years,0.0007283099938494111,18.871518987341773,136.34264437191746,NPAS1;HLA-DQA2;HLA-DQB2,0.03257678883029341,GTEx_Tissue_Expression_Down,NPAS1;HLA-DQA2;HLA-DQB2,NPAS1;HLA-DQA2;HLA-DQB2,NPAS1;HLA-DQA2;HLA-DQB2,3,3,3
37,GTEX-OXRL-0008-SM-3NB29 skin male 50-59 years,0.0007578748269685305,3.508662339563711,25.209711969847984,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,6
38,GTEX-XBED-0008-SM-47JWO skin male 60-69 years,0.000758254427024228,3.9379064133622337,28.2918554418151,TSPAN15;TOX2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;TOX2;KCNQ1;CHST15;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,9,5
39,GTEX-PVOW-2626-SM-32PL8 brain male 40-49 years,0.0007630599185474132,3.694047969393761,26.51651908701805,TOX2;GRN;SHARPIN;SNRPD2;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,GRN;SHARPIN;SNRPD2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,TOX2;SNRPD2;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,SNRPD2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8,9,6
34,GTEX-T6MN-0008-SM-4DM7H skin male 50-59 years,0.0006923232543831534,3.5483542306870657,25.81590068703956,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03257678883029341,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
377,Cerebrovascular accident,0.005704033902612337,4.08491168333688,21.10502975411673,TSPAN15;CDKN2B;GIPR;KCNQ1;APOE;HLA-DRB1,0.03293240543308889,DisGeNET,GIPR;APOE;HLA-DRB1,TSPAN15;CDKN2B;GIPR;KCNQ1;HLA-DRB1,GIPR;HLA-DRB1,3,5,2
378,Malignant mesothelioma,0.005705063819297709,6.081338600976063,31.418634493354006,CDKN2B;CCND2;IDUA;IGF2BP3,0.03293240543308889,DisGeNET,IDUA,CDKN2B;CCND2;IGF2BP3,,1,3,0
39,Vibrio cholerae infection,0.006237758643052818,18.319374137137597,93.00992375609684,KCNQ1;PLCG2,0.032948161037663605,BioPlanet_2019,PLCG2,KCNQ1,,1,1,0
132,Creatinine Levels,0.005185385420771686,6.254180602006689,32.90894237025274,GIPR;KCNQ1;APOE;HLA-DQA1,0.03303719044597719,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;KCNQ1;HLA-DQA1,GIPR;HLA-DQA1,3,3,2
131,Free Cholesterol To Total Lipids Ratio In Very Large VLDL,0.005180691162792406,20.232723577235774,106.48111760263689,CCND2;HLA-DQA1,0.03303719044597719,GWAS_Catalog_2023,HLA-DQA1,CCND2;HLA-DQA1,HLA-DQA1,1,2,1
130,Glucose Homeostasis Traits,0.005180691162792406,20.232723577235774,106.48111760263689,MTNR1B;KCNQ1,0.03303719044597719,GWAS_Catalog_2023,,MTNR1B;KCNQ1,,0,2,0
51,GTEX-TKQ2-0826-SM-33HB6 muscle male 50-59 years,0.001016523816394623,2.7394362472896505,18.878459170767098,GRN;IDUA;ZC3H4;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;TOX2;SHARPIN;CCND2;SNRPD2;SLC22A18;HESX1;CHST15;APOE;PVRL2;HLA-DQB2;PICALM;JAZF1,0.03314348290586192,GTEx_Tissue_Expression_Down,GRN;IDUA;ZC3H4;QPCTL;TREM2;NPAS1;EML2;SHARPIN;SNRPD2;HESX1;APOE;PVRL2;HLA-DQB2;PICALM;JAZF1,ZC3H4;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;SNRPD2;SLC22A18;CHST15;HLA-DQB2;JAZF1,ZC3H4;QPCTL;NPAS1;EML2;SNRPD2;HLA-DQB2;JAZF1,15,13,7
52,GTEX-N7MT-1226-SM-2D7W4 brain female 60-69 years,0.0010351117784413333,3.7694112845628,25.908090504759,CDKN1C;GRN;SLC22A18;PLCG2;HLA-DRA;ALPK2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;ALPK2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;SLC22A18;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,7,5
50,GTEX-XGQ4-0008-SM-4AT3Z skin male 50-59 years,0.0010120271829418502,3.558535978384528,24.538951858359493,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
43,GTEX-RVPU-2426-SM-2XCAR muscle male 50-59 years,0.0008846519811436926,2.7763326567674396,19.518496542141847,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;LRRC16A;NPAS1;EML2;TOX2;APH1B;SHARPIN;CCND2;KCNQ1;SLC22A18;PLCG2;APOE;PVRL2;HLA-DQB2;PICALM;JAZF1,0.03314348290586192,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SHARPIN;PLCG2;APOE;PVRL2;HLA-DQB2;PICALM;JAZF1,GIPR;QPCTL;LRRC16A;NPAS1;EML2;TOX2;CCND2;KCNQ1;SLC22A18;HLA-DQB2;JAZF1,GIPR;QPCTL;NPAS1;EML2;HLA-DQB2;JAZF1,16,11,6
48,GTEX-QEL4-0626-SM-3GIJM muscle male 50-59 years,0.000987935599084154,2.77391852047942,19.195219478521928,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;TOX2;APH1B;CCND2;SNRPD2;KCNQ1;SLC22A18;HESX1;APOE;PICALM;JAZF1,0.03314348290586192,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;SNRPD2;HESX1;APOE;PICALM;JAZF1,GIPR;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;SNRPD2;KCNQ1;SLC22A18;JAZF1,GIPR;QPCTL;NPAS1;EML2;SNRPD2;JAZF1,14,12,6
47,GTEX-QV44-0008-SM-447AX skin male 50-59 years,0.0009610589612357118,3.583106754436176,24.8935438708062,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
46,GTEX-TML8-0008-SM-4DXUI skin female 40-49 years,0.000943066078644721,3.5921184738955825,25.024041477820777,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
45,GTEX-SIU7-1126-SM-2XCDW thyroid male 50-59 years,0.0009277437091919496,5.967137592137592,41.667060088480405,ATP8B4;GIPR;IL17RD;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,ATP8B4;GIPR;IL17RD;HLA-DRB1;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRB1;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,4,4
44,GTEX-XBEW-0008-SM-4AT3Y skin male 40-49 years,0.000918629920559599,3.833478423081706,26.806085548166852,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
42,GTEX-OXRK-0008-SM-3NB28 skin female 50-59 years,0.0008660226123900201,3.450603336378059,24.33227289413566,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,6
41,GTEX-QV31-0008-SM-447AT skin male 30-39 years,0.000832853243608483,3.651718112987769,25.893066392727032,TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
40,GTEX-X4XX-0008-SM-46MVK skin male 60-69 years,0.0008045689301770682,3.90544273634044,27.827075872575435,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03314348290586192,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
49,GTEX-R55F-1526-SM-2TF4X muscle male 50-59 years,0.0010092727243213103,2.8023487261146496,19.332073537306577,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;APH1B;CCND2;KCNQ1;SLC22A18;HESX1;HLA-DRA;HLA-DQA2;PICALM;JAZF1,0.03314348290586192,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;QPCTL;TREM2;NPAS1;EML2;APH1B;HESX1;HLA-DRA;HLA-DQA2;PICALM;JAZF1,GIPR;QPCTL;JADE2;LRRC16A;NPAS1;EML2;CCND2;KCNQ1;SLC22A18;HLA-DRA;HLA-DQA2;JAZF1,GIPR;QPCTL;NPAS1;EML2;HLA-DRA;HLA-DQA2;JAZF1,14,12,7
379,Ovarian Carcinoma,0.0057609720138773034,2.7859118385036497,14.365969680262822,CDKN1C;CDKN2B;GRN;CCND2;CHST15;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.033167390327916296,DisGeNET,GRN;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;CCND2;CHST15;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,HLA-DRB1;JAZF1,5,8,2
3,resveratrol DB02709 human GSE36930 sample 3498,0.0001950791975845304,10.542896876337185,90.05853149342975,GRN;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB1,0.033293516387759854,Drug_Perturbations_from_GEO_down,GRN;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,5,3,3
136,Free Cholesterol Levels In IDL,0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DQA1,0.03329881876518429,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
135,Free Cholesterol Levels In Large LDL,0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DQA1,0.03329881876518429,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
133,Nonalcoholic Fatty Liver Disease (Imputed),0.005384826815772965,19.818815331010452,103.53686305193918,HLA-DQA1;JAZF1,0.03329881876518429,GWAS_Catalog_2023,HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,2,2,2
134,Body Mass Index (Joint Analysis Main Effects And Physical Activity Interaction),0.005384826815772965,19.818815331010452,103.53686305193918,GIPR;ZC3H4,0.03329881876518429,GWAS_Catalog_2023,GIPR;ZC3H4,GIPR;ZC3H4,GIPR;ZC3H4,2,2,2
93,Positive Regulation Of Biosynthetic Process (GO:0009891),0.004033525091037281,23.130081300813007,127.51878829292204,PLCG2;APOE,0.03339585290428716,GO_Biological_Process_2023,PLCG2;APOE,,,2,0,0
380,Keloid,0.0058977548930665615,8.834375,45.34846822211778,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03386552941229273,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
137,High Density Lipoprotein Cholesterol Levels,0.005562854595870916,4.107323682521572,21.323761883977756,CCND2;GIPR;ZC3H4;SLC22A18;APOE;HLA-DQA1,0.03414861835859445,GWAS_Catalog_2023,GIPR;ZC3H4;APOE;HLA-DQA1,CCND2;GIPR;ZC3H4;SLC22A18;HLA-DQA1,GIPR;ZC3H4;HLA-DQA1,4,5,3
53,GTEX-QDT8-0011-R10A-SM-32PKG brain female 30-39 years,0.0011118161004313475,3.7313764732043584,25.379929009577396,GRN;SHARPIN;KCNQ1;HLA-DRA;ALPK2;IGF2BP2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03455768427678104,GTEx_Tissue_Expression_Down,GRN;SHARPIN;HLA-DRA;ALPK2;PVRL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,KCNQ1;HLA-DRA;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,8,6,4
54,GTEX-XUW1-0008-SM-4BOQH skin female 50-59 years,0.001134574778835982,3.7206395290227627,25.23150707825555,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03455768427678104,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
55,GTEX-TKQ2-0008-SM-4DM5L skin male 50-59 years,0.0011415451262600344,3.501664097533632,23.72507884200447,CDKN1C;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03455768427678104,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,7
96,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),0.004401016444674392,22.07649667405765,119.78529941576386,TREM2;APPL1,0.034935903736075066,GO_Biological_Process_2023,TREM2;APPL1,,,2,0,0
97,Regulation Of Interleukin-10 Production (GO:0032653),0.004401016444674392,22.07649667405765,119.78529941576386,PLCG2;HLA-DRB1,0.034935903736075066,GO_Biological_Process_2023,PLCG2;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
95,Positive Regulation Of MAPK Cascade (GO:0043410),0.004342044383891917,6.586559410088822,35.8269970258904,PLCG2;TREM2;APOE;HLA-DRB1,0.034935903736075066,GO_Biological_Process_2023,PLCG2;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
94,Regulation Of Cellular Component Organization (GO:0051128),0.004329954319218911,9.9035,53.89681073389184,JADE2;APOE;PICALM,0.034935903736075066,GO_Biological_Process_2023,APOE;PICALM,JADE2,,2,1,0
138,Body Mass Index (Joint Analysis Main Effects And Smoking Interaction),0.005804046626383199,19.039693926351028,98.03919026153727,ZC3H4;QPCTL,0.035116569876174605,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
139,Triglyceride Levels In Medium HDL,0.005804046626383199,19.039693926351028,98.03919026153727,CCND2;APOE,0.035116569876174605,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
9,Tau Protein Binding (GO:0048156),0.0031810145747939787,26.262359920896508,151.0231473713992,APOE;PICALM,0.035698052450465756,GO_Molecular_Function_2023,APOE;PICALM,,,2,0,0
381,Immunoglobulin A deficiency (disorder),0.006237758643052818,18.319374137137597,93.00992375609684,PLCG2;HLA-DQB1,0.03572385658567257,DisGeNET,PLCG2;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
20,DAP12 Interactions R-HSA-2172127,0.0038554225788541055,23.695419393218323,131.70564916179435,PLCG2;TREM2,0.03576574415572211,Reactome_2022,PLCG2;TREM2,,,2,0,0
21,Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.0038715496251039406,10.319270833333333,57.31426659503001,CDKN1C;CDKN2B;CCND2,0.03576574415572211,Reactome_2022,,CDKN1C;CDKN2B;CCND2,,0,3,0
140,BMI (Adjusted For Smoking Behaviour),0.006019099019507137,18.672607879924954,95.46963998767033,ZC3H4;QPCTL,0.03615758768146787,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
56,GTEX-WH7G-0008-SM-4LVNM skin male 40-49 years,0.001239084989834437,3.4632526359600444,23.180873143059745,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03684065192989888,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,9,6
141,Itch Intensity From Mosquito Bite,0.006237758643052818,18.319374137137597,93.00992375609684,HLA-DQA2;HLA-DQA1,0.036943345202869154,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
142,Sphingomyelin Levels,0.006237758643052818,18.319374137137597,93.00992375609684,APOE;HLA-DQA1,0.036943345202869154,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
59,GTEX-N7MS-0008-SM-4E3JI skin male 60-69 years,0.0013142063510087757,3.141711451012815,20.84375477901304,CDKN1C;ATP8B4;TREM2;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03708734871914596,GTEx_Tissue_Expression_Down,ATP8B4;TREM2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,6
57,GTEX-VUSG-0008-SM-4KL24 skin male 50-59 years,0.0013049085935327145,3.647051837776854,24.22234075642871,TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03708734871914596,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,9,6
58,GTEX-WFG8-2426-SM-3GILL muscle male 20-29 years,0.0013128495296162576,2.768477785870357,18.370387419143267,ATP8B4;GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;JADE2;LRRC16A;EML2;TOX2;SHARPIN;CCND2;KCNQ1;APOE;PVRL2;HLA-DQA1;HLA-DQB1,0.03708734871914596,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;EML2;SHARPIN;APOE;PVRL2;HLA-DQA1;HLA-DQB1,GIPR;ZC3H4;QPCTL;JADE2;LRRC16A;EML2;TOX2;CCND2;KCNQ1;HLA-DQA1;HLA-DQB1,GIPR;ZC3H4;QPCTL;EML2;HLA-DQA1;HLA-DQB1,13,11,6
382,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",0.006581072009459029,5.8303976217019695,29.289338444116243,CDKN2B;GRN;CCND2;IGF2BP3,0.037532137753828784,DisGeNET,GRN,CDKN2B;CCND2;IGF2BP3,,1,3,0
383,Cerebrovascular Disorders,0.0065879050227847956,8.478,42.58092357205864,APOE;HLA-DRB1;HLA-DQB1,0.037532137753828784,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
384,Abnormality of epiphysis morphology,0.006685836582770361,17.651441241685145,88.39425081534023,IDUA;TREM2,0.03762409770270743,DisGeNET,IDUA;TREM2,,,2,0,0
385,Abnormality of the voice,0.006685836582770361,17.651441241685145,88.39425081534023,HESX1;IL17RD,0.03762409770270743,DisGeNET,HESX1;IL17RD,,,2,0,0
386,Atrophic,0.006685836582770361,17.651441241685145,88.39425081534023,GRN;APOE,0.03762409770270743,DisGeNET,GRN;APOE,,,2,0,0
387,Scleroderma,0.006690261186365941,8.42940340909091,42.2068857392452,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03762409770270743,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
388,Myasthenia Gravis,0.006690261186365941,8.42940340909091,42.2068857392452,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03762409770270743,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
144,Cholesteryl Esters To Total Lipids Ratio In Very Large VLDL,0.006460009734687234,17.979223125564587,90.65348059020808,APOE;HLA-DQA1,0.03772825129772197,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
143,Cholesterol To Total Lipids Ratio In Very Large VLDL,0.006460009734687234,17.979223125564587,90.65348059020808,CCND2;HLA-DQA1,0.03772825129772197,GWAS_Catalog_2023,HLA-DQA1,CCND2;HLA-DQA1,HLA-DQA1,1,2,1
32,Cystic fibrosis,0.008572851807857029,158.36507936507937,753.6839332107746,HLA-DRA,0.03777412827837003,Jensen_DISEASES,HLA-DRA,HLA-DRA,HLA-DRA,1,1,1
60,GTEX-S95S-0008-SM-4AT5M skin male 60-69 years,0.001384093870635243,3.616331821127673,23.805262190237407,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03840860491012799,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,9,5
390,Heart valve disease,0.006915223521981038,17.335365853658537,86.2266296466296,IDUA;APOE,0.03859083817125991,DisGeNET,IDUA;APOE,,,2,0,0
389,Silicosis,0.006915223521981038,17.335365853658537,86.2266296466296,HLA-DRB1;HLA-DQB1,0.03859083817125991,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
391,Inclusion Body Myositis (disorder),0.006915223521981038,17.335365853658537,86.2266296466296,APOE;HLA-DRB1,0.03859083817125991,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
393,Retinal Diseases,0.006982452988834796,5.7289794725692165,28.440687848756774,IDUA;APOE;HLA-DRB1;HLA-DQB1,0.03876771608559167,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
392,"Liver Cirrhosis, Experimental",0.006971575421911125,3.9086180520142784,19.40986130363712,GRN;HLA-DRA;IGF2BP3;HLA-DRB1;HLA-DQA1;APPL1,0.03876771608559167,DisGeNET,GRN;HLA-DRA;HLA-DRB1;HLA-DQA1;APPL1,HLA-DRA;IGF2BP3;HLA-DRB1;HLA-DQA1,HLA-DRA;HLA-DRB1;HLA-DQA1,5,4,3
394,Forgetful,0.0071481549361583725,17.03038083012409,84.14542578402569,GRN;TREM2,0.03938705573408477,DisGeNET,GRN;TREM2,,,2,0,0
395,Alopecia Areata,0.0071481549361583725,17.03038083012409,84.14542578402569,HLA-DRB1;HLA-DQB1,0.03938705573408477,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
396,Nephrocalcinosis,0.0071481549361583725,17.03038083012409,84.14542578402569,CDKN1C;KCNQ1,0.03938705573408477,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
145,Serum Metabolite Levels (CMS),0.006915223521981038,17.335365853658537,86.2266296466296,MTNR1B;APOE,0.039562605319633015,GWAS_Catalog_2023,APOE,MTNR1B,,1,1,0
146,Triglycerides To Total Lipids Ratio In Small VLDL,0.006915223521981038,17.335365853658537,86.2266296466296,GIPR;HLA-DQA1,0.039562605319633015,GWAS_Catalog_2023,GIPR;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,2,2,2
147,Waist Circumference Adjusted For BMI In Active Individuals,0.006915223521981038,17.335365853658537,86.2266296466296,KCNQ1;JAZF1,0.039562605319633015,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
397,Proteinuria,0.007216301156473271,8.194475138121547,40.41033927851615,APOE;HLA-DRB1;HLA-DQA1,0.03966239073910498,DisGeNET,APOE;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
34,non-Hodgkin lymphoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03972056543117914,Jensen_DISEASES,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
33,Hemolytic anemia,0.010491791832734732,13.858536585365854,63.1555971026974,HLA-DRA;IL17RD,0.03972056543117914,Jensen_DISEASES,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
36,Acute urate nephropathy,0.010704833236771683,118.76785714285714,538.8568862241955,LRRC16A,0.03972056543117914,Jensen_DISEASES,,LRRC16A,,0,1,0
37,Agraphia,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03972056543117914,Jensen_DISEASES,GRN,,,1,0,0
38,Tic disorder,0.010704833236771683,118.76785714285714,538.8568862241955,PICALM,0.03972056543117914,Jensen_DISEASES,PICALM,,,1,0,0
35,Echolalia,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03972056543117914,Jensen_DISEASES,GRN,,,1,0,0
218,Lymphoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB2,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB2,HLA-DQB2,HLA-DQB2,1,1,1
213,Alkenylphosphatidylethanolamine (P-18:0/20:5) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
214,Lamb Liking,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
212,Longevity (Age >90Th Survival Percentile),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
216,Killer Cell Immunoglobulin-Like Receptor 2DL5A Levels (KIR2DL5A.8000.17.3),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
217,Neutrophil Collagenase Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
219,Apolipoprotein E Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
226,Serum Levels Of Protein CXCL2;CXCL3,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
221,Apolipoprotein M Levels,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
222,"Sphingomyelin (D18:1/20:0, D16:1/22:0) Levels",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
223,"Sphingomyelin (D18:1/22:1, D18:2/22:0, D16:1/24:1) Levels",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
224,X-16935 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,ATP8B4,0.03973626442293962,GWAS_Catalog_2023,ATP8B4,,,1,0,0
225,Body Mass Index (SNP X SNP Interaction),0.010704833236771683,118.76785714285714,538.8568862241955,GIPR,0.03973626442293962,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
227,IgG Glycosylation,0.010747428365657561,7.0525,31.969608584459383,PLCG2;IGF2BP3;HLA-DQB2,0.03973626442293962,GWAS_Catalog_2023,PLCG2;HLA-DQB2,IGF2BP3;HLA-DQB2,HLA-DQB2,2,2,1
228,Colorectal Cancer Or Advanced Adenoma,0.010772732804316568,13.662658880109928,61.90191516841718,TOX2;CCND2,0.03973626442293962,GWAS_Catalog_2023,,TOX2;CCND2,,0,2,0
211,Alkyldiacylglycerol (O-52:2) [NL-16:0] Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
220,Tumor Necrosis Factor Ligand Superfamily Member 18 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
210,Alkenylphosphatidylethanolamine (P-18:1/20:3) (B) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
215,Two-hour Glucose Challenge,0.010704833236771683,118.76785714285714,538.8568862241955,GIPR,0.03973626442293962,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
208,Cerebrospinal Fluid P-Tau Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
175,Fasting Total Lipids In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
174,Fasting Free Cholesterol In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
173,Fasting Phospholipid Levels In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
172,Postprandial Phospholipid Levels In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
171,T Wave Morphology Restitution During Recovery From Exercise (MTAG),0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
170,T Wave Morphology Restitution During Recovery From Exercise,0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
169,IDP dMRI ProbtrackX ISOVF Slf R,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
168,IDP dMRI ProbtrackX ISOVF Ifo R,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
167,Serum Levels Of Protein LRP1B,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
209,Cholesteryl Ester (16:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
164,Nonatopic Asthma Or Type 2 Diabetes,0.010704833236771683,118.76785714285714,538.8568862241955,JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
163,Cervical Intraepithelial Neoplasia Grade 3 And Invasive Cervical Cancer,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
162,Psychosis Proneness (Hypomanic Personality Scale),0.010704833236771683,118.76785714285714,538.8568862241955,CDKN2B,0.03973626442293962,GWAS_Catalog_2023,,CDKN2B,,0,1,0
161,Total Triglycerides Levels,0.010214181683643169,14.060091905266878,64.45115426643397,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
160,Triglyceride Levels In LDL,0.009939917315218262,14.267575322812052,65.79059448688477,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
159,Eosinophil Percentage Of White Cells,0.009650291916518373,5.200212568088216,24.13297547008951,TOX2;SHARPIN;ALPK2;HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,SHARPIN;ALPK2;HLA-DQB1,TOX2;HLA-DQB1,HLA-DQB1,3,2,1
158,Alanine Aminotransferase Levels,0.009316289339638652,5.255739025372534,24.575787692946022,CCND2;ZC3H4;APOE;JAZF1,0.03973626442293962,GWAS_Catalog_2023,ZC3H4;APOE;JAZF1,CCND2;ZC3H4;JAZF1,ZC3H4;JAZF1,3,3,2
157,Triglyceride Levels In Medium LDL,0.008876618402253058,15.16234756097561,71.63200327629296,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
156,Triglycerides To Total Lipids Ratio In Medium VLDL,0.00861930890913937,15.40379403794038,73.22579161456777,APOE;HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
155,Free Cholesterol To Total Lipids Ratio In Medium LDL,0.00861930890913937,15.40379403794038,73.22579161456777,GIPR;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
154,Free Cholesterol To Total Lipids Ratio In Large LDL,0.00861930890913937,15.40379403794038,73.22579161456777,GIPR;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
153,Appendicular Lean Mass,0.008529120608179874,3.7369586453923804,17.80387629128009,CCND2;IDUA;ZC3H4;KCNQ1;HLA-DRB1;JAZF1,0.03973626442293962,GWAS_Catalog_2023,IDUA;ZC3H4;HLA-DRB1;JAZF1,CCND2;ZC3H4;KCNQ1;HLA-DRB1;JAZF1,ZC3H4;HLA-DRB1;JAZF1,4,5,3
152,Cholesterol To Total Lipids Ratio In Medium VLDL,0.008365435911281352,15.65302911093627,74.87856315796849,APOE;HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
151,Total Bilirubin Levels,0.008223727852321358,7.802763157894737,37.45897214868451,CCND2;SLC22A18;JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,CCND2;SLC22A18;JAZF1,JAZF1,1,3,1
150,Triglyceride Levels In Large LDL,0.008115014693377984,15.910435825669731,76.593462825792,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
149,Adult Body Size,0.00790722141739211,5.520710059171598,26.720119832722453,GIPR;ZC3H4;JADE2;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;ZC3H4;APOE,GIPR;ZC3H4;JADE2,GIPR;ZC3H4,3,3,2
148,Waist Circumference Adjusted For BMI (Joint Analysis Main Effects And Physical Activity Interaction),0.0073846152576013385,16.735912531539107,82.14582442458652,KCNQ1;JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
176,Plasma Amyloid Beta Peptide Concentrations (ABx-42),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
177,Postprandial Triglycerides In LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
166,Asthma And Major Depressive Disorder,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
179,Alpha-L-iduronidase Levels (IDUA.3169.70.2),0.010704833236771683,118.76785714285714,538.8568862241955,IDUA,0.03973626442293962,GWAS_Catalog_2023,IDUA,,,1,0,0
193,Hepatocellular Carcinoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
194,Lysoalkenylphosphatidylcholine (P-16:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
195,Ceramide (D18:2/20:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
196,Integral Membrane Protein 2B Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
197,Hippocampus Volume Change Rate X Age Interaction (2Df),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
178,Postprandial Phospholipid Levels In Medium VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
199,Lateral Ventricle Volume Change Rate X Age Interaction (2Df),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
200,Complement C1q Tumor Necrosis Factor-Related Protein 1 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03973626442293962,GWAS_Catalog_2023,GRN,,,1,0,0
201,Pyridoxine-5-phosphate Oxidase Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
202,Cervical Dysplasia,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
203,Surfeit Locus Protein 1 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
204,Facial Morphology (Segment 9),0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
205,Parental Longevity (Mother'S Attained Age),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
206,Total Lysoalkenylphosphatidylcholine Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
207,Total Lysophosphatidylethanolamine Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
192,Lean Nonalcoholic Fatty Liver Disease,0.010704833236771683,118.76785714285714,538.8568862241955,BTNL2,0.03973626442293962,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
191,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio (Abnormal Vs Normal),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
198,X-24870 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
185,Postprandial Triglycerides Levels In Very Large HDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
180,Fasting Triglycerides Levels In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
181,Fasting Free Cholesterol In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
182,Fasting Free Cholesterol In Medium VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
183,"Fasting Monounsaturated Fatty Acids (16:1, 18:1)",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
184,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels (USP25.9215.117.3),0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
186,"N2,N5-diacetylornithine Levels In Elite Athletes",0.010704833236771683,118.76785714285714,538.8568862241955,JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
187,Fasting Triglycerides Levels In Large LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
188,Fasting Triglycerides In LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
165,IDP dMRI TBSS ISOVF Anterior Corona Radiata L,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
189,Postprandial Very Small VLDL Particle Concentration,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
190,Cutaneous Lupus Erythematosus,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
398,"Lymphoma, Follicular",0.007258891401572193,5.663271939328277,27.894605422335975,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQB1,0.03979623376439831,DisGeNET,HLA-DRB1;HLA-DQB1,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,4,2
39,Diabetes mellitus,0.011056989691574752,13.472222222222221,60.688218399017316,KCNQ1;APPL1,0.03997527042338564,Jensen_DISEASES,APPL1,KCNQ1,,1,1,0
61,GTEX-PX3G-0008-SM-48U2L skin female 20-29 years,0.00150883900173023,2.9019866789159394,18.852509201362935,CDKN1C;ATP8B4;IDUA;TREM2;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03999809723529782,GTEx_Tissue_Expression_Down,ATP8B4;IDUA;TREM2;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,11,6
66,GTEX-Q2AI-1526-SM-3GIJ3 muscle male 40-49 years,0.001585510160678472,2.676132206613989,17.252620388616766,GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;NPAS1;EML2;TOX2;APH1B;SHARPIN;CCND2;SNRPD2;SLC22A18;HESX1;APOE;PVRL2;HLA-DRB1;PICALM,0.03999809723529782,GTEx_Tissue_Expression_Down,GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;NPAS1;EML2;APH1B;SHARPIN;SNRPD2;HESX1;APOE;PVRL2;HLA-DRB1;PICALM,GIPR;ZC3H4;QPCTL;NPAS1;EML2;TOX2;CCND2;SNRPD2;SLC22A18;HLA-DRB1,GIPR;ZC3H4;QPCTL;NPAS1;EML2;SNRPD2;HLA-DRB1,16,10,7
65,GTEX-TSE9-0008-SM-4DXT8 skin female 60-69 years,0.001584336661294421,3.54647686283587,22.866226874564664,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03999809723529782,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
64,GTEX-R45C-0008-SM-48FF2 skin female 60-69 years,0.0015742779959055208,3.3524885506465516,21.636822068474025,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03999809723529782,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,10,5
63,GTEX-OIZG-0008-SM-4E3J2 skin male 50-59 years,0.0015694188091417793,3.073573938902406,19.846220336071795,CDKN1C;TREM2;CCND2;KCNQ1;HESX1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03999809723529782,GTEx_Tissue_Expression_Down,TREM2;HESX1;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,6
62,GTEX-PWOO-0008-SM-48TDU skin female 40-49 years,0.0015160540513439818,3.2127589213239935,20.856088262503448,TSPAN15;CCND2;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.03999809723529782,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;CCND2;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,11,7
399,MIXED LINEAGE LEUKEMIA,0.007324376147591877,8.149038461538462,40.0651330071299,GRN;IGF2BP3;PICALM,0.04005460840612901,DisGeNET,GRN;PICALM,IGF2BP3,,2,1,0
400,Factor V Leiden mutation,0.0073846152576013385,16.735912531539107,82.14582442458652,SLC22A18;APOE,0.04008266291563711,DisGeNET,APOE,SLC22A18,,1,1,0
402,Bullous pemphigoid,0.0073846152576013385,16.735912531539107,82.14582442458652,HLA-DRB1;HLA-DQB1,0.04008266291563711,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
401,Autoimmune thyroiditis,0.0073846152576013385,16.735912531539107,82.14582442458652,HLA-DRB1;HLA-DQB1,0.04008266291563711,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
67,GTEX-T2IS-0008-SM-4DM75 skin female 20-29 years,0.0016147915658334345,3.5367003367003367,22.735852799322977,CDKN1C;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.040089669036966175,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
68,GTEX-UJHI-0008-SM-4IHL1 skin female 50-59 years,0.0016510302341001572,3.3307110337439743,21.337719954523138,TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.040089669036966175,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,9,5
69,GTEX-W5WG-0008-SM-4KL25 skin female 50-59 years,0.0016613736718022018,3.5221283039119853,22.542010360220157,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.040089669036966175,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
29,Glutamatergic Synapse (GO:0098978),0.012226879787613523,12.760590500641849,56.19915256188674,APOE;APPL1,0.04010105542953923,GO_Cellular_Component_2023,APOE;APPL1,,,2,0,0
28,Lytic Vacuole (GO:0000323),0.012159859531829595,6.728522727272727,29.670194437651755,GRN;KCNQ1;HLA-DRA,0.04010105542953923,GO_Cellular_Component_2023,GRN;HLA-DRA,KCNQ1;HLA-DRA,HLA-DRA,2,2,1
27,Cytoplasmic Stress Granule (GO:0010494),0.011635391796872908,13.106789716545814,58.37375928178501,IGF2BP3;IGF2BP2,0.04010105542953923,GO_Cellular_Component_2023,,IGF2BP3;IGF2BP2,,0,2,0
31,Macropinosome (GO:0044354),0.012832337737452553,95.00952380952381,413.84123997008294,APPL1,0.04010105542953923,GO_Cellular_Component_2023,APPL1,,,1,0,0
30,Low-Density Lipoprotein Particle (GO:0034362),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04010105542953923,GO_Cellular_Component_2023,APOE,,,1,0,0
32,Pinosome (GO:0044352),0.012832337737452553,95.00952380952381,413.84123997008294,APPL1,0.04010105542953923,GO_Cellular_Component_2023,APPL1,,,1,0,0
403,Hashimoto Disease,0.00743341174066821,8.104098360655737,39.724428986169265,PLCG2;HLA-DRB1;HLA-DQB1,0.0402474055040646,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
70,GTEX-Q734-0008-SM-48U2I skin female 40-49 years,0.0016930365336452727,3.5124749067966734,22.413915858318948,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.04027008326456256,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
257,Total Alkyldiacylglycerol Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
254,Tumor Protein P53-Inducible Protein 11 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
242,Postprandial Triglycerides Levels In Small LDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
244,Postprandial Total Lipids In Very Small VLDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
245,Age Of Onset Of Parkinson Disease,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
246,Dehydrocholesteryl Ester (18:2) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
247,Serum Total Cholesterol Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
248,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQB1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
249,Trihexosylcermide (D18:1/24:0) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
250,Lysophosphatidylethanolamine (16:0) [Sn2] Levels,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQB1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
251,Phosphatidylcholine (16:1 18:2) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
252,Inactive Gamma-Glutamyltranspeptidase 2 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
241,Fasting Triglycerides Levels In Very Large HDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
253,Putamen Volume Change Rate X Age Interaction (2Df),0.012832337737452553,95.00952380952381,413.84123997008294,APH1B,0.04057141367367518,GWAS_Catalog_2023,APH1B,,,1,0,0
256,Upper Eyelid Morphology,0.012832337737452553,95.00952380952381,413.84123997008294,PLCG2,0.04057141367367518,GWAS_Catalog_2023,PLCG2,,,1,0,0
258,Alkenylphosphatidylcholine (P-38:5) (B) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
259,Longevity (Age >99Th Survival Percentile),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
260,Alkenylphosphatidylcholine (P-18:0/22:5) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
261,Alzheimer's Disease Biomarkers,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
262,Granulins Levels,0.012832337737452553,95.00952380952381,413.84123997008294,GRN,0.04057141367367518,GWAS_Catalog_2023,GRN,,,1,0,0
263,F-fatty Food Liking (Derived Food-Liking Factor),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
264,Endothelial Monocyte-Activating Polypeptide 2 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
265,Spread Type: Flora Pro-Active/Benecol (UKB Data Field 1428 2),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
266,EGFR Mutation-Positive Lung Adenocarcinoma,0.012832337737452553,95.00952380952381,413.84123997008294,BTNL2,0.04057141367367518,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
255,Transmembrane And Coiled-Coil Domains Protein 3 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
240,Postprandial Linoleic Acid (18:2),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
243,Fasting Omega-3 Fatty Acids,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
238,Chronic Rhinosinusitis,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQA1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
239,Postprandial Triglycerides Levels In IDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
230,Cervical Cancer,0.011635391796872908,13.106789716545814,58.37375928178501,HLA-DQA2;HLA-DQA1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
231,Coffee Consumption,0.012831336034903537,12.432145090681676,54.152745328721444,ZC3H4;JADE2,0.04057141367367518,GWAS_Catalog_2023,ZC3H4,ZC3H4;JADE2,ZC3H4,1,2,1
232,Respiratory Diseases,0.012831336034903537,12.432145090681676,54.152745328721444,SHARPIN;JAZF1,0.04057141367367518,GWAS_Catalog_2023,SHARPIN;JAZF1,JAZF1,JAZF1,2,1,1
233,Psychosis Proneness (Hypomanic Personality Scale And Revised Physical Anhedonia Scale),0.012832337737452553,95.00952380952381,413.84123997008294,CDKN2B,0.04057141367367518,GWAS_Catalog_2023,,CDKN2B,,0,1,0
229,Gout,0.011056989691574752,13.472222222222221,60.688218399017316,KCNQ1;JAZF1,0.04057141367367518,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
235,T Wave Morphology Restitution During Exercise (MTAG),0.012832337737452553,95.00952380952381,413.84123997008294,KCNQ1,0.04057141367367518,GWAS_Catalog_2023,,KCNQ1,,0,1,0
236,Serum Levels Of Protein KLRC3,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
237,Cerebral Amyloid Angiopathy,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
234,Cerebral Microbleeds,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
404,Obesity,0.007525400016102721,2.7967009924980197,13.674389269589854,GRN;CCND2;MTNR1B;GIPR;QPCTL;KCNQ1;IGF2BP2;APOE;HLA-DRB1;APPL1,0.04064461097805975,DisGeNET,GRN;GIPR;QPCTL;APOE;HLA-DRB1;APPL1,CCND2;MTNR1B;GIPR;QPCTL;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;QPCTL;HLA-DRB1,6,7,3
73,GTEX-RU72-0011-R11A-SM-2TF6J brain female 50-59 years,0.001824677809103842,3.474343686710957,21.910433737927974,CDKN2B;GRN;KCNQ1;SLC22A18;CHST15;PLCG2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2,0.040916308004302925,GTEx_Tissue_Expression_Down,GRN;PLCG2;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQB2,CDKN2B;KCNQ1;SLC22A18;CHST15;HLA-DQA2;HLA-DRB1;HLA-DQB2,HLA-DQA2;HLA-DRB1;HLA-DQB2,6,7,3
77,GTEX-XMD1-0011-R11A-SM-4AT5J brain male 60-69 years,0.0018922256554542495,2.906060863342511,18.22100610957139,CDKN1C;CDKN2B;GRN;GIPR;SHARPIN;CCND2;SLC22A18;CHST15;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DQB2,0.040916308004302925,GTEx_Tissue_Expression_Down,GRN;GIPR;SHARPIN;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DQB2,CDKN1C;CDKN2B;GIPR;CCND2;SLC22A18;CHST15;HLA-DRA;HLA-DQA2;HLA-DQB2,GIPR;HLA-DRA;HLA-DQA2;HLA-DQB2,9,9,4
76,GTEX-R55E-0008-SM-48FCG skin male 20-29 years,0.0018845220974172464,3.1228034178012924,19.592721651093647,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.040916308004302925,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;TREM2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,10,5
75,GTEX-S341-1826-SM-3K2AB muscle female 40-49 years,0.0018651981292520721,2.8316085489313836,17.79492677428967,ATP8B4;GRN;IDUA;QPCTL;LRRC16A;NPAS1;EML2;TOX2;CCND2;SLC22A18;IGF2BP2;PVRL2;HLA-DQB2;PICALM;JAZF1,0.040916308004302925,GTEx_Tissue_Expression_Down,ATP8B4;GRN;IDUA;QPCTL;NPAS1;EML2;PVRL2;HLA-DQB2;PICALM;JAZF1,QPCTL;LRRC16A;NPAS1;EML2;TOX2;CCND2;SLC22A18;IGF2BP2;HLA-DQB2;JAZF1,QPCTL;NPAS1;EML2;HLA-DQB2;JAZF1,10,10,5
71,GTEX-S4P3-1626-SM-3K2AZ muscle female 50-59 years,0.001748945101928072,2.648945630081301,16.81747362692461,ATP8B4;GRN;GIPR;IDUA;ZC3H4;QPCTL;LRRC16A;NPAS1;EML2;APH1B;CCND2;SLC22A18;HESX1;PLCG2;IGF2BP2;PVRL2;HLA-DQB2;PICALM;JAZF1,0.040916308004302925,GTEx_Tissue_Expression_Down,ATP8B4;GRN;GIPR;IDUA;ZC3H4;QPCTL;NPAS1;EML2;APH1B;HESX1;PLCG2;PVRL2;HLA-DQB2;PICALM;JAZF1,GIPR;ZC3H4;QPCTL;LRRC16A;NPAS1;EML2;CCND2;SLC22A18;IGF2BP2;HLA-DQB2;JAZF1,GIPR;ZC3H4;QPCTL;NPAS1;EML2;HLA-DQB2;JAZF1,15,11,7
72,GTEX-TMZS-0008-SM-47JWM skin male 60-69 years,0.0017993768867856656,3.4814351272423862,22.003766127128575,CDKN1C;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.040916308004302925,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
74,GTEX-R55F-1226-SM-2TF59 brain male 50-59 years,0.001858438332791064,3.0093550955414012,18.922881266021577,CDKN1C;GRN;GIPR;SHARPIN;SNRPD2;SLC22A18;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DQB2;HLA-DQA1,0.040916308004302925,GTEx_Tissue_Expression_Down,GRN;GIPR;SHARPIN;SNRPD2;PLCG2;HLA-DRA;ALPK2;PVRL2;HLA-DQA2;HLA-DQB2;HLA-DQA1,CDKN1C;GIPR;SNRPD2;SLC22A18;HLA-DRA;HLA-DQA2;HLA-DQB2;HLA-DQA1,GIPR;SNRPD2;HLA-DRA;HLA-DQA2;HLA-DQB2;HLA-DQA1,11,8,6
405,Dyspnea,0.007654372956756307,8.015675675675675,39.05620471648322,TREM2;BTNL2;HLA-DRB1,0.04123911553491917,DisGeNET,TREM2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
33,P-body (GO:0000932),0.013762080364943018,11.969888587774767,51.301006580269814,IGF2BP3;IGF2BP2,0.04170327383316066,GO_Cellular_Component_2023,,IGF2BP3;IGF2BP2,,0,2,0
267,High Light Scatter Reticulocyte Percentage Of Red Cells,0.013322932038499354,4.713604826546003,20.35461131501662,TSPAN15;ZC3H4;KCNQ1;APOE,0.04196474099017961,GWAS_Catalog_2023,ZC3H4;APOE,TSPAN15;ZC3H4;KCNQ1,ZC3H4,2,3,1
407,Osteomyelitis,0.007868060585360347,16.17642276422764,78.37385720842586,HLA-DRB1;HLA-DQB1,0.04203524841148281,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
408,Precursor cell lymphoblastic lymphoma,0.007868060585360347,16.17642276422764,78.37385720842586,CDKN2B;IDUA,0.04203524841148281,DisGeNET,IDUA,CDKN2B,,1,1,0
406,Xerostomia,0.007868060585360347,16.17642276422764,78.37385720842586,TREM2;HLA-DRB1,0.04203524841148281,DisGeNET,TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
409,Dermatitis,0.007879201008385184,7.929144385026738,38.40503899102268,GRN;SHARPIN;HLA-DQA1,0.04203524841148281,DisGeNET,GRN;SHARPIN;HLA-DQA1,HLA-DQA1,HLA-DQA1,3,1,1
296,Multiple Sclerosis (OCB Status),0.014955374188168613,79.17063492063492,332.7292054829482,BTNL2,0.04206511602759132,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
270,1-stearoyl-2-linoleoyl-GPE (18:0/18:2) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
268,Liver Proton Density Fat Fraction,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
269,"Malignant Lymphoma (Non-Hodgkin Lymphoma, Multiple Myeloma, Or Hodgkin Lymphoma)",0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQB1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
271,Autoimmune Hepatitis Type-1,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
297,Beta-endorphin Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
273,Plasma Amyloid Beta Peptide Concentrations (ABx-40),0.014955374188168613,79.17063492063492,332.7292054829482,KCNQ1,0.04206511602759132,GWAS_Catalog_2023,,KCNQ1,,0,1,0
299,Endoplasmic Reticulum Resident Protein 29 Levels,0.014955374188168613,79.17063492063492,332.7292054829482,BTNL2,0.04206511602759132,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
298,F-fruit Liking (Derived Food-Liking Factor),0.014955374188168613,79.17063492063492,332.7292054829482,SNRPD2,0.04206511602759132,GWAS_Catalog_2023,SNRPD2,SNRPD2,SNRPD2,1,1,1
272,4-Hydroxyglutamate Levels In Elite Athletes,0.014955374188168613,79.17063492063492,332.7292054829482,APPL1,0.04206511602759132,GWAS_Catalog_2023,APPL1,,,1,0,0
295,Immunoglobulin A,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
294,Liver Liking,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
293,F-savour/caloric Food Liking (Derived Food-Liking Factor),0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
292,Cerebrospinal Fluid p-Tau181p:AB1-42 Ratio,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
291,Alkenylphosphatidylcholine (P-17:0/20:4) (B) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
289,Total Cholesteryl Ester Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
288,Alkyldiacylglycerol (O-50:1) [NL-16:0] Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
287,Asthma (Time To Onset),0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
286,Chronic Widespread Musculoskeletal Pain,0.014955374188168613,79.17063492063492,332.7292054829482,PLCG2,0.04206511602759132,GWAS_Catalog_2023,PLCG2,,,1,0,0
285,tRNA (guanine-N(7)-)-methyltransferase Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
290,Alkenylphosphatidylcholine (P-17:0/20:4) (A) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
277,Fasting Triglycerides Levels In Small LDL,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
279,Homoarginine Levels In Elite Athletes,0.014955374188168613,79.17063492063492,332.7292054829482,KCNQ1,0.04206511602759132,GWAS_Catalog_2023,,KCNQ1,,0,1,0
280,Lipoprotein(a) Levels Adjusted For Apolipoprotein(A) Isoforms,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
281,Ceramide Levels (C24:0),0.014955374188168613,79.17063492063492,332.7292054829482,PLCG2,0.04206511602759132,GWAS_Catalog_2023,PLCG2,,,1,0,0
284,Vigorous Physical Activity,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
282,Medication Use (Antihistamines For Systemic Use),0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
278,Response To Taxane Treatment (Placlitaxel),0.014955374188168613,79.17063492063492,332.7292054829482,TSPAN15,0.04206511602759132,GWAS_Catalog_2023,,TSPAN15,,0,1,0
276,Antineutrophil Cytoplasmic Antibody-Associated Vasculitis,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
275,Alcohol-associated Liver Disease In Heavy Drinkers,0.014955374188168613,79.17063492063492,332.7292054829482,JAZF1,0.04206511602759132,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
274,Fasting Linoleic Acid (18:2),0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
283,Pancreatic Beta-Cell Glucose Sensitivity,0.014955374188168613,79.17063492063492,332.7292054829482,GIPR,0.04206511602759132,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
98,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),0.005384826815772965,19.818815331010452,103.53686305193918,HLA-DRA;HLA-DRB1,0.04230935355250187,GO_Biological_Process_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
34,Late Endosome Membrane (GO:0031902),0.014398447391082573,11.68028210402586,49.53181191205112,HLA-DRA;HLA-DRB1,0.042348374679654625,GO_Cellular_Component_2023,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
410,Platelet Count measurement,0.00799307005063061,7.88656914893617,38.085664813269844,IGF2BP2;APOE;PICALM,0.042538728903599984,DisGeNET,APOE;PICALM,IGF2BP2,,2,1,0
411,Idiopathic hypogonadotropic hypogonadism,0.008115014693377984,15.910435825669731,76.593462825792,HESX1;IL17RD,0.04308263275170501,DisGeNET,HESX1;IL17RD,,,2,0,0
300,Late-onset Alzheimer's Disease,0.015376516399398747,11.271128757799206,47.055991472096665,APH1B;APOE,0.04310550097298115,GWAS_Catalog_2023,APH1B;APOE,,,2,0,0
99,Regulation Of Peptide Hormone Secretion (GO:0090276),0.005592617272449293,19.421463414634147,100.72568904417493,MTNR1B;GIPR,0.04349813434127228,GO_Biological_Process_2023,GIPR,MTNR1B;GIPR,GIPR,1,2,1
100,Negative Regulation Of Gene Expression (GO:0010629),0.005764877471718453,6.062712388013593,31.259171553577687,IGF2BP3;IGF2BP2;APOE;PICALM,0.04381486178740258,GO_Biological_Process_2023,APOE;PICALM,IGF2BP3;IGF2BP2,,2,2,0
101,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),0.005804046626383199,19.039693926351028,98.03919026153727,TREM2;APOE,0.04381486178740258,GO_Biological_Process_2023,TREM2;APOE,,,2,0,0
102,mRNA Stabilization (GO:0048255),0.005804046626383199,19.039693926351028,98.03919026153727,IGF2BP3;IGF2BP2,0.04381486178740258,GO_Biological_Process_2023,,IGF2BP3;IGF2BP2,,0,2,0
412,Hepatomegaly,0.008283418055481084,5.44451393231881,26.098275286715687,CDKN1C;IDUA;KCNQ1;APOE,0.04386994708024205,DisGeNET,IDUA;APOE,CDKN1C;KCNQ1,,2,2,0
413,Eclampsia,0.008340520412797967,7.76151832460733,37.15151385755788,CDKN1C;APOE;HLA-DRB1,0.04406541293153792,DisGeNET,APOE;HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,2,2,1
301,Mean Reticulocyte Volume,0.015857989292081355,4.466346153846154,18.508904029156497,GIPR;IDUA;IGF2BP2;APOE,0.04430753818817416,GWAS_Catalog_2023,GIPR;IDUA;APOE,GIPR;IGF2BP2,GIPR,3,2,1
40,Interleukin-12-mediated signaling events,0.00861930890913937,15.40379403794038,73.22579161456777,HLA-DRA;HLA-DRB1,0.04438944088206776,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
10,Cyclin-Dependent Protein Serine/Threonine Kinase Regulator Activity (GO:0016538),0.004401016444674392,22.07649667405765,119.78529941576386,CDKN2B;CCND2,0.04445026609121135,GO_Molecular_Function_2023,,CDKN2B;CCND2,,0,2,0
10,neoplasm of lung,0.029692279563515972,36.527472527472526,128.46230708138887,SLC22A18,0.04453841934527396,ClinVar_2019,,SLC22A18,,0,1,0
9,hypogonadotropic hypogonadism 7 with or without anosmia,0.029692279563515972,36.527472527472526,128.46230708138887,IL17RD,0.04453841934527396,ClinVar_2019,IL17RD,,,1,0,0
8,lung cancer,0.029692279563515972,36.527472527472526,128.46230708138887,SLC22A18,0.04453841934527396,ClinVar_2019,,SLC22A18,,0,1,0
7,age-related macular degeneration,0.027600267431624026,39.573412698412696,142.06577419675818,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
6,romano-ward syndrome,0.02340301917551725,47.49285714285714,178.33046577189359,KCNQ1,0.04453841934527396,ClinVar_2019,,KCNQ1,,0,1,0
4,hyperlipoproteinemia,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
3,atrial fibrillation,0.012832337737452553,95.00952380952381,413.84123997008294,KCNQ1,0.04453841934527396,ClinVar_2019,,KCNQ1,,0,1,0
5,alzheimer's disease,0.0212977650246516,52.77248677248677,203.12938317607103,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
414,Stomach Neoplasms,0.008481404590747303,3.741662048055293,17.84727600336238,CDKN2B;CCND2;PLCG2;IGF2BP3;APOE;HLA-DQB1,0.04470150921983241,DisGeNET,PLCG2;APOE;HLA-DQB1,CDKN2B;CCND2;IGF2BP3;HLA-DQB1,HLA-DQB1,3,4,1
103,Regulation Of Lipid Metabolic Process (GO:0019216),0.006019099019507137,18.672607879924954,95.46963998767033,PLCG2;TREM2,0.04499714800990773,GO_Biological_Process_2023,PLCG2;TREM2,,,2,0,0
415,Hyperinsulinism,0.008592737958684057,5.385027840791916,25.615704287927098,CDKN1C;KCNQ1;APOE;HLA-DRB1,0.04507056304290532,DisGeNET,APOE;HLA-DRB1,CDKN1C;KCNQ1;HLA-DRB1,HLA-DRB1,2,3,1
416,Drug-Induced Liver Disease,0.008592737958684057,5.385027840791916,25.615704287927098,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04507056304290532,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
417,Limitation of joint mobility,0.00861930890913937,15.40379403794038,73.22579161456777,IDUA;TREM2,0.04510151568283479,DisGeNET,IDUA;TREM2,,,2,0,0
419,Cervix carcinoma,0.008676958012418379,3.3397338595426027,15.853998074408102,CDKN2B;GRN;SHARPIN;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.04518644960166325,DisGeNET,GRN;SHARPIN;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,5,4
418,Hepatitis B,0.008673436953429745,3.7229161935044286,17.674507949234567,CDKN2B;CCND2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2,0.04518644960166325,DisGeNET,APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2,CDKN2B;CCND2;HLA-DQA2;HLA-DRB1;HLA-DQB2,HLA-DQA2;HLA-DRB1;HLA-DQB2,4,5,3
40,Sporotrichosis,0.012832337737452553,95.00952380952381,413.84123997008294,BTNL2,0.04523399052452025,Jensen_DISEASES,BTNL2,BTNL2,BTNL2,1,1,1
22,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.005180691162792406,20.232723577235774,106.48111760263689,IDUA;CHST15,0.045684276617351215,Reactome_2022,IDUA,CHST15,,1,1,0
41,T cell receptor signaling in naive CD4+ T cells,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRA;HLA-DRB1,0.04590960795228703,BioPlanet_2019,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
308,PH And SEC7 Domain-Containing Protein 1 Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
309,PEG-asparaginase Hypersensitivity Without Enzyme Activity In Childhood Acute Lymphoblastic Leukaemia,0.017073951550447674,67.85714285714286,276.1922295799092,HLA-DQA1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
310,Alkenylphosphatidylethanolamine (P-18:1/20:3) (A) Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
311,Alkenylphosphatidylcholine (P-18:0/20:4) Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
312,QT Interval (Drug Interaction),0.017073951550447674,67.85714285714286,276.1922295799092,CCND2,0.04602305530104646,GWAS_Catalog_2023,,CCND2,,0,1,0
305,Lamb Consumption,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
304,Infant Head Circumference (MTAG),0.017073951550447674,67.85714285714286,276.1922295799092,IGF2BP3,0.04602305530104646,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
307,Oral Cavity Cancer,0.017073951550447674,67.85714285714286,276.1922295799092,HLA-DQB1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
306,Cis-4-decenoylcarnitine (C10:1) Levels In Elite Athletes,0.017073951550447674,67.85714285714286,276.1922295799092,KCNQ1,0.04602305530104646,GWAS_Catalog_2023,,KCNQ1,,0,1,0
302,Cancer (Pleiotropy),0.017068397821674058,10.649155722326453,43.34767169794486,HLA-DQB1;JAZF1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,2,2
303,Relative Carbohydrate Intake,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
78,GTEX-RTLS-0008-SM-48FET skin female 60-69 years,0.002170536652638979,3.207087862318841,19.668366983453307,CDKN1C;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.04633260931594744,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,10,6
313,C-reactive Protein Levels,0.01729393173749476,4.347157190635452,17.638153870896787,TREM2;IGF2BP3;APOE;JAZF1,0.0464670817611281,GWAS_Catalog_2023,TREM2;APOE;JAZF1,IGF2BP3;JAZF1,JAZF1,3,2,1
314,Cigarettes Smoked Per Day (MTAG),0.017415911980779488,10.53287380699894,42.66204670923194,JADE2;APOE,0.04664580247081385,GWAS_Catalog_2023,APOE,JADE2,,1,1,0
79,GTEX-SE5C-0008-SM-4B64J skin female 40-49 years,0.002220494106154541,3.3755437587554376,20.62465856902267,CDKN1C;TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.046799021351231776,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,9,5
421,Skin blisters,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
422,Toxic Epidermal Necrolysis,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
423,Abnormal blistering of the skin,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
424,Idiopathic Inflammatory Myopathies,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQA1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,2,2
425,Joint swelling,0.009137349155552274,14.928330206378988,70.09425716368078,BTNL2;HLA-DRB1,0.046802102951678554,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
426,Arteriopathic disease,0.009137349155552274,14.928330206378988,70.09425716368078,CDKN2B;APOE,0.046802102951678554,DisGeNET,APOE,CDKN2B,,1,1,0
420,Gastric Adenocarcinoma,0.009070828253138711,5.298153034300792,24.915580305818118,IGF2BP3;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,IGF2BP3;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
80,GTEX-T6MO-0008-SM-4DM6T skin female 40-49 years,0.0022612687840256745,3.18880342430484,19.425645859057013,CDKN1C;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.047062656567534354,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,8,10,7
427,Chronic Lymphocytic Leukemia,0.00931208487055865,3.292103424178896,15.395331622973984,CDKN2B;CCND2;PLCG2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04749566200722322,DisGeNET,PLCG2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;CCND2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,3
428,"Hepatitis C, Chronic",0.009316289339638652,5.255739025372534,24.575787692946022,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04749566200722322,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
429,Skin bullae,0.009401485980373181,14.70140428677014,68.60980018036983,HLA-DRB1;HLA-DQB1,0.047698630751454724,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
430,Human papilloma virus infection,0.009401485980373181,14.70140428677014,68.60980018036983,CDKN2B;HLA-DRB1,0.047698630751454724,DisGeNET,HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,1,2,1
431,Glioblastoma Multiforme,0.009421681876203935,3.654194288628251,17.04587234362587,CDKN2B;GRN;SLC22A18;IGF2BP3;IGF2BP2;HLA-DRB1,0.047698630751454724,DisGeNET,GRN;HLA-DRB1,CDKN2B;SLC22A18;IGF2BP3;IGF2BP2;HLA-DRB1,HLA-DRB1,2,5,1
432,"Cardiomyopathy, Familial Idiopathic",0.00948232679497518,5.227831196581197,24.352939635811737,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.047894530246842225,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4,4,4
42,Psoriatic arthritis,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DRB1,0.04792517637572215,Jensen_DISEASES,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
43,Graves' disease,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DRB1,0.04792517637572215,Jensen_DISEASES,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
44,Panhypopituitarism,0.014955374188168613,79.17063492063492,332.7292054829482,HESX1,0.04792517637572215,Jensen_DISEASES,HESX1,,,1,0,0
41,Endometrial stromal nodule,0.014955374188168613,79.17063492063492,332.7292054829482,JAZF1,0.04792517637572215,Jensen_DISEASES,JAZF1,JAZF1,JAZF1,1,1,1
434,Papilloma,0.009562545887048374,7.371641791044776,34.277406608692765,CDKN2B;APOE;HLA-DRB1,0.04807713162566717,DisGeNET,APOE;HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,2,2,1
433,Osteogenesis Imperfecta,0.009562545887048374,7.371641791044776,34.277406608692765,CDKN1C;HESX1;TREM2,0.04807713162566717,DisGeNET,HESX1;TREM2,CDKN1C,,2,1,0
436,Cervical Intraepithelial Neoplasia,0.009690196471539413,7.334777227722772,34.00872572160105,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.04849543280022706,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
435,Kallmann Syndrome,0.009669013732444937,14.48125227520932,67.17605253596004,HESX1;IL17RD,0.04849543280022706,DisGeNET,HESX1;IL17RD,,,2,0,0
86,GTEX-QXCU-0008-SM-48FCH skin male 50-59 years,0.0025139869472756565,3.005652598920481,17.99149189165487,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,11,6
84,GTEX-RVPV-0008-SM-47JYW skin male 60-69 years,0.002501844132124292,2.8979583975346688,17.360878098600566,CDKN1C;ATP8B4;IDUA;TSPAN15;KCNQ1;PLCG2;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,ATP8B4;IDUA;PLCG2;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;KCNQ1;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,9,6
83,GTEX-QESD-0008-SM-447B2 skin male 20-29 years,0.0024701521708599843,3.5467914438502675,21.293075616937454,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,6,8,5
82,GTEX-U3ZM-0008-SM-4DXTQ skin male 40-49 years,0.002452110116414679,3.1527937054026505,18.95083243445242,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;CCND2;KCNQ1;CHST15;HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,10,5
81,GTEX-WL46-2826-SM-3LK81 brain male 50-59 years,0.0023838657083508456,3.1653132992327366,19.115427866504586,CDKN1C;GRN;SLC22A18;CHST15;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,GRN;PLCG2;HLA-DRA;PVRL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;SLC22A18;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,8,8,5
85,GTEX-XUJ4-0008-SM-4BOQI skin female 60-69 years,0.002513945793579073,3.31394084384515,19.836924233169185,TSPAN15;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.048671956595511254,GTEx_Tissue_Expression_Down,PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,TSPAN15;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,9,6
88,GTEX-WWYW-0526-SM-3NB2W muscle female 50-59 years,0.0025774405747873005,2.542220580994584,15.154071121104733,GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;JADE2;LRRC16A;NPAS1;EML2;APH1B;CCND2;SNRPD2;KCNQ1;SLC22A18;HESX1;PLCG2;PICALM;JAZF1,0.04876634723887336,GTEx_Tissue_Expression_Down,GRN;GIPR;IDUA;ZC3H4;QPCTL;TREM2;NPAS1;EML2;APH1B;SNRPD2;HESX1;PLCG2;PICALM;JAZF1,GIPR;ZC3H4;QPCTL;JADE2;LRRC16A;NPAS1;EML2;CCND2;SNRPD2;KCNQ1;SLC22A18;JAZF1,GIPR;ZC3H4;QPCTL;NPAS1;EML2;SNRPD2;JAZF1,14,12,7
87,GTEX-QVUS-0008-SM-447AY skin female 60-69 years,0.0025625887946327587,3.1332995438418654,18.69557520878387,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04876634723887336,GTEx_Tissue_Expression_Down,GIPR;PLCG2;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;TSPAN15;GIPR;KCNQ1;CHST15;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,10,6
35,Chylomicron (GO:0042627),0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.048782718715564784,GO_Cellular_Component_2023,APOE,,,1,0,0
319,Galactonate Levels In Elite Athletes,0.01918807882344009,59.37202380952381,234.72528267100722,KCNQ1,0.04890052815307005,GWAS_Catalog_2023,,KCNQ1,,0,1,0
316,Rheumatic Heart Disease,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
330,Posterior Urethral Valves,0.01918807882344009,59.37202380952381,234.72528267100722,ALPK2,0.04890052815307005,GWAS_Catalog_2023,ALPK2,,,1,0,0
329,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Carboplatin),0.01918807882344009,59.37202380952381,234.72528267100722,PLCG2,0.04890052815307005,GWAS_Catalog_2023,PLCG2,,,1,0,0
328,Personality Dimensions,0.01918807882344009,59.37202380952381,234.72528267100722,IGF2BP3,0.04890052815307005,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
327,Lewy Body Disease,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
315,Nasopharyngeal Carcinoma,0.01918807882344009,59.37202380952381,234.72528267100722,CDKN2B,0.04890052815307005,GWAS_Catalog_2023,,CDKN2B,,0,1,0
325,Diacylglycerol (18:1 20:4) Levels,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
326,Hip Circumference Variance,0.01918807882344009,59.37202380952381,234.72528267100722,GIPR,0.04890052815307005,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
323,GIP Levels In Response To Oral Glucose Tolerance Test (120 Minutes),0.01918807882344009,59.37202380952381,234.72528267100722,GIPR,0.04890052815307005,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
322,Acute Anterior Uveitis (With Or Without Ankylosing Spondylitis),0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQA2,0.04890052815307005,GWAS_Catalog_2023,HLA-DQA2,HLA-DQA2,HLA-DQA2,1,1,1
321,Infant Length,0.01918807882344009,59.37202380952381,234.72528267100722,IGF2BP3,0.04890052815307005,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
320,Bullous Pemphigoid,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
318,Parkinson's Disease (Age Of Onset),0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
317,Serum IgE Levels,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DRB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
324,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
89,GTEX-TSE9-0526-SM-3DB7Z muscle female 60-69 years,0.0026165170766042885,2.7931386228001265,16.607754236288,IDUA;QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;APH1B;CCND2;SNRPD2;SLC22A18;HLA-DRA;APOE;PICALM,0.04894944868029371,GTEx_Tissue_Expression_Down,IDUA;QPCTL;NPAS1;EML2;APH1B;SNRPD2;HLA-DRA;APOE;PICALM,QPCTL;JADE2;LRRC16A;NPAS1;EML2;TOX2;CCND2;SNRPD2;SLC22A18;HLA-DRA,QPCTL;NPAS1;EML2;SNRPD2;HLA-DRA,9,10,5
104,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.006617338192362546,4.625524408848207,23.211168615975406,CDKN1C;APOE;HLA-DRB1;PICALM;NEUROG3,0.0489937539242227,GO_Biological_Process_2023,APOE;HLA-DRB1;PICALM,CDKN1C;HLA-DRB1;NEUROG3,HLA-DRB1,3,3,1
105,Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),0.006690261186365941,8.42940340909091,42.2068857392452,TREM2;APOE;HLA-DRB1,0.04906191536668357,GO_Biological_Process_2023,TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,3,1,1
437,"Glaucoma, Open-Angle",0.009939917315218262,14.267575322812052,65.79059448688477,CDKN2B;APOE,0.04963134915745137,DisGeNET,APOE,CDKN2B,,1,1,0
438,Ischemic stroke,0.00999204001426169,5.145825115055884,23.701498102715213,CDKN2B;KCNQ1;TREM2;APOE,0.049777697057349336,DisGeNET,TREM2;APOE,CDKN2B;KCNQ1,,2,2,0
